Breast Invasive Carcinoma: PARADIGM pathway analysis of mRNA expression and copy number data
Maintained by TCGA GDAC Team (Broad Institute/Dana-Farber Cancer Institute/Harvard Medical School)
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 50 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
Signaling events regulated by Ret tyrosine kinase 96
Signaling events mediated by Stem cell factor receptor (c-Kit) 93
Endothelins 77
IGF1 pathway 73
Osteopontin-mediated events 70
FOXM1 transcription factor network 70
IL4-mediated signaling events 69
Plasma membrane estrogen receptor signaling 66
EGFR-dependent Endothelin signaling events 64
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 63
Results

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway.

Pathway.Name Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
Signaling events regulated by Ret tyrosine kinase 96 7934 82 -0.16 0.036 1000 -1000 -0.038 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 93 7276 78 -0.31 0.13 1000 -1000 -0.023 -1000
Endothelins 77 7431 96 -0.18 0.035 1000 -1000 -0.027 -1000
IGF1 pathway 73 4169 57 -0.079 0.052 1000 -1000 -0.024 -1000
Osteopontin-mediated events 70 2670 38 -0.14 0.04 1000 -1000 -0.015 -1000
FOXM1 transcription factor network 70 3588 51 -0.44 0.034 1000 -1000 -0.055 -1000
IL4-mediated signaling events 69 6346 91 -0.53 0.43 1000 -1000 -0.05 -1000
Plasma membrane estrogen receptor signaling 66 5722 86 -0.22 0.21 1000 -1000 -0.036 -1000
EGFR-dependent Endothelin signaling events 64 1361 21 -0.072 0.048 1000 -1000 -0.003 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 63 4295 68 -0.35 0.15 1000 -1000 -0.039 -1000
Syndecan-1-mediated signaling events 57 1956 34 -0.13 0.042 1000 -1000 -0.026 -1000
Glucocorticoid receptor regulatory network 57 6608 114 -0.39 0.19 1000 -1000 -0.039 -1000
HIF-1-alpha transcription factor network 56 4289 76 -0.18 0.05 1000 -1000 -0.016 -1000
Signaling events mediated by the Hedgehog family 53 2797 52 -0.096 0.052 1000 -1000 -0.016 -1000
Thromboxane A2 receptor signaling 49 5164 105 -0.11 0.062 1000 -1000 -0.029 -1000
Fc-epsilon receptor I signaling in mast cells 49 4827 97 -0.098 0.036 1000 -1000 -0.046 -1000
Wnt signaling 49 344 7 -0.067 0.03 1000 -1000 -0.002 -1000
IL12-mediated signaling events 47 4122 87 -0.26 0.043 1000 -1000 -0.031 -1000
FAS signaling pathway (CD95) 47 2211 47 -0.1 0.049 1000 -1000 -0.025 -1000
Stabilization and expansion of the E-cadherin adherens junction 46 3458 74 -0.095 0.059 1000 -1000 -0.045 -1000
IL23-mediated signaling events 46 2766 60 -0.2 0.036 1000 -1000 -0.045 -1000
Noncanonical Wnt signaling pathway 45 1171 26 -0.067 0.036 1000 -1000 -0.048 -1000
TCR signaling in naïve CD8+ T cells 45 4220 93 -0.072 0.048 1000 -1000 -0.032 -1000
IL27-mediated signaling events 44 2248 51 -0.2 0.099 1000 -1000 -0.048 -1000
Nongenotropic Androgen signaling 43 2271 52 -0.12 0.063 1000 -1000 -0.019 -1000
IL6-mediated signaling events 42 3154 75 -0.14 0.038 1000 -1000 -0.032 -1000
LPA receptor mediated events 40 4086 102 -0.077 0.036 1000 -1000 -0.057 -1000
Signaling mediated by p38-gamma and p38-delta 39 590 15 -0.056 0.033 1000 -1000 -0.026 -1000
Syndecan-4-mediated signaling events 39 2670 67 -0.061 0.087 1000 -1000 -0.029 -1000
E-cadherin signaling in keratinocytes 39 1714 43 -0.062 0.036 1000 -1000 -0.021 -1000
Ephrin B reverse signaling 36 1731 48 -0.12 0.073 1000 -1000 -0.037 -1000
Arf6 signaling events 35 2217 62 -0.069 0.079 1000 -1000 -0.01 -1000
E-cadherin signaling in the nascent adherens junction 35 2712 76 -0.082 0.056 1000 -1000 -0.045 -1000
IL2 signaling events mediated by PI3K 34 2013 58 -0.23 0.036 1000 -1000 -0.035 -1000
E-cadherin signaling events 34 173 5 -0.011 0.028 1000 -1000 0.021 -1000
ErbB4 signaling events 33 2318 69 -0.1 0.059 1000 -1000 -0.023 -1000
TCGA08_p53 33 234 7 -0.028 0.026 1000 -1000 -0.009 -1000
Canonical Wnt signaling pathway 33 1695 51 -0.15 0.09 1000 -1000 -0.034 -1000
Coregulation of Androgen receptor activity 31 2360 76 -0.15 0.054 1000 -1000 -0.034 -1000
PLK2 and PLK4 events 31 93 3 -0.013 0.03 1000 -1000 0.002 -1000
Syndecan-2-mediated signaling events 31 2158 69 -0.019 0.048 1000 -1000 -0.031 -1000
Signaling events mediated by PTP1B 31 2423 76 -0.091 0.062 1000 -1000 -0.024 -1000
Integrins in angiogenesis 30 2577 84 -0.12 0.06 1000 -1000 -0.019 -1000
Cellular roles of Anthrax toxin 29 1133 39 -0.074 0.035 1000 -1000 -0.018 -1000
amb2 Integrin signaling 29 2401 82 -0.049 0.047 1000 -1000 -0.016 -1000
Reelin signaling pathway 28 1575 56 -0.068 0.07 1000 -1000 -0.016 -1000
TCGA08_retinoblastoma 28 231 8 -0.011 0.024 1000 -1000 -0.01 -1000
Caspase cascade in apoptosis 27 2058 74 -0.066 0.047 1000 -1000 -0.025 -1000
Regulation of nuclear SMAD2/3 signaling 27 3797 136 -0.19 0.067 1000 -1000 -0.036 -1000
Visual signal transduction: Rods 27 1405 52 -0.064 0.067 1000 -1000 -0.017 -1000
BMP receptor signaling 26 2184 81 -0.11 0.067 1000 -1000 -0.02 -1000
Nectin adhesion pathway 26 1663 63 -0.047 0.054 1000 -1000 -0.031 -1000
mTOR signaling pathway 25 1371 53 -0.068 0.045 1000 -1000 -0.022 -1000
BCR signaling pathway 25 2521 99 -0.1 0.065 1000 -1000 -0.04 -1000
Aurora B signaling 25 1706 67 -0.062 0.053 1000 -1000 -0.03 -1000
IL1-mediated signaling events 24 1530 62 -0.028 0.075 1000 -1000 -0.024 -1000
PDGFR-alpha signaling pathway 23 1054 44 -0.14 0.05 1000 -1000 -0.024 -1000
IFN-gamma pathway 23 1602 68 -0.061 0.059 1000 -1000 -0.035 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 23 1038 45 -0.041 0.055 1000 -1000 -0.022 -1000
Arf6 downstream pathway 22 961 43 -0.047 0.048 1000 -1000 -0.029 -1000
Ceramide signaling pathway 22 1680 76 -0.069 0.069 1000 -1000 -0.019 -1000
Visual signal transduction: Cones 21 816 38 -0.023 0.051 1000 -1000 0 -1000
Presenilin action in Notch and Wnt signaling 21 1303 61 -0.2 0.071 1000 -1000 -0.033 -1000
Glypican 1 network 21 1041 48 -0.025 0.049 1000 -1000 -0.021 -1000
PLK1 signaling events 21 1837 85 -0.074 0.052 1000 -1000 -0.032 -1000
S1P1 pathway 21 775 36 -0.034 0.036 1000 -1000 -0.019 -1000
Insulin Pathway 21 1580 74 -0.063 0.081 1000 -1000 -0.021 -1000
FOXA2 and FOXA3 transcription factor networks 20 958 46 -0.2 0.043 1000 -1000 -0.055 -1000
TRAIL signaling pathway 20 983 48 -0.022 0.037 1000 -1000 -0.02 -1000
ceramide signaling pathway 20 991 49 -0.057 0.049 1000 -1000 -0.019 -1000
Calcium signaling in the CD4+ TCR pathway 20 644 31 -0.035 0.045 1000 -1000 -0.036 -1000
Class I PI3K signaling events 20 1499 73 -0.061 0.045 1000 -1000 -0.024 -1000
VEGFR1 specific signals 20 1175 56 -0.028 0.036 1000 -1000 -0.034 -1000
EPHB forward signaling 19 1699 85 -0.047 0.11 1000 -1000 -0.043 -1000
PDGFR-beta signaling pathway 19 1917 97 -0.065 0.067 1000 -1000 -0.028 -1000
ErbB2/ErbB3 signaling events 18 1198 65 -0.045 0.048 1000 -1000 -0.079 -1000
RXR and RAR heterodimerization with other nuclear receptor 18 949 52 -0.057 0.063 1000 -1000 -0.02 -1000
Ras signaling in the CD4+ TCR pathway 18 306 17 -0.002 0.05 1000 -1000 -0.014 -1000
EPO signaling pathway 17 970 55 -0.11 0.046 1000 -1000 -0.02 -1000
Syndecan-3-mediated signaling events 17 607 35 -0.031 0.069 1000 -1000 -0.022 -1000
Regulation of Telomerase 17 1754 102 -0.15 0.063 1000 -1000 -0.044 -1000
Aurora A signaling 16 979 60 -0.007 0.05 1000 -1000 -0.008 -1000
p75(NTR)-mediated signaling 16 2022 125 -0.045 0.086 1000 -1000 -0.039 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 15 824 54 -0.035 0.05 1000 -1000 -0.021 -1000
HIF-2-alpha transcription factor network 15 660 43 -0.1 0.11 1000 -1000 -0.034 -1000
S1P3 pathway 15 636 42 -0.016 0.044 1000 -1000 -0.011 -1000
S1P4 pathway 15 399 25 -0.009 0.044 1000 -1000 -0.008 -1000
LPA4-mediated signaling events 14 176 12 -0.029 0.021 1000 -1000 -0.018 -1000
Hedgehog signaling events mediated by Gli proteins 14 954 65 -0.022 0.076 1000 -1000 -0.032 -1000
Atypical NF-kappaB pathway 14 453 31 -0.017 0.036 1000 -1000 -0.009 -1000
Signaling events mediated by VEGFR1 and VEGFR2 14 1753 125 -0.025 0.045 1000 -1000 -0.016 -1000
Regulation of Androgen receptor activity 14 1036 70 -0.14 0.048 1000 -1000 -0.033 -1000
Sphingosine 1-phosphate (S1P) pathway 13 383 28 -0.009 0.044 1000 -1000 -0.002 -1000
S1P5 pathway 13 236 17 -0.001 0.035 1000 -1000 -0.012 -1000
Retinoic acid receptors-mediated signaling 13 786 58 -0.071 0.068 1000 -1000 -0.026 -1000
Signaling mediated by p38-alpha and p38-beta 13 576 44 -0.055 0.056 1000 -1000 -0.012 -1000
Regulation of p38-alpha and p38-beta 13 711 54 -0.018 0.073 1000 -1000 -0.02 -1000
Glypican 2 network 13 54 4 0 0.014 1000 -1000 0 -1000
IL2 signaling events mediated by STAT5 13 291 22 -0.024 0.037 1000 -1000 -0.022 -1000
Neurotrophic factor-mediated Trk receptor signaling 13 1602 120 -0.077 0.09 1000 -1000 -0.037 -1000
p38 MAPK signaling pathway 13 584 44 -0.051 0.058 1000 -1000 -0.013 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 12 1102 85 -0.14 0.064 1000 -1000 -0.031 -1000
FoxO family signaling 12 807 64 -0.092 0.049 1000 -1000 -0.023 -1000
Nephrin/Neph1 signaling in the kidney podocyte 11 374 34 -0.039 0.076 1000 -1000 -0.033 -1000
Paxillin-independent events mediated by a4b1 and a4b7 11 413 37 -0.024 0.073 1000 -1000 -0.02 -1000
TCGA08_rtk_signaling 11 292 26 -0.026 0.043 1000 -1000 -0.011 -1000
Angiopoietin receptor Tie2-mediated signaling 11 1054 88 -0.063 0.063 1000 -1000 -0.051 -1000
BARD1 signaling events 10 582 57 -0.048 0.07 1000 -1000 -0.043 -1000
Signaling events mediated by HDAC Class III 10 411 40 -0.064 0.065 1000 -1000 -0.041 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 10 844 83 -0.057 0.069 1000 -1000 -0.01 -1000
Paxillin-dependent events mediated by a4b1 10 379 36 -0.061 0.064 1000 -1000 -0.038 -1000
Effects of Botulinum toxin 10 273 26 -0.062 0.051 1000 -1000 -0.001 -1000
Signaling events mediated by PRL 10 357 34 -0.038 0.051 1000 -1000 -0.027 -1000
Signaling events mediated by HDAC Class II 9 691 75 -0.089 0.076 1000 -1000 -0.026 -1000
a4b1 and a4b7 Integrin signaling 9 49 5 0.021 0.042 1000 -1000 0.024 -1000
Class IB PI3K non-lipid kinase events 9 27 3 -0.026 0.026 1000 -1000 -0.025 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 8 279 33 -0.015 0.072 1000 -1000 -0.025 -1000
JNK signaling in the CD4+ TCR pathway 7 122 17 -0.01 0.08 1000 -1000 -0.017 -1000
Class I PI3K signaling events mediated by Akt 7 529 68 -0.053 0.076 1000 -1000 -0.019 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 6 139 23 0 0.055 1000 -1000 -0.011 -1000
Ephrin A reverse signaling 6 44 7 0 0.042 1000 -1000 0 -1000
Insulin-mediated glucose transport 6 211 32 0 0.042 1000 -1000 -0.008 -1000
Canonical NF-kappaB pathway 5 195 39 0 0.074 1000 -1000 -0.01 -1000
Arf6 trafficking events 5 406 71 -0.041 0.043 1000 -1000 -0.026 -1000
Alternative NF-kappaB pathway 5 77 13 0 0.082 1000 -1000 0 -1000
Circadian rhythm pathway 4 101 22 -0.01 0.067 1000 -1000 -0.035 -1000
Aurora C signaling 3 22 7 0 0.054 1000 -1000 -0.006 -1000
Signaling events mediated by HDAC Class I 3 365 104 -0.047 0.081 1000 -1000 -0.029 -1000
Arf1 pathway 3 196 54 -0.001 0.062 1000 -1000 -0.011 -1000
Rapid glucocorticoid signaling 2 55 20 -0.001 0.044 1000 -1000 0 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0 18 27 0 0.081 1000 -1000 -0.021 -1000
Total 3452 212603 7203 -11 8 131000 -131000 -3.2 -131000
Signaling events regulated by Ret tyrosine kinase

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.038 0.13 -10000 0 -0.52 30 30
Crk/p130 Cas/Paxillin -0.13 0.16 -10000 0 -0.33 166 166
JUN -0.13 0.18 0.19 2 -0.4 113 115
HRAS 0.032 0.036 -10000 0 -0.42 3 3
RET51/GFRalpha1/GDNF/GRB10 -0.1 0.2 -10000 0 -0.31 228 228
RAP1A 0.031 0.045 -10000 0 -0.42 5 5
FRS2 0.033 0.022 -10000 0 -0.42 1 1
RAP1A/GDP 0.023 0.032 -10000 0 -0.3 5 5
RET51/GFRalpha1/GDNF/DOK1 -0.097 0.21 -10000 0 -0.32 220 220
EntrezGene:5979 0 0 -10000 0 -10000 0 0
PTPN11 0.036 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.032 0.023 -10000 0 -0.42 1 1
RET9/GFRalpha1/GDNF/Enigma -0.041 0.14 -10000 0 -0.23 171 171
RHOA 0.026 0.061 -10000 0 -0.42 9 9
RAP1A/GTP -0.093 0.18 -10000 0 -0.28 221 221
GRB7 0.024 0.058 -10000 0 -0.42 8 8
RET51/GFRalpha1/GDNF -0.092 0.2 -10000 0 -0.31 217 217
MAPKKK cascade -0.11 0.19 -10000 0 -0.32 203 203
BCAR1 0.03 0.014 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/IRS1 -0.064 0.17 -10000 0 -0.28 181 181
lamellipodium assembly -0.11 0.16 -10000 0 -0.3 173 173
RET51/GFRalpha1/GDNF/SHC -0.08 0.18 -10000 0 -0.29 195 195
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
RET9/GFRalpha1/GDNF/SHC -0.028 0.12 -10000 0 -0.23 123 123
RET9/GFRalpha1/GDNF/Shank3 -0.042 0.14 -10000 0 -0.23 174 174
MAPK3 -0.11 0.15 0.24 3 -0.38 90 93
DOK1 0.027 0.061 -10000 0 -0.42 9 9
DOK6 0.005 0.11 -10000 0 -0.42 31 31
PXN 0.036 0.004 -10000 0 -10000 0 0
neurite development -0.11 0.16 0.28 2 -0.37 102 104
DOK5 0.012 0.089 -10000 0 -0.42 20 20
GFRA1 -0.13 0.21 -10000 0 -0.42 177 177
MAPK8 -0.12 0.18 -10000 0 -0.3 218 218
HRAS/GTP -0.11 0.22 -10000 0 -0.35 217 217
tube development -0.03 0.14 0.22 24 -0.22 163 187
MAPK1 -0.12 0.16 0.24 3 -0.38 90 93
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.053 0.12 -10000 0 -0.22 157 157
Rac1/GDP 0.026 0.004 -10000 0 -10000 0 0
SRC 0.033 0.029 -10000 0 -0.42 2 2
PDLIM7 0.035 0.007 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok6 -0.093 0.21 -10000 0 -0.32 220 220
SHC1 0.028 0.025 -10000 0 -0.42 1 1
RET51/GFRalpha1/GDNF/Dok4 -0.1 0.2 -10000 0 -0.31 220 220
RET51/GFRalpha1/GDNF/Dok5 -0.1 0.2 -10000 0 -0.32 213 213
PRKCA 0.032 0.012 -10000 0 -10000 0 0
HRAS/GDP 0.024 0.025 -10000 0 -0.3 3 3
CREB1 -0.086 0.17 -10000 0 -0.33 147 147
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.039 0.11 -10000 0 -0.23 115 115
RET51/GFRalpha1/GDNF/Grb7 -0.095 0.2 -10000 0 -0.32 211 211
mol:GDP 0 0 -10000 0 -10000 0 0
RET -0.095 0.2 -10000 0 -0.42 137 137
DOK4 0.028 0.032 -10000 0 -0.42 2 2
JNK cascade -0.13 0.17 0.19 2 -0.4 113 115
RET9/GFRalpha1/GDNF/FRS2 -0.042 0.14 -10000 0 -0.23 169 169
SHANK3 0.035 0.029 -10000 0 -0.42 2 2
RASA1 0.029 0.05 -10000 0 -0.42 6 6
NCK1 0.034 0.021 -10000 0 -0.42 1 1
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.036 0.1 -10000 0 -0.22 114 114
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.1 0.18 -10000 0 -0.3 205 205
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK -0.12 0.19 -10000 0 -0.31 220 220
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.11 0.19 -10000 0 -0.34 181 181
PI3K -0.16 0.25 0.24 1 -0.46 173 174
SOS1 0.035 0.021 -10000 0 -0.42 1 1
RET9/GFRalpha1/GDNF/Shank3/Grb2 -0.028 0.14 -10000 0 -0.22 163 163
GRB10 0.023 0.075 -10000 0 -0.42 14 14
activation of MAPKK activity -0.081 0.15 -10000 0 -0.33 93 93
RET51/GFRalpha1/GDNF/FRS2 -0.095 0.2 -10000 0 -0.31 216 216
GAB1 0.027 0.061 -10000 0 -0.42 9 9
IRS1 -0.014 0.14 -10000 0 -0.42 54 54
IRS2 0.008 0.099 -10000 0 -0.42 25 25
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.12 0.2 -10000 0 -0.35 186 186
RET51/GFRalpha1/GDNF/PKC alpha -0.089 0.2 -10000 0 -0.32 200 200
GRB2 0.033 0.011 -10000 0 -10000 0 0
PRKACA 0.036 0.005 -10000 0 -10000 0 0
GDNF 0.032 0.036 -10000 0 -0.42 3 3
RAC1 0.035 0.006 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 -0.12 0.23 -10000 0 -0.35 226 226
Rac1/GTP -0.12 0.2 -10000 0 -0.36 170 170
RET9/GFRalpha1/GDNF -0.06 0.14 -10000 0 -0.25 172 172
GFRalpha1/GDNF -0.074 0.16 -10000 0 -0.3 172 172
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.12 0.19 0.38 1 -0.41 134 135
CRKL -0.13 0.2 -10000 0 -0.42 139 139
HRAS -0.077 0.17 -10000 0 -0.36 97 97
mol:PIP3 -0.088 0.2 0.28 2 -0.41 105 107
SPRED1 0.02 0.08 -10000 0 -0.42 16 16
SPRED2 0.02 0.082 -10000 0 -0.42 17 17
GAB1 -0.14 0.21 -10000 0 -0.44 138 138
FOXO3 -0.1 0.2 -10000 0 -0.4 126 126
AKT1 -0.11 0.22 -10000 0 -0.43 124 124
BAD -0.1 0.2 -10000 0 -0.4 118 118
megakaryocyte differentiation -0.13 0.21 -10000 0 -0.44 135 135
GSK3B -0.1 0.2 0.34 1 -0.4 123 124
RAF1 -0.056 0.15 0.26 4 -0.3 87 91
SHC1 0.028 0.025 -10000 0 -0.42 1 1
STAT3 -0.12 0.2 -10000 0 -0.43 133 133
STAT1 -0.31 0.48 -10000 0 -0.88 185 185
HRAS/SPRED1 -0.054 0.16 0.26 1 -0.32 94 95
cell proliferation -0.13 0.21 -10000 0 -0.43 136 136
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
TEC 0.031 0.045 -10000 0 -0.42 5 5
RPS6KB1 -0.13 0.22 -10000 0 -0.45 135 135
HRAS/SPRED2 -0.053 0.16 0.26 1 -0.31 95 96
LYN/TEC/p62DOK -0.092 0.22 -10000 0 -0.42 124 124
MAPK3 -0.034 0.12 0.25 7 -0.25 37 44
STAP1 -0.13 0.21 -10000 0 -0.44 135 135
GRAP2 0.032 0.023 -10000 0 -0.42 1 1
JAK2 -0.26 0.41 -10000 0 -0.73 192 192
STAT1 (dimer) -0.3 0.46 -10000 0 -0.86 185 185
mol:Gleevec 0.005 0.008 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.099 0.22 -10000 0 -0.42 127 127
actin filament polymerization -0.13 0.21 -10000 0 -0.43 135 135
LYN 0.03 0.014 -10000 0 -10000 0 0
STAP1/STAT5A (dimer) -0.19 0.3 -10000 0 -0.54 187 187
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
CBL/CRKL/GRB2 -0.1 0.2 -10000 0 -0.39 129 129
PI3K -0.1 0.23 -10000 0 -0.45 126 126
PTEN 0.027 0.061 -10000 0 -0.42 9 9
SCF/KIT/EPO/EPOR -0.3 0.53 -10000 0 -1.1 128 128
MAPK8 -0.13 0.21 -10000 0 -0.44 136 136
STAT3 (dimer) -0.12 0.2 -10000 0 -0.42 133 133
positive regulation of transcription -0.025 0.1 0.23 8 -0.21 32 40
mol:GDP -0.083 0.17 -10000 0 -0.37 96 96
PIK3C2B -0.12 0.2 -10000 0 -0.41 129 129
CBL/CRKL -0.12 0.2 -10000 0 -0.41 135 135
FER -0.13 0.21 -10000 0 -0.44 134 134
SH2B3 -0.13 0.21 -10000 0 -0.44 135 135
PDPK1 -0.07 0.19 0.31 12 -0.38 96 108
SNAI2 -0.14 0.22 -10000 0 -0.46 137 137
positive regulation of cell proliferation -0.22 0.36 -10000 0 -0.68 167 167
KITLG -0.051 0.16 -10000 0 -0.44 72 72
cell motility -0.22 0.36 -10000 0 -0.68 167 167
PTPN6 0.038 0.032 -10000 0 -0.41 2 2
EPOR -0.068 0.18 -10000 0 -0.75 10 10
STAT5A (dimer) -0.19 0.3 -10000 0 -0.55 184 184
SOCS1 0.032 0.023 -10000 0 -0.42 1 1
cell migration 0.13 0.21 0.44 135 -10000 0 135
SOS1 0.035 0.021 -10000 0 -0.42 1 1
EPO 0.012 0.029 -10000 0 -10000 0 0
VAV1 0.019 0.082 -10000 0 -0.42 17 17
GRB10 -0.14 0.21 -10000 0 -0.45 136 136
PTPN11 0.041 0.009 -10000 0 -10000 0 0
SCF/KIT -0.14 0.22 -10000 0 -0.46 135 135
GO:0007205 0.007 0.011 -10000 0 -10000 0 0
MAP2K1 -0.042 0.13 0.24 6 -0.25 73 79
CBL 0.032 0.012 -10000 0 -10000 0 0
KIT -0.27 0.53 -10000 0 -1.3 102 102
MAP2K2 -0.043 0.13 0.27 7 -0.25 75 82
SHC/Grb2/SOS1 -0.08 0.2 -10000 0 -0.41 99 99
STAT5A -0.2 0.32 -10000 0 -0.57 184 184
GRB2 0.033 0.011 -10000 0 -10000 0 0
response to radiation -0.14 0.22 -10000 0 -0.45 138 138
SHC/GRAP2 0.038 0.032 -10000 0 -0.3 2 2
PTPRO -0.14 0.21 -10000 0 -0.45 134 134
SH2B2 -0.13 0.21 -10000 0 -0.44 135 135
DOK1 0.027 0.061 -10000 0 -0.42 9 9
MATK -0.13 0.21 -10000 0 -0.44 135 135
CREBBP -0.008 0.08 -10000 0 -0.12 161 161
BCL2 -0.3 0.56 -10000 0 -1.3 114 114
Endothelins

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.011 0.19 0.27 72 -0.33 93 165
PTK2B 0.028 0.015 -10000 0 -10000 0 0
mol:Ca2+ -0.056 0.26 -10000 0 -0.65 55 55
EDN1 -0.01 0.19 0.23 65 -0.43 65 130
EDN3 -0.011 0.12 -10000 0 -0.42 38 38
EDN2 -0.054 0.18 -10000 0 -0.42 93 93
HRAS/GDP -0.065 0.23 0.28 4 -0.45 101 105
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.059 0.2 -10000 0 -0.4 101 101
ADCY4 -0.011 0.17 0.26 8 -0.42 40 48
ADCY5 -0.015 0.16 0.23 4 -0.39 44 48
ADCY6 -0.01 0.16 0.26 6 -0.39 44 50
ADCY7 -0.013 0.16 0.27 4 -0.38 42 46
ADCY1 -0.009 0.16 0.25 7 -0.38 43 50
ADCY2 -0.026 0.17 0.26 5 -0.39 61 66
ADCY3 -0.01 0.16 0.26 9 -0.38 47 56
ADCY8 -0.006 0.14 0.26 4 -0.36 38 42
ADCY9 -0.013 0.16 0.24 8 -0.38 44 52
arachidonic acid secretion -0.089 0.26 0.28 1 -0.5 114 115
ETB receptor/Endothelin-1/Gq/GTP -0.05 0.16 -10000 0 -0.32 106 106
GNAO1 0.03 0.014 -10000 0 -10000 0 0
HRAS 0.032 0.036 -10000 0 -0.42 3 3
ETA receptor/Endothelin-1/G12/GTP 0.03 0.21 0.37 72 -0.31 87 159
ETA receptor/Endothelin-1/Gs/GTP 0.025 0.2 0.35 71 -0.32 75 146
mol:GTP -0.001 0.006 -10000 0 -10000 0 0
COL3A1 -0.016 0.21 0.27 73 -0.42 71 144
EDNRB 0.003 0.097 -10000 0 -0.37 25 25
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.008 0.2 0.27 68 -0.5 39 107
CYSLTR1 -0.025 0.23 0.27 70 -0.55 53 123
SLC9A1 -0.004 0.13 0.19 72 -0.3 40 112
mol:GDP -0.081 0.24 0.26 6 -0.47 107 113
SLC9A3 -0.12 0.35 -10000 0 -0.7 109 109
RAF1 -0.094 0.24 -10000 0 -0.48 114 114
JUN -0.098 0.36 -10000 0 -0.94 63 63
JAK2 -0.008 0.19 0.27 73 -0.33 89 162
mol:IP3 -0.074 0.21 0.23 1 -0.42 104 105
ETA receptor/Endothelin-1 0.014 0.25 0.42 72 -0.38 101 173
PLCB1 -0.023 0.14 -10000 0 -0.42 59 59
PLCB2 0.032 0.023 -10000 0 -0.43 1 1
ETA receptor/Endothelin-3 0 0.15 -10000 0 -0.32 72 72
FOS -0.14 0.36 -10000 0 -0.87 87 87
Gai/GDP -0.11 0.32 -10000 0 -0.72 101 101
CRK 0.032 0.023 -10000 0 -0.42 1 1
mol:Ca ++ -0.089 0.27 0.25 9 -0.5 112 121
BCAR1 0.03 0.014 -10000 0 -10000 0 0
PRKCB1 -0.077 0.22 0.26 12 -0.44 104 116
GNAQ -0.001 0.007 -10000 0 -10000 0 0
GNAZ 0.023 0.07 -10000 0 -0.42 12 12
GNAL 0.031 0.036 -10000 0 -0.42 3 3
Gs family/GDP -0.064 0.22 0.26 4 -0.44 101 105
ETA receptor/Endothelin-1/Gq/GTP -0.041 0.2 0.2 44 -0.4 85 129
MAPK14 -0.068 0.17 0.23 1 -0.35 98 99
TRPC6 -0.061 0.28 -10000 0 -0.7 54 54
GNAI2 0.028 0.054 -10000 0 -0.42 7 7
GNAI3 0.035 0.006 -10000 0 -10000 0 0
GNAI1 0.017 0.087 -10000 0 -0.42 19 19
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.067 0.18 -10000 0 -0.35 109 109
ETB receptor/Endothelin-2 -0.04 0.15 -10000 0 -0.31 111 111
ETB receptor/Endothelin-3 -0.009 0.11 -10000 0 -0.3 57 57
ETB receptor/Endothelin-1 -0.012 0.17 -10000 0 -0.31 99 99
MAPK3 -0.14 0.34 -10000 0 -0.76 98 98
MAPK1 -0.14 0.34 -10000 0 -0.78 96 96
Rac1/GDP -0.062 0.23 0.27 6 -0.45 100 106
cAMP biosynthetic process -0.004 0.17 0.28 14 -0.4 43 57
MAPK8 -0.072 0.3 -10000 0 -0.67 75 75
SRC 0.033 0.03 -10000 0 -0.42 2 2
ETB receptor/Endothelin-1/Gi/GTP -0.043 0.15 -10000 0 -0.33 86 86
p130Cas/CRK/Src/PYK2 -0.1 0.26 -10000 0 -0.55 100 100
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.062 0.23 0.28 5 -0.46 97 102
COL1A2 -0.074 0.3 0.28 52 -0.54 117 169
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.031 0.18 -10000 0 -0.32 122 122
mol:DAG -0.074 0.21 0.23 1 -0.42 103 104
MAP2K2 -0.11 0.28 0.33 1 -0.58 108 109
MAP2K1 -0.11 0.28 0.3 2 -0.58 111 113
EDNRA 0.016 0.17 0.23 67 -0.44 45 112
positive regulation of muscle contraction -0.012 0.17 0.23 73 -0.34 62 135
Gq family/GDP -0.058 0.22 -10000 0 -0.45 88 88
HRAS/GTP -0.08 0.23 -10000 0 -0.45 103 103
PRKCH -0.075 0.21 0.23 4 -0.42 101 105
RAC1 0.035 0.006 -10000 0 -10000 0 0
PRKCA -0.061 0.21 0.24 22 -0.42 94 116
PRKCB -0.074 0.2 0.22 1 -0.41 106 107
PRKCE -0.076 0.2 0.22 1 -0.42 101 102
PRKCD -0.075 0.2 0.22 1 -0.42 98 99
PRKCG -0.079 0.21 0.22 1 -0.42 101 102
regulation of vascular smooth muscle contraction -0.18 0.42 -10000 0 -1.1 85 85
PRKCQ -0.069 0.2 0.23 7 -0.42 99 106
PLA2G4A -0.099 0.28 0.28 1 -0.54 114 115
GNA14 -0.012 0.13 -10000 0 -0.42 43 43
GNA15 0.026 0.048 -10000 0 -0.42 5 5
GNA12 0.035 0.007 -10000 0 -10000 0 0
GNA11 0.029 0.039 -10000 0 -0.42 3 3
Rac1/GTP 0.03 0.21 0.37 72 -0.31 88 160
MMP1 -0.17 0.35 -10000 0 -0.78 120 120
IGF1 pathway

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0.036 0.005 -10000 0 -10000 0 0
PTK2 0.028 0.016 -10000 0 -10000 0 0
CRKL -0.071 0.15 0.17 2 -0.29 145 147
GRB2/SOS1/SHC 0.052 0.036 -10000 0 -0.26 1 1
HRAS 0.032 0.036 -10000 0 -0.42 3 3
IRS1/Crk -0.064 0.16 -10000 0 -0.28 151 151
IGF-1R heterotetramer/IGF1/PTP1B -0.036 0.16 -10000 0 -0.29 132 132
AKT1 -0.077 0.14 0.17 14 -0.28 125 139
BAD -0.075 0.13 0.16 14 -0.35 59 73
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.068 0.15 0.17 2 -0.3 130 132
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.06 0.16 -10000 0 -0.3 142 142
RAF1 -0.037 0.14 0.29 1 -0.49 14 15
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos -0.025 0.17 -10000 0 -0.29 129 129
YWHAZ 0.027 0.016 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.063 0.17 0.17 2 -0.3 152 154
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
RPS6KB1 -0.071 0.13 0.17 12 -0.29 107 119
GNB2L1 0.034 0.035 -10000 0 -0.42 3 3
positive regulation of MAPKKK cascade -0.023 0.14 0.3 10 -0.39 15 25
PXN 0.036 0.004 -10000 0 -10000 0 0
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0.048 0.023 -10000 0 -0.3 1 1
HRAS/GTP -0.04 0.13 -10000 0 -0.26 114 114
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc 0.003 0.13 -10000 0 -0.24 103 103
IGF-1R heterotetramer -0.061 0.18 -10000 0 -0.46 84 84
IGF-1R heterotetramer/IGF1/IRS/Nck -0.043 0.17 -10000 0 -0.28 151 151
Crk/p130 Cas/Paxillin -0.039 0.16 -10000 0 -0.27 142 142
IGF1R -0.061 0.18 -10000 0 -0.46 84 84
IGF1 -0.06 0.18 -10000 0 -0.46 78 78
IRS2/Crk -0.071 0.16 0.17 2 -0.29 150 152
PI3K -0.038 0.17 -10000 0 -0.29 145 145
apoptosis 0.05 0.11 0.31 46 -0.3 4 50
HRAS/GDP 0.024 0.025 -10000 0 -0.3 3 3
PRKCD -0.062 0.18 0.21 1 -0.34 129 130
RAF1/14-3-3 E -0.018 0.13 0.29 4 -0.43 13 17
BAD/14-3-3 -0.053 0.12 0.31 4 -0.33 46 50
PRKCZ -0.075 0.14 0.16 14 -0.27 135 149
Crk/p130 Cas/Paxillin/FAK1 -0.031 0.13 -10000 0 -0.34 44 44
PTPN1 0.03 0.031 -10000 0 -0.42 2 2
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 -0.075 0.18 -10000 0 -0.35 130 130
BCAR1 0.03 0.014 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/SHC/GRB10 -0.018 0.14 -10000 0 -0.26 122 122
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0.035 0.021 -10000 0 -0.42 1 1
IRS1/NCK2 -0.054 0.16 -10000 0 -0.28 151 151
GRB10 0.023 0.075 -10000 0 -0.42 14 14
PTPN11 -0.072 0.15 0.17 2 -0.29 142 144
IRS1 -0.075 0.16 -10000 0 -0.3 152 152
IRS2 -0.079 0.16 0.17 2 -0.3 151 153
IGF-1R heterotetramer/IGF1 -0.072 0.19 -10000 0 -0.37 140 140
GRB2 0.033 0.011 -10000 0 -10000 0 0
PDPK1 -0.075 0.14 0.18 14 -0.28 135 149
YWHAE 0.032 0.012 -10000 0 -10000 0 0
PRKD1 -0.071 0.2 0.21 5 -0.37 126 131
SHC1 0.028 0.025 -10000 0 -0.42 1 1
Osteopontin-mediated events

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.037 0.15 0.36 1 -0.27 130 131
NF kappa B1 p50/RelA/I kappa B alpha -0.034 0.17 0.33 1 -0.4 54 55
alphaV/beta3 Integrin/Osteopontin/Src -0.043 0.16 -10000 0 -0.32 125 125
AP1 -0.085 0.23 -10000 0 -0.48 90 90
ILK -0.046 0.14 0.38 1 -0.26 125 126
bone resorption -0.053 0.14 -10000 0 -0.34 47 47
PTK2B 0.028 0.015 -10000 0 -10000 0 0
PYK2/p130Cas -0.027 0.16 -10000 0 -0.26 134 134
ITGAV 0.018 0.082 -10000 0 -0.43 15 15
mol:GTP 0 0 -10000 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.04 0.064 -10000 0 -0.3 17 17
alphaV/beta3 Integrin/Osteopontin -0.022 0.16 -10000 0 -0.28 127 127
MAP3K1 -0.059 0.14 0.29 2 -0.27 142 144
JUN -0.001 0.12 -10000 0 -0.42 39 39
MAPK3 -0.059 0.14 0.23 6 -0.27 127 133
MAPK1 -0.064 0.15 0.23 6 -0.28 140 146
Rac1/GDP 0.026 0.004 -10000 0 -10000 0 0
NFKB1 0.036 0.005 -10000 0 -10000 0 0
MAPK8 -0.064 0.13 0.22 8 -0.25 142 150
ITGB3 0.024 0.051 -10000 0 -0.43 5 5
NFKBIA -0.068 0.16 0.35 3 -0.42 59 62
FOS -0.031 0.15 -10000 0 -0.42 66 66
CD44 0.022 0.075 -10000 0 -0.42 14 14
CHUK 0.026 0.067 -10000 0 -0.42 11 11
PLAU -0.14 0.36 -10000 0 -1.1 54 54
NF kappa B1 p50/RelA -0.022 0.19 -10000 0 -0.45 56 56
BCAR1 0.03 0.014 -10000 0 -10000 0 0
RELA 0.035 0.006 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.031 0.081 -10000 0 -0.31 21 21
mol:GDP 0 0 -10000 0 -10000 0 0
SYK -0.06 0.15 0.22 7 -0.28 146 153
VAV3 -0.099 0.15 0.22 8 -0.27 203 211
MAP3K14 -0.049 0.14 0.25 4 -0.27 127 131
ROCK2 0.033 0.035 -10000 0 -0.42 3 3
SPP1 -0.076 0.19 -10000 0 -0.42 115 115
RAC1 0.035 0.006 -10000 0 -10000 0 0
Rac1/GTP -0.082 0.15 0.19 1 -0.25 200 201
MMP2 -0.1 0.19 -10000 0 -0.45 88 88
FOXM1 transcription factor network

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 -0.24 0.52 -9999 0 -1.2 81 81
PLK1 0.017 0.098 -9999 0 -1.1 3 3
BIRC5 -0.087 0.39 -9999 0 -1.4 41 41
HSPA1B -0.25 0.52 -9999 0 -1.1 98 98
MAP2K1 0.005 0.057 -9999 0 -10000 0 0
BRCA2 -0.27 0.54 -9999 0 -1.2 94 94
FOXM1 -0.39 0.86 -9999 0 -1.8 98 98
XRCC1 -0.24 0.52 -9999 0 -1.2 84 84
FOXM1B/p19 -0.3 0.58 -9999 0 -1.3 100 100
Cyclin D1/CDK4 -0.29 0.53 -9999 0 -1 136 136
CDC2 -0.27 0.56 -9999 0 -1.3 85 85
TGFA -0.28 0.5 -9999 0 -1 116 116
SKP2 -0.24 0.52 -9999 0 -1.2 82 82
CCNE1 0.024 0.05 -9999 0 -0.43 5 5
CKS1B -0.22 0.53 -9999 0 -1.2 81 81
RB1 -0.15 0.4 -9999 0 -1 67 67
FOXM1C/SP1 -0.3 0.62 -9999 0 -1.3 102 102
AURKB -0.08 0.31 -9999 0 -0.93 54 54
CENPF -0.23 0.56 -9999 0 -1.2 84 84
CDK4 0.016 0.037 -9999 0 -10000 0 0
MYC -0.23 0.45 -9999 0 -0.99 95 95
CHEK2 0.001 0.066 -9999 0 -0.45 3 3
ONECUT1 -0.28 0.52 -9999 0 -1.1 105 105
CDKN2A 0.014 0.075 -9999 0 -0.42 14 14
LAMA4 -0.25 0.53 -9999 0 -1.2 84 84
FOXM1B/HNF6 -0.35 0.65 -9999 0 -1.4 105 105
FOS -0.33 0.6 -9999 0 -1.2 131 131
SP1 0.034 0.024 -9999 0 -0.42 1 1
CDC25B -0.25 0.52 -9999 0 -1.2 84 84
response to radiation -0.004 0.032 -9999 0 -10000 0 0
CENPB -0.24 0.52 -9999 0 -1.2 84 84
CENPA -0.27 0.55 -9999 0 -1.2 92 92
NEK2 -0.26 0.58 -9999 0 -1.2 100 100
HIST1H2BA -0.25 0.52 -9999 0 -1.2 86 86
CCNA2 0.005 0.11 -9999 0 -0.43 28 28
EP300 0.032 0.03 -9999 0 -0.42 2 2
CCNB1/CDK1 -0.32 0.65 -9999 0 -1.5 86 86
CCNB2 -0.26 0.53 -9999 0 -1.2 86 86
CCNB1 -0.27 0.57 -9999 0 -1.3 86 86
ETV5 -0.25 0.53 -9999 0 -1.2 85 85
ESR1 -0.44 0.65 -9999 0 -1.2 206 206
CCND1 -0.32 0.52 -9999 0 -1.1 137 137
GSK3A 0.008 0.052 -9999 0 -10000 0 0
Cyclin A-E1/CDK1-2 0.022 0.11 -9999 0 -0.33 29 29
CDK2 0.03 0.034 -9999 0 -0.43 2 2
G2/M transition of mitotic cell cycle -0.006 0.036 -9999 0 -10000 0 0
FOXM1B/Cbp/p300 -0.27 0.57 -9999 0 -1.2 98 98
GAS1 -0.32 0.59 -9999 0 -1.2 118 118
MMP2 -0.28 0.57 -9999 0 -1.3 98 98
RB1/FOXM1C -0.3 0.55 -9999 0 -1.1 132 132
CREBBP 0.033 0.011 -9999 0 -10000 0 0
IL4-mediated signaling events

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.37 0.64 -10000 0 -1.3 138 138
STAT6 (cleaved dimer) -0.38 0.65 -10000 0 -1.3 142 142
IGHG1 -0.083 0.24 -10000 0 -0.42 72 72
IGHG3 -0.36 0.61 -10000 0 -1.2 144 144
AKT1 -0.12 0.32 -10000 0 -0.77 50 50
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.066 0.26 -10000 0 -0.8 25 25
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.14 0.36 -10000 0 -0.84 58 58
THY1 -0.38 0.66 -10000 0 -1.3 135 135
MYB -0.055 0.18 -10000 0 -0.42 97 97
HMGA1 0.034 0.029 -10000 0 -0.42 2 2
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.14 0.35 -10000 0 -0.66 97 97
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.12 0.33 -10000 0 -0.86 38 38
SP1 0.023 0.052 -10000 0 -0.21 5 5
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.019 0.056 -10000 0 -0.42 4 4
STAT6 (dimer)/ETS1 -0.37 0.64 -10000 0 -1.3 140 140
SOCS1 -0.2 0.39 -10000 0 -0.75 126 126
SOCS3 -0.12 0.32 -10000 0 -0.94 25 25
FCER2 -0.23 0.46 -10000 0 -0.93 100 100
PARP14 0.03 0.051 -10000 0 -0.42 6 6
CCL17 -0.43 0.71 -10000 0 -1.4 155 155
GRB2 0.033 0.011 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.076 0.26 -10000 0 -0.7 30 30
T cell proliferation -0.38 0.67 -10000 0 -1.3 140 140
IL4R/JAK1 -0.37 0.65 -10000 0 -1.3 136 136
EGR2 -0.41 0.7 -10000 0 -1.4 148 148
JAK2 -0.005 0.07 -10000 0 -0.46 2 2
JAK3 0.039 0.014 -10000 0 -10000 0 0
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
JAK1 0.018 0.048 -10000 0 -0.41 3 3
COL1A2 -0.22 0.54 -10000 0 -1.5 72 72
CCL26 -0.37 0.64 -10000 0 -1.3 135 135
IL4R -0.4 0.71 -10000 0 -1.4 135 135
PTPN6 0.022 0.045 -10000 0 -0.41 2 2
IL13RA2 -0.41 0.68 -10000 0 -1.3 153 153
IL13RA1 -0.009 0.087 -10000 0 -0.46 8 8
IRF4 -0.005 0.16 -10000 0 -1 5 5
ARG1 -0.066 0.26 -10000 0 -0.88 25 25
CBL -0.14 0.32 -10000 0 -0.62 95 95
GTF3A 0.024 0.046 -10000 0 -0.11 28 28
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
IL13RA1/JAK2 -0.001 0.1 -10000 0 -0.36 8 8
IRF4/BCL6 -0.005 0.16 -10000 0 -0.97 5 5
CD40LG 0.039 0.038 -10000 0 -0.29 5 5
MAPK14 -0.14 0.33 -10000 0 -0.65 89 89
mitosis -0.11 0.31 -10000 0 -0.72 49 49
STAT6 -0.48 0.88 -10000 0 -1.7 143 143
SPI1 0.033 0.051 -10000 0 -0.25 13 13
RPS6KB1 -0.093 0.3 -10000 0 -0.72 43 43
STAT6 (dimer) -0.48 0.88 -10000 0 -1.6 143 143
STAT6 (dimer)/PARP14 -0.42 0.73 -10000 0 -1.4 142 142
mast cell activation 0.005 0.017 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.14 0.34 -10000 0 -0.74 71 71
FRAP1 -0.12 0.32 -10000 0 -0.77 49 49
LTA -0.37 0.64 -10000 0 -1.3 138 138
FES 0.03 0.046 -10000 0 -0.42 5 5
T-helper 1 cell differentiation 0.43 0.78 1.5 143 -10000 0 143
CCL11 -0.4 0.66 -10000 0 -1.3 146 146
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.1 0.31 -10000 0 -0.84 32 32
IL2RG 0.034 0.042 -10000 0 -0.41 4 4
IL10 -0.33 0.65 -10000 0 -1.3 119 119
IRS1 -0.014 0.14 -10000 0 -0.42 54 54
IRS2 0.008 0.099 -10000 0 -0.42 25 25
IL4 -0.063 0.29 -10000 0 -1.3 18 18
IL5 -0.37 0.64 -10000 0 -1.3 138 138
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.26 0.51 -10000 0 -0.93 145 145
COL1A1 -0.26 0.59 -10000 0 -1.4 90 90
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.39 0.69 -10000 0 -1.4 127 127
IL2R gamma/JAK3 0.054 0.035 -10000 0 -0.29 4 4
TFF3 -0.53 0.76 -10000 0 -1.4 193 193
ALOX15 -0.38 0.65 -10000 0 -1.3 133 133
MYBL1 -0.011 0.13 -10000 0 -0.42 43 43
T-helper 2 cell differentiation -0.28 0.52 -10000 0 -0.98 143 143
SHC1 0.028 0.025 -10000 0 -0.42 1 1
CEBPB 0.029 0.056 -10000 0 -0.26 14 14
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.13 0.34 -10000 0 -0.75 59 59
mol:PI-3-4-5-P3 -0.12 0.33 -10000 0 -0.77 49 49
PI3K -0.13 0.35 -10000 0 -0.84 49 49
DOK2 0.009 0.086 -10000 0 -0.42 19 19
ETS1 0.015 0.043 -10000 0 -0.38 1 1
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.062 0.25 -10000 0 -0.62 30 30
ITGB3 -0.37 0.65 -10000 0 -1.3 135 135
PIGR -0.46 0.77 -10000 0 -1.4 170 170
IGHE 0.011 0.088 0.18 57 -0.22 10 67
MAPKKK cascade -0.06 0.24 -10000 0 -0.61 30 30
BCL6 0.018 0.085 -10000 0 -0.42 18 18
OPRM1 -0.37 0.64 -10000 0 -1.3 131 131
RETNLB -0.37 0.64 -10000 0 -1.3 134 134
SELP -0.43 0.75 -10000 0 -1.4 158 158
AICDA -0.36 0.62 -10000 0 -1.3 128 128
Plasma membrane estrogen receptor signaling

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 -0.007 0.13 -10000 0 -0.22 134 134
ER alpha/Gai/GDP/Gbeta gamma -0.12 0.21 -10000 0 -0.36 160 160
AKT1 -0.22 0.37 -10000 0 -0.74 167 167
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.22 0.38 -10000 0 -0.75 167 167
mol:Ca2+ -0.071 0.15 -10000 0 -0.42 60 60
IGF1R -0.042 0.17 -10000 0 -0.42 84 84
E2/ER alpha (dimer)/Striatin -0.037 0.13 -10000 0 -0.25 135 135
SHC1 0.028 0.025 -10000 0 -0.42 1 1
apoptosis 0.21 0.35 0.7 167 -10000 0 167
RhoA/GTP -0.038 0.11 -10000 0 -0.21 127 127
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.1 0.2 -10000 0 -0.38 151 151
regulation of stress fiber formation 0.038 0.1 0.31 8 -0.26 3 11
E2/ERA-ERB (dimer) -0.037 0.13 -10000 0 -0.25 132 132
KRAS 0.028 0.054 -10000 0 -0.42 7 7
G13/GTP -0.032 0.12 -10000 0 -0.23 123 123
pseudopodium formation -0.038 0.1 0.26 3 -0.31 8 11
E2/ER alpha (dimer)/PELP1 -0.038 0.13 -10000 0 -0.25 131 131
GRB2 0.033 0.011 -10000 0 -10000 0 0
GNG2 0.034 0.021 -10000 0 -0.42 1 1
GNAO1 0.03 0.014 -10000 0 -10000 0 0
HRAS 0.032 0.036 -10000 0 -0.42 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.14 0.23 -10000 0 -0.44 164 164
E2/ER beta (dimer) 0.026 0.005 -10000 0 -10000 0 0
mol:GDP -0.075 0.17 -10000 0 -0.33 137 137
mol:NADP -0.14 0.23 -10000 0 -0.44 164 164
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
mol:IP3 -0.072 0.15 -10000 0 -0.4 69 69
IGF-1R heterotetramer -0.042 0.17 -10000 0 -0.42 84 84
PLCB1 -0.072 0.16 -10000 0 -0.36 91 91
PLCB2 -0.051 0.15 -10000 0 -0.42 57 57
IGF1 -0.038 0.16 -10000 0 -0.42 78 78
mol:L-citrulline -0.14 0.23 -10000 0 -0.44 164 164
RHOA 0.026 0.061 -10000 0 -0.42 9 9
Gai/GDP -0.099 0.27 -10000 0 -0.62 102 102
JNK cascade 0.026 0.005 -10000 0 -10000 0 0
BCAR1 0.03 0.014 -10000 0 -10000 0 0
ESR2 0.035 0.007 -10000 0 -10000 0 0
GNAQ 0 0 -10000 0 -10000 0 0
ESR1 -0.089 0.2 -10000 0 -0.42 132 132
Gq family/GDP/Gbeta gamma -0.015 0.17 -10000 0 -0.69 22 22
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 -0.034 0.13 -10000 0 -0.57 7 7
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.089 0.19 0.27 1 -0.38 122 123
GNAZ 0.023 0.07 -10000 0 -0.42 12 12
E2/ER alpha (dimer) -0.062 0.14 -10000 0 -0.3 132 132
STRN 0.031 0.045 -10000 0 -0.42 5 5
GNAL 0.031 0.036 -10000 0 -0.42 3 3
PELP1 0.033 0.011 -10000 0 -10000 0 0
MAPK11 0.016 0.006 -10000 0 -10000 0 0
GNAI2 0.028 0.054 -10000 0 -0.42 7 7
GNAI3 0.035 0.006 -10000 0 -10000 0 0
GNAI1 0.017 0.087 -10000 0 -0.42 19 19
HBEGF -0.11 0.2 0.32 5 -0.48 64 69
cAMP biosynthetic process -0.028 0.1 -10000 0 -0.2 129 129
SRC -0.11 0.2 0.25 1 -0.36 141 142
PI3K 0.036 0.065 -10000 0 -0.3 17 17
GNB1 0.032 0.045 -10000 0 -0.42 5 5
G13/GDP/Gbeta gamma -0.049 0.16 -10000 0 -0.32 114 114
SOS1 0.035 0.021 -10000 0 -0.42 1 1
IGF-1R heterotetramer/IGF1 -0.13 0.19 -10000 0 -0.4 147 147
Gs family/GTP -0.022 0.11 -10000 0 -0.21 129 129
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.053 0.054 -10000 0 -0.23 15 15
vasodilation -0.13 0.22 -10000 0 -0.42 164 164
mol:DAG -0.072 0.15 -10000 0 -0.4 69 69
Gs family/GDP/Gbeta gamma -0.064 0.15 -10000 0 -0.32 110 110
MSN -0.042 0.11 0.31 2 -0.33 8 10
Gq family/GTP -0.052 0.15 -10000 0 -0.43 59 59
mol:PI-3-4-5-P3 -0.21 0.36 -10000 0 -0.72 167 167
NRAS 0.029 0.054 -10000 0 -0.42 7 7
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.13 0.22 0.42 164 -10000 0 164
GRB2/SOS1 0.048 0.023 -10000 0 -0.3 1 1
RhoA/GDP -0.061 0.17 -10000 0 -0.32 140 140
NOS3 -0.14 0.24 -10000 0 -0.47 164 164
GNA11 0.033 0.036 -10000 0 -0.42 3 3
MAPKKK cascade -0.15 0.26 -10000 0 -0.52 159 159
E2/ER alpha (dimer)/PELP1/Src -0.11 0.21 0.28 1 -0.39 152 153
ruffle organization -0.038 0.1 0.26 3 -0.31 8 11
ROCK2 -0.039 0.12 0.33 2 -0.33 10 12
GNA14 -0.009 0.13 -10000 0 -0.42 43 43
GNA15 0.03 0.046 -10000 0 -0.42 5 5
GNA13 0.029 0.037 -10000 0 -0.42 3 3
MMP9 -0.12 0.2 0.35 7 -0.47 66 73
MMP2 -0.11 0.19 0.27 3 -0.46 64 67
EGFR-dependent Endothelin signaling events

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.032 0.036 -10000 0 -0.42 3 3
EGFR -0.015 0.13 -10000 0 -0.42 49 49
EGF/EGFR -0.072 0.18 -10000 0 -0.27 199 199
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.001 0.13 -10000 0 -0.23 104 104
mol:GTP 0 0 -10000 0 -10000 0 0
EDNRA -0.002 0.12 -10000 0 -0.42 41 41
response to oxidative stress 0 0 -10000 0 -10000 0 0
EGF -0.069 0.19 -10000 0 -0.42 110 110
EGF/EGFR dimer/SHC -0.029 0.14 -10000 0 -0.26 120 120
mol:GDP -0.005 0.12 -10000 0 -0.23 104 104
mol:Ca2+ 0 0 -10000 0 -10000 0 0
EDN1 -0.038 0.16 -10000 0 -0.42 77 77
GRB2/SOS1 0.048 0.023 -10000 0 -0.3 1 1
HRAS/GTP -0.017 0.11 -10000 0 -0.21 106 106
SHC1 0.028 0.025 -10000 0 -0.42 1 1
HRAS/GDP -0.007 0.12 -10000 0 -0.22 106 106
FRAP1 -0.017 0.14 0.38 10 -0.23 74 84
EGF/EGFR dimer -0.061 0.16 -10000 0 -0.3 152 152
SOS1 0.035 0.021 -10000 0 -0.42 1 1
GRB2 0.033 0.011 -10000 0 -10000 0 0
ETA receptor/Endothelin-1 -0.029 0.16 -10000 0 -0.33 103 103
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.034 0.034 -10000 0 -0.26 4 4
NFATC2 -0.052 0.21 -10000 0 -0.51 51 51
NFATC3 -0.018 0.12 -10000 0 -0.26 69 69
CD40LG -0.19 0.38 -10000 0 -0.76 131 131
ITCH 0.013 0.071 -10000 0 -0.22 42 42
CBLB 0.014 0.07 -10000 0 -0.22 41 41
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.14 0.33 -10000 0 -0.82 68 68
JUNB 0.032 0.041 -10000 0 -0.42 4 4
CaM/Ca2+/Calcineurin A alpha-beta B1 0.022 0.087 -10000 0 -0.26 44 44
T cell anergy -0.016 0.12 0.26 2 -0.36 45 47
TLE4 -0.045 0.17 -10000 0 -0.52 34 34
Jun/NFAT1-c-4/p21SNFT -0.17 0.4 -10000 0 -0.79 123 123
AP-1/NFAT1-c-4 -0.19 0.46 -10000 0 -0.85 131 131
IKZF1 -0.039 0.14 -10000 0 -0.36 48 48
T-helper 2 cell differentiation -0.17 0.3 -10000 0 -0.8 66 66
AP-1/NFAT1 -0.045 0.2 -10000 0 -0.41 79 79
CALM1 0.028 0.058 -10000 0 -0.16 42 42
EGR2 -0.23 0.49 -10000 0 -1.1 89 89
EGR3 -0.29 0.55 -10000 0 -1.1 131 131
NFAT1/FOXP3 -0.018 0.16 -10000 0 -0.39 43 43
EGR1 -0.038 0.16 -10000 0 -0.42 76 76
JUN -0.003 0.12 -10000 0 -0.42 39 39
EGR4 0 0.005 -10000 0 -10000 0 0
mol:Ca2+ -0.005 0.046 -10000 0 -0.15 45 45
GBP3 -0.089 0.25 -10000 0 -0.61 79 79
FOSL1 0.035 0.007 -10000 0 -10000 0 0
NFAT1-c-4/MAF/IRF4 -0.16 0.4 -10000 0 -0.77 125 125
DGKA -0.04 0.16 -10000 0 -0.44 39 39
CREM 0.034 0.007 -10000 0 -10000 0 0
NFAT1-c-4/PPARG -0.18 0.41 -10000 0 -0.81 126 126
CTLA4 -0.027 0.14 -10000 0 -0.38 33 33
NFAT1-c-4 (dimer)/EGR1 -0.2 0.43 -10000 0 -0.84 135 135
NFAT1-c-4 (dimer)/EGR4 -0.17 0.39 -10000 0 -0.78 127 127
FOS -0.034 0.15 -10000 0 -0.42 66 66
IFNG -0.19 0.43 -10000 0 -1.1 75 75
T cell activation -0.1 0.26 -10000 0 -0.78 29 29
MAF 0.015 0.078 -10000 0 -0.42 15 15
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.15 0.34 0.68 122 -10000 0 122
TNF -0.2 0.38 -10000 0 -0.76 136 136
FASLG -0.35 0.65 -10000 0 -1.2 156 156
TBX21 -0.044 0.17 -10000 0 -0.43 84 84
BATF3 0 0.001 -10000 0 -10000 0 0
PRKCQ 0.021 0.061 -10000 0 -0.32 11 11
PTPN1 -0.038 0.15 -10000 0 -0.41 39 39
NFAT1-c-4/ICER1 -0.17 0.4 -10000 0 -0.78 126 126
GATA3 -0.047 0.18 -10000 0 -0.42 91 91
T-helper 1 cell differentiation -0.19 0.41 -10000 0 -1 75 75
IL2RA -0.14 0.33 -10000 0 -0.78 74 74
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.035 0.14 -10000 0 -0.39 36 36
E2F1 0.033 0.054 -10000 0 -0.42 7 7
PPARG 0.012 0.093 -10000 0 -0.42 22 22
SLC3A2 -0.035 0.14 -10000 0 -0.38 41 41
IRF4 0.031 0.031 -10000 0 -0.42 2 2
PTGS2 -0.18 0.36 -10000 0 -0.77 111 111
CSF2 -0.19 0.38 -10000 0 -0.75 132 132
JunB/Fra1/NFAT1-c-4 -0.15 0.39 -10000 0 -0.77 124 124
IL4 -0.18 0.32 -10000 0 -0.85 63 63
IL5 -0.19 0.38 -10000 0 -0.75 133 133
IL2 -0.1 0.27 -10000 0 -0.82 26 26
IL3 -0.013 0.14 -10000 0 -0.85 10 10
RNF128 -0.016 0.16 -10000 0 -0.52 44 44
NFATC1 -0.15 0.34 -10000 0 -0.68 121 121
CDK4 0.1 0.22 0.59 27 -10000 0 27
PTPRK -0.069 0.22 -10000 0 -0.64 55 55
IL8 -0.2 0.39 -10000 0 -0.77 131 131
POU2F1 0.034 0.017 -10000 0 -10000 0 0
Syndecan-1-mediated signaling events

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.035 0.021 -10000 0 -0.42 1 1
CCL5 -0.014 0.14 -10000 0 -0.42 52 52
SDCBP 0.023 0.058 -10000 0 -0.42 8 8
FGFR/FGF2/Syndecan-1 -0.11 0.23 0.22 6 -0.53 91 97
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
RP11-540L11.1 0 0 -10000 0 -10000 0 0
Syndecan-1/Laminin-5 -0.11 0.22 -10000 0 -0.5 91 91
Syndecan-1/Syntenin -0.1 0.22 0.26 1 -0.49 92 93
MAPK3 -0.097 0.2 0.24 1 -0.46 89 90
HGF/MET 0.042 0.055 -10000 0 -0.3 12 12
TGFB1/TGF beta receptor Type II 0.035 0.021 -10000 0 -0.42 1 1
BSG 0.035 0.008 -10000 0 -10000 0 0
keratinocyte migration -0.11 0.22 -10000 0 -0.49 91 91
Syndecan-1/RANTES -0.13 0.24 0.26 1 -0.5 113 114
Syndecan-1/CD147 -0.096 0.23 0.27 1 -0.49 93 94
Syndecan-1/Syntenin/PIP2 -0.1 0.21 0.25 1 -0.47 92 93
LAMA5 0.027 0.05 -10000 0 -0.42 6 6
positive regulation of cell-cell adhesion -0.099 0.2 0.24 1 -0.46 92 93
MMP7 -0.032 0.15 -10000 0 -0.42 68 68
HGF 0.028 0.057 -10000 0 -0.42 8 8
Syndecan-1/CASK -0.12 0.21 -10000 0 -0.5 95 95
Syndecan-1/HGF/MET -0.1 0.23 0.27 1 -0.49 96 97
regulation of cell adhesion -0.1 0.19 0.23 1 -0.45 87 88
HPSE 0.015 0.091 -10000 0 -0.42 21 21
positive regulation of cell migration -0.11 0.23 0.22 6 -0.53 91 97
SDC1 -0.11 0.23 0.28 1 -0.53 91 92
Syndecan-1/Collagen -0.11 0.23 0.22 6 -0.53 91 97
PPIB 0.033 0.03 -10000 0 -0.42 2 2
MET 0.03 0.041 -10000 0 -0.42 4 4
PRKACA 0.036 0.005 -10000 0 -10000 0 0
MMP9 -0.013 0.14 -10000 0 -0.42 52 52
MAPK1 -0.1 0.21 0.24 1 -0.46 93 94
homophilic cell adhesion -0.12 0.22 0.22 6 -0.52 92 98
MMP1 -0.074 0.18 -10000 0 -0.42 107 107
Glucocorticoid receptor regulatory network

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.054 0.15 0.31 10 -0.83 8 18
SMARCC2 0.036 0.005 -10000 0 -10000 0 0
SMARCC1 0.033 0.03 -10000 0 -0.42 2 2
TBX21 -0.15 0.28 0.36 1 -0.71 92 93
SUMO2 0.029 0.02 -10000 0 -10000 0 0
STAT1 (dimer) 0.021 0.091 -10000 0 -0.38 23 23
FKBP4 0.03 0.046 -10000 0 -0.42 5 5
FKBP5 -0.003 0.12 -10000 0 -0.42 41 41
GR alpha/HSP90/FKBP51/HSP90 0.061 0.14 0.25 113 -0.25 26 139
PRL -0.035 0.13 -10000 0 -0.96 2 2
cortisol/GR alpha (dimer)/TIF2 0.14 0.24 0.52 114 -0.38 2 116
RELA -0.02 0.11 -10000 0 -0.19 113 113
FGG 0.14 0.23 0.45 139 -0.38 3 142
GR beta/TIF2 0.07 0.14 0.28 100 -0.3 9 109
IFNG -0.26 0.41 -10000 0 -0.87 122 122
apoptosis -0.003 0.17 0.51 4 -0.51 10 14
CREB1 0.038 0.042 -10000 0 -0.37 5 5
histone acetylation -0.025 0.11 0.31 4 -0.32 34 38
BGLAP -0.047 0.14 -10000 0 -0.5 14 14
GR/PKAc 0.11 0.12 0.32 56 -0.26 14 70
NF kappa B1 p50/RelA -0.039 0.19 -10000 0 -0.32 132 132
SMARCD1 0.036 0.004 -10000 0 -10000 0 0
MDM2 0.072 0.1 0.24 108 -10000 0 108
GATA3 -0.039 0.18 -10000 0 -0.41 91 91
AKT1 0.03 0.036 0.19 8 -0.43 2 10
CSF2 -0.05 0.13 -10000 0 -0.86 5 5
GSK3B 0.03 0.02 -10000 0 -10000 0 0
NR1I3 0.029 0.18 0.54 5 -0.67 6 11
CSN2 0.12 0.19 0.38 137 -0.36 6 143
BRG1/BAF155/BAF170/BAF60A 0.083 0.037 -10000 0 -0.23 3 3
NFATC1 0.023 0.09 -10000 0 -0.4 21 21
POU2F1 0.033 0.021 -10000 0 -0.25 1 1
CDKN1A -0.047 0.26 -10000 0 -1.5 14 14
response to stress 0 0 -10000 0 -10000 0 0
response to UV -0.001 0.006 -10000 0 -10000 0 0
SFN 0.012 0.099 -10000 0 -0.42 25 25
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.07 0.14 0.29 60 -0.23 42 102
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.079 0.31 0.46 4 -0.78 78 82
JUN -0.15 0.23 0.37 4 -0.47 138 142
IL4 -0.087 0.19 -10000 0 -0.59 32 32
CDK5R1 0.033 0.01 -10000 0 -10000 0 0
PRKACA 0.036 0.005 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.097 0.21 0.21 69 -0.38 139 208
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.086 0.13 0.29 68 -0.23 31 99
cortisol/GR alpha (monomer) 0.19 0.31 0.6 151 -0.41 4 155
NCOA2 0.025 0.047 -10000 0 -0.42 5 5
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.081 0.16 -10000 0 -0.41 79 79
AP-1/NFAT1-c-4 -0.27 0.37 -10000 0 -0.74 160 160
AFP -0.12 0.19 -10000 0 -0.71 13 13
SUV420H1 0.033 0.022 -10000 0 -0.42 1 1
IRF1 0.095 0.21 0.41 67 -0.71 13 80
TP53 0.014 0.13 -10000 0 -0.46 32 32
PPP5C 0.032 0.041 -10000 0 -0.42 4 4
KRT17 -0.38 0.56 -10000 0 -1.2 146 146
KRT14 -0.26 0.49 -10000 0 -1.2 97 97
TBP 0.04 0.019 -10000 0 -0.28 1 1
CREBBP 0.066 0.096 0.28 80 -10000 0 80
HDAC1 0.03 0.021 -10000 0 -0.42 1 1
HDAC2 0.031 0.023 -10000 0 -0.42 1 1
AP-1 -0.27 0.38 -10000 0 -0.75 161 161
MAPK14 0.033 0.014 -10000 0 -10000 0 0
MAPK10 0.009 0.089 -10000 0 -0.42 20 20
MAPK11 0.028 0.02 -10000 0 -10000 0 0
KRT5 -0.39 0.57 -10000 0 -1.2 150 150
interleukin-1 receptor activity -0.001 0.007 -10000 0 -10000 0 0
NCOA1 0.032 0.048 -10000 0 -0.37 6 6
STAT1 0.021 0.091 -10000 0 -0.38 23 23
CGA -0.071 0.17 -10000 0 -0.55 29 29
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.081 0.16 0.36 93 -0.39 2 95
MAPK3 0.027 0.028 -10000 0 -0.42 1 1
MAPK1 0.03 0.025 -10000 0 -0.42 1 1
ICAM1 -0.16 0.3 0.33 1 -0.64 107 108
NFKB1 -0.021 0.11 -10000 0 -0.2 100 100
MAPK8 -0.11 0.2 0.56 2 -0.38 130 132
MAPK9 0.016 0.085 -10000 0 -0.42 18 18
cortisol/GR alpha (dimer) -0.005 0.18 0.52 4 -0.53 10 14
BAX -0.01 0.1 -10000 0 -10000 0 0
POMC -0.091 0.2 0.62 1 -1.2 5 6
EP300 0.066 0.099 0.28 84 -0.43 2 86
cortisol/GR alpha (dimer)/p53 0.12 0.25 0.52 110 -0.39 2 112
proteasomal ubiquitin-dependent protein catabolic process 0.053 0.11 0.26 76 -10000 0 76
SGK1 0.08 0.14 0.33 94 -0.33 4 98
IL13 -0.22 0.26 -10000 0 -0.63 99 99
IL6 -0.2 0.38 -10000 0 -0.87 98 98
PRKACG 0.034 0.029 -10000 0 -0.42 2 2
IL5 -0.18 0.22 -10000 0 -0.57 69 69
IL2 -0.22 0.33 -10000 0 -0.74 113 113
CDK5 0.034 0.008 -10000 0 -10000 0 0
PRKACB 0.008 0.099 -10000 0 -0.42 25 25
HSP90AA1 0 0 -10000 0 -10000 0 0
IL8 -0.18 0.34 -10000 0 -0.82 91 91
CDK5R1/CDK5 0.047 0.018 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc -0.001 0.18 -10000 0 -0.34 64 64
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.16 0.24 0.48 147 -0.35 2 149
SMARCA4 0.035 0.021 -10000 0 -0.42 1 1
chromatin remodeling 0.11 0.16 0.34 130 -10000 0 130
NF kappa B1 p50/RelA/Cbp 0.026 0.18 0.35 40 -0.3 58 98
JUN (dimer) -0.15 0.23 0.37 4 -0.47 137 141
YWHAH 0.031 0.036 -10000 0 -0.42 3 3
VIPR1 -0.1 0.21 -10000 0 -0.48 89 89
NR3C1 0.12 0.21 0.39 142 -0.41 8 150
NR4A1 0.037 0.045 -10000 0 -0.44 4 4
TIF2/SUV420H1 0.037 0.046 -10000 0 -0.35 5 5
MAPKKK cascade -0.003 0.17 0.51 4 -0.51 10 14
cortisol/GR alpha (dimer)/Src-1 0.18 0.26 0.52 151 -0.34 2 153
PBX1 0.02 0.077 -10000 0 -0.4 15 15
POU1F1 0.04 0.025 -10000 0 -0.33 2 2
SELE -0.23 0.42 -10000 0 -0.93 124 124
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.11 0.16 0.34 129 -10000 0 129
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.16 0.24 0.48 147 -0.35 2 149
mol:cortisol 0.11 0.18 0.35 150 -10000 0 150
MMP1 -0.37 0.54 -10000 0 -1.2 155 155
HIF-1-alpha transcription factor network

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.055 0.35 -10000 0 -0.72 76 76
HDAC7 0 0.003 -10000 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.008 0.35 -10000 0 -0.71 57 57
SMAD4 0.029 0.054 -10000 0 -0.42 7 7
ID2 -0.056 0.36 -10000 0 -0.72 76 76
AP1 -0.033 0.16 -10000 0 -0.35 88 88
ABCG2 -0.057 0.36 -10000 0 -0.73 77 77
HIF1A -0.023 0.16 -10000 0 -0.48 46 46
TFF3 -0.1 0.37 -10000 0 -0.74 88 88
GATA2 0.018 0.054 -10000 0 -0.42 5 5
AKT1 0.012 0.09 -10000 0 -0.31 6 6
response to hypoxia -0.007 0.066 -10000 0 -0.14 32 32
MCL1 -0.058 0.35 -10000 0 -0.72 76 76
NDRG1 -0.065 0.33 -10000 0 -0.74 66 66
SERPINE1 -0.063 0.36 -10000 0 -0.73 79 79
FECH -0.062 0.36 -10000 0 -0.72 79 79
FURIN -0.057 0.35 -10000 0 -0.72 77 77
NCOA2 0.026 0.047 -10000 0 -0.42 5 5
EP300 0.008 0.11 -10000 0 -0.3 27 27
HMOX1 -0.066 0.36 -10000 0 -0.73 80 80
BHLHE40 -0.077 0.34 -10000 0 -0.71 77 77
BHLHE41 -0.077 0.34 -10000 0 -0.71 77 77
HIF1A/ARNT/SMAD3/SMAD4/SP1 0.05 0.17 -10000 0 -0.33 45 45
ENG -0.007 0.13 0.27 1 -0.31 43 44
JUN -0.009 0.12 -10000 0 -0.43 39 39
RORA -0.064 0.36 -10000 0 -0.73 77 77
ABCB1 -0.029 0.24 -10000 0 -0.94 28 28
TFRC -0.072 0.36 -10000 0 -0.73 83 83
CXCR4 -0.067 0.37 -10000 0 -0.74 83 83
TF -0.056 0.35 -10000 0 -0.72 75 75
CITED2 -0.059 0.35 -10000 0 -0.74 72 72
HIF1A/ARNT -0.035 0.43 -10000 0 -0.88 60 60
LDHA 0.01 0.19 -10000 0 -0.91 15 15
ETS1 -0.065 0.35 -10000 0 -0.72 76 76
PGK1 -0.053 0.36 -10000 0 -0.72 76 76
NOS2 -0.077 0.34 -10000 0 -0.71 77 77
ITGB2 -0.064 0.36 -10000 0 -0.74 79 79
ALDOA -0.05 0.35 -10000 0 -0.74 70 70
Cbp/p300/CITED2 -0.057 0.36 -10000 0 -0.8 62 62
FOS -0.038 0.15 -10000 0 -0.42 66 66
HK2 -0.054 0.36 -10000 0 -0.72 76 76
SP1 0.035 0.039 -10000 0 -0.19 7 7
GCK 0.013 0.18 -10000 0 -1.2 4 4
HK1 -0.053 0.35 -10000 0 -0.72 76 76
NPM1 -0.052 0.35 -10000 0 -0.73 73 73
EGLN1 -0.065 0.33 -10000 0 -0.72 71 71
CREB1 0.039 0.027 -10000 0 -0.42 1 1
PGM1 -0.059 0.35 -10000 0 -0.72 77 77
SMAD3 0.027 0.061 -10000 0 -0.42 9 9
EDN1 -0.18 0.48 -10000 0 -1.2 86 86
IGFBP1 -0.053 0.35 -10000 0 -0.72 75 75
VEGFA -0.042 0.27 0.44 1 -0.59 63 64
HIF1A/JAB1 0.003 0.12 -10000 0 -0.34 43 43
CP -0.12 0.38 -10000 0 -0.77 90 90
CXCL12 -0.071 0.38 -10000 0 -0.74 85 85
COPS5 0.027 0.043 -10000 0 -0.42 4 4
SMAD3/SMAD4 0.041 0.063 -10000 0 -0.3 16 16
BNIP3 -0.06 0.36 -10000 0 -0.73 77 77
EGLN3 -0.08 0.38 -10000 0 -0.77 81 81
CA9 -0.06 0.35 -10000 0 -0.72 76 76
TERT -0.056 0.35 -10000 0 -0.72 75 75
ENO1 -0.056 0.35 -10000 0 -0.73 74 74
PFKL -0.056 0.36 -10000 0 -0.72 76 76
NCOA1 0.032 0.045 -10000 0 -0.42 5 5
ADM -0.08 0.38 -10000 0 -0.75 89 89
ARNT 0.015 0.078 -10000 0 -0.16 2 2
HNF4A 0.035 0.033 -10000 0 -0.22 6 6
ADFP -0.064 0.37 -10000 0 -0.74 81 81
SLC2A1 -0.03 0.29 -10000 0 -0.6 60 60
LEP -0.072 0.36 -10000 0 -0.73 79 79
HIF1A/ARNT/Cbp/p300 -0.022 0.35 -10000 0 -0.72 59 59
EPO -0.027 0.28 -10000 0 -0.71 39 39
CREBBP 0.017 0.098 -10000 0 -0.28 18 18
HIF1A/ARNT/Cbp/p300/HDAC7 -0.021 0.34 -10000 0 -0.69 59 59
PFKFB3 -0.058 0.35 -10000 0 -0.74 73 73
NT5E -0.059 0.36 -10000 0 -0.74 75 75
Signaling events mediated by the Hedgehog family

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 -0.04 0.19 -10000 0 -0.58 53 53
IHH 0.017 0.088 -10000 0 -0.28 24 24
SHH Np/Cholesterol/GAS1 -0.027 0.11 -10000 0 -0.24 101 101
LRPAP1 0.035 0.007 -10000 0 -10000 0 0
dorsoventral neural tube patterning 0.027 0.1 0.23 101 -10000 0 101
SMO/beta Arrestin2 -0.022 0.17 -10000 0 -0.42 56 56
SMO -0.038 0.16 -10000 0 -0.37 83 83
AKT1 -0.015 0.16 -10000 0 -0.54 29 29
ARRB2 0.033 0.011 -10000 0 -10000 0 0
BOC 0.014 0.093 -10000 0 -0.42 22 22
ADRBK1 0.034 0.01 -10000 0 -10000 0 0
heart looping -0.034 0.16 -10000 0 -0.37 83 83
STIL -0.006 0.14 0.2 77 -0.23 104 181
DHH N/PTCH2 0.052 0.011 -10000 0 -10000 0 0
DHH N/PTCH1 -0.001 0.12 -10000 0 -0.29 69 69
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
DHH 0.036 0.005 -10000 0 -10000 0 0
PTHLH -0.064 0.25 -10000 0 -0.73 56 56
determination of left/right symmetry -0.034 0.16 -10000 0 -0.37 83 83
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
skeletal system development -0.063 0.25 -10000 0 -0.72 56 56
IHH N/Hhip 0.035 0.065 -10000 0 -0.29 12 12
DHH N/Hhip 0.049 0.029 -10000 0 -0.3 3 3
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.034 0.16 -10000 0 -0.37 83 83
pancreas development 0.032 0.036 -10000 0 -0.42 3 3
HHAT -0.017 0.13 -10000 0 -0.42 50 50
PI3K 0.036 0.065 -10000 0 -0.3 17 17
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.03 0.16 -10000 0 -0.42 71 71
somite specification -0.034 0.16 -10000 0 -0.37 83 83
SHH Np/Cholesterol/PTCH1 -0.031 0.11 -10000 0 -0.23 102 102
SHH Np/Cholesterol/PTCH2 0.003 0.074 -10000 0 -0.23 44 44
SHH Np/Cholesterol/Megalin -0.055 0.14 -10000 0 -0.27 133 133
SHH -0.016 0.09 -10000 0 -0.3 46 46
catabolic process -0.025 0.12 -10000 0 -0.32 70 70
SMO/Vitamin D3 -0.019 0.15 0.2 34 -0.33 63 97
SHH Np/Cholesterol/Hhip 0.002 0.075 -10000 0 -0.23 45 45
LRP2 -0.096 0.2 -10000 0 -0.42 144 144
receptor-mediated endocytosis -0.071 0.18 -10000 0 -0.36 98 98
SHH Np/Cholesterol/BOC -0.007 0.085 -10000 0 -0.23 63 63
SHH Np/Cholesterol/CDO -0.007 0.083 -10000 0 -0.24 56 56
mesenchymal cell differentiation -0.001 0.074 0.23 45 -10000 0 45
mol:Vitamin D3 -0.007 0.13 0.2 62 -0.24 102 164
IHH N/PTCH2 0.037 0.06 -10000 0 -0.27 10 10
CDON 0.021 0.067 -10000 0 -0.42 11 11
IHH N/PTCH1 -0.005 0.13 -10000 0 -0.33 70 70
Megalin/LRPAP1 -0.049 0.16 -10000 0 -0.3 144 144
PTCH2 0.035 0.006 -10000 0 -10000 0 0
SHH Np/Cholesterol -0.007 0.07 -10000 0 -0.23 46 46
PTCH1 -0.025 0.12 -10000 0 -0.32 70 70
HHIP 0.032 0.036 -10000 0 -0.42 3 3
Thromboxane A2 receptor signaling

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 0.017 0.085 -10000 0 -0.42 18 18
GNB1/GNG2 -0.05 0.08 -10000 0 -0.18 127 127
AKT1 -0.013 0.13 0.23 5 -0.24 47 52
EGF -0.069 0.19 -10000 0 -0.42 110 110
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR 0.016 0.063 0.25 5 -0.26 3 8
mol:Ca2+ -0.035 0.17 -10000 0 -0.3 132 132
LYN 0.015 0.057 0.26 4 -0.28 2 6
RhoA/GTP -0.014 0.075 -10000 0 -0.13 111 111
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK -0.055 0.19 -10000 0 -0.35 131 131
GNG2 0.034 0.021 -10000 0 -0.42 1 1
ARRB2 0.033 0.011 -10000 0 -10000 0 0
TP alpha/Gq family/GDP/G beta5/gamma2 -0.012 0.14 -10000 0 -0.46 32 32
G beta5/gamma2 -0.053 0.11 -10000 0 -0.24 124 124
PRKCH -0.051 0.2 0.3 3 -0.36 129 132
DNM1 0.033 0.035 -10000 0 -0.42 3 3
TXA2/TP beta/beta Arrestin3 0.028 0.027 -10000 0 -10000 0 0
mol:GTP 0 0.002 -10000 0 -10000 0 0
PTGDR 0.028 0.054 -10000 0 -0.42 7 7
G12 family/GTP -0.048 0.16 -10000 0 -0.3 118 118
ADRBK1 0.034 0.01 -10000 0 -10000 0 0
ADRBK2 0.024 0.067 -10000 0 -0.42 11 11
RhoA/GTP/ROCK1 0.041 0.04 -10000 0 -0.25 8 8
mol:GDP 0.022 0.14 0.43 31 -0.23 2 33
mol:NADP 0.035 0.007 -10000 0 -10000 0 0
RAB11A 0.034 0.021 -10000 0 -0.42 1 1
PRKG1 0.035 0.006 -10000 0 -10000 0 0
mol:IP3 -0.052 0.21 -10000 0 -0.38 132 132
cell morphogenesis 0.04 0.039 -10000 0 -0.25 8 8
PLCB2 -0.086 0.27 -10000 0 -0.52 131 131
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK 0.007 0.058 0.25 4 -0.24 4 8
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK 0.01 0.075 0.25 5 -0.32 8 13
RHOA 0.026 0.061 -10000 0 -0.42 9 9
PTGIR 0.033 0.029 -10000 0 -0.42 2 2
PRKCB1 -0.055 0.21 -10000 0 -0.4 121 121
GNAQ 0 0 -10000 0 -10000 0 0
mol:L-citrulline 0.035 0.007 -10000 0 -10000 0 0
TXA2/TXA2-R family -0.087 0.27 -10000 0 -0.52 131 131
LCK -0.005 0.09 0.25 5 -0.31 12 17
TXA2/TP beta/beta Arrestin3/RAB11/GDP 0.049 0.047 0.23 1 -0.2 9 10
TXA2-R family/G12 family/GDP/G beta/gamma 0.036 0.093 -10000 0 -0.48 12 12
TXA2/TP beta/beta Arrestin2/RAB11/GDP 0.044 0.047 0.23 1 -0.2 9 10
MAPK14 -0.032 0.13 0.22 3 -0.24 127 130
TGM2/GTP -0.062 0.23 -10000 0 -0.42 130 130
MAPK11 -0.034 0.13 0.25 3 -0.23 128 131
ARHGEF1 -0.011 0.11 0.24 4 -0.18 111 115
GNAI2 0.028 0.054 -10000 0 -0.42 7 7
JNK cascade -0.054 0.21 -10000 0 -0.38 131 131
RAB11/GDP 0.034 0.021 -10000 0 -0.42 1 1
ICAM1 -0.036 0.16 -10000 0 -0.3 129 129
cAMP biosynthetic process -0.049 0.19 -10000 0 -0.34 131 131
Gq family/GTP/EBP50 -0.021 0.096 -10000 0 -0.23 78 78
actin cytoskeleton reorganization 0.04 0.039 -10000 0 -0.25 8 8
SRC 0.015 0.064 0.25 5 -0.27 2 7
GNB5 0.025 0.067 -10000 0 -0.42 11 11
GNB1 0.032 0.045 -10000 0 -0.42 5 5
EGF/EGFR -0.034 0.11 0.22 7 -0.3 37 44
VCAM1 -0.041 0.17 -10000 0 -0.31 129 129
TP beta/Gq family/GDP/G beta5/gamma2 -0.012 0.14 -10000 0 -0.46 32 32
platelet activation -0.04 0.17 0.31 1 -0.3 130 131
PGI2/IP 0.025 0.021 -10000 0 -0.3 2 2
PRKACA 0.019 0.035 -10000 0 -0.23 9 9
Gq family/GDP/G beta5/gamma2 -0.007 0.12 -10000 0 -0.4 33 33
TXA2/TP beta/beta Arrestin2 0.009 0.066 -10000 0 -0.44 6 6
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R 0.008 0.029 -10000 0 -0.21 8 8
mol:DAG -0.064 0.23 -10000 0 -0.43 129 129
EGFR -0.015 0.13 -10000 0 -0.42 49 49
TXA2/TP alpha -0.074 0.25 -10000 0 -0.47 131 131
Gq family/GTP -0.016 0.077 0.22 2 -0.22 57 59
YES1 0.014 0.068 0.25 5 -0.28 6 11
GNAI2/GTP 0.022 0.052 -10000 0 -0.21 16 16
PGD2/DP 0.02 0.038 -10000 0 -0.3 7 7
SLC9A3R1 -0.009 0.13 -10000 0 -0.42 46 46
FYN 0.011 0.067 0.25 4 -0.28 6 10
mol:NO 0.035 0.007 -10000 0 -10000 0 0
GNA15 0.03 0.046 -10000 0 -0.42 5 5
PGK/cGMP 0.046 0.012 -10000 0 -10000 0 0
RhoA/GDP 0.026 0.06 -10000 0 -0.41 9 9
TP alpha/TGM2/GDP/G beta/gamma 0.056 0.075 0.28 2 -0.22 22 24
NOS3 0.035 0.007 -10000 0 -10000 0 0
RAC1 0.035 0.006 -10000 0 -10000 0 0
PRKCA -0.04 0.19 0.3 4 -0.35 114 118
PRKCB -0.052 0.19 -10000 0 -0.36 130 130
PRKCE -0.052 0.2 0.29 2 -0.36 128 130
PRKCD -0.059 0.2 -10000 0 -0.39 128 128
PRKCG -0.058 0.21 -10000 0 -0.39 130 130
muscle contraction -0.081 0.25 -10000 0 -0.48 131 131
PRKCZ -0.046 0.18 -10000 0 -0.34 131 131
ARR3 0.036 0.002 -10000 0 -10000 0 0
TXA2/TP beta 0.042 0.056 0.28 1 -0.21 11 12
PRKCQ -0.048 0.2 0.3 2 -0.37 124 126
MAPKKK cascade -0.07 0.24 -10000 0 -0.45 130 130
SELE -0.055 0.19 -10000 0 -0.37 129 129
TP beta/GNAI2/GDP/G beta/gamma 0.062 0.067 0.28 2 -0.23 16 18
ROCK1 0.036 0.006 -10000 0 -10000 0 0
GNA14 -0.009 0.13 -10000 0 -0.42 43 43
chemotaxis -0.11 0.31 -10000 0 -0.61 129 129
GNA12 0.035 0.007 -10000 0 -10000 0 0
GNA13 0.029 0.037 -10000 0 -0.42 3 3
GNA11 0.033 0.036 -10000 0 -0.42 3 3
Rac1/GTP 0.026 0.005 -10000 0 -10000 0 0
Fc-epsilon receptor I signaling in mast cells

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.029 0.05 -10000 0 -0.42 6 6
LAT2 -0.049 0.14 -10000 0 -0.31 87 87
AP1 -0.06 0.21 -10000 0 -0.46 74 74
mol:PIP3 -0.025 0.19 0.3 20 -0.36 81 101
IKBKB 0.011 0.13 0.26 45 -0.24 44 89
AKT1 0.014 0.18 0.33 74 -0.37 24 98
IKBKG -0.008 0.12 0.22 17 -0.24 47 64
MS4A2 -0.076 0.19 -10000 0 -0.41 120 120
mol:Sphingosine-1-phosphate 0 0 -10000 0 -10000 0 0
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
MAP3K1 -0.04 0.16 0.25 7 -0.38 63 70
mol:Ca2+ -0.013 0.16 0.27 21 -0.28 77 98
LYN 0.032 0.017 -10000 0 -10000 0 0
CBLB -0.047 0.14 -10000 0 -0.31 84 84
SHC1 0.028 0.025 -10000 0 -0.42 1 1
RasGAP/p62DOK 0.035 0.092 -10000 0 -0.24 46 46
positive regulation of cell migration -0.005 0.063 -10000 0 -0.3 23 23
INPP5D 0 0 -10000 0 -10000 0 0
PLD2 -0.004 0.18 0.31 74 -0.3 61 135
PTPN13 -0.07 0.2 -10000 0 -0.56 42 42
PTPN11 0.033 0.024 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
regulation of mast cell degranulation -0.004 0.15 0.33 16 -0.32 28 44
SYK 0.006 0.12 -10000 0 -0.42 34 34
GRB2 0.033 0.011 -10000 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.056 0.16 -10000 0 -0.36 87 87
LAT -0.045 0.13 -10000 0 -0.3 82 82
PAK2 -0.035 0.17 0.26 8 -0.4 55 63
NFATC2 -0.012 0.066 -10000 0 -0.59 4 4
HRAS -0.036 0.18 0.26 9 -0.42 58 67
GAB2 0.031 0.013 -10000 0 -10000 0 0
PLA2G1B 0.013 0.11 -10000 0 -0.94 5 5
Fc epsilon R1 -0.029 0.16 -10000 0 -0.3 109 109
Antigen/IgE/Fc epsilon R1 -0.024 0.14 -10000 0 -0.27 109 109
mol:GDP -0.051 0.18 0.25 1 -0.47 54 55
JUN -0.001 0.12 -10000 0 -0.42 39 39
mol:Ca++ 0 0 -10000 0 -10000 0 0
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
FOS -0.031 0.15 -10000 0 -0.42 66 66
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.044 0.14 -10000 0 -0.32 86 86
CHUK -0.011 0.12 0.22 17 -0.24 50 67
KLRG1 -0.038 0.12 0.16 1 -0.28 76 77
VAV1 -0.051 0.14 -10000 0 -0.32 88 88
calcium-dependent protein kinase C activity 0 0 -10000 0 -10000 0 0
CBL -0.045 0.13 -10000 0 -0.31 80 80
negative regulation of mast cell degranulation -0.041 0.11 -10000 0 -0.32 47 47
BTK -0.057 0.18 -10000 0 -0.51 50 50
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.063 0.18 -10000 0 -0.35 115 115
GAB2/PI3K/SHP2 -0.052 0.1 -10000 0 -0.3 52 52
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.048 0.13 -10000 0 -0.26 108 108
RAF1 0.014 0.11 -10000 0 -1 5 5
Fc epsilon R1/FcgammaRIIB/SHIP -0.024 0.16 -10000 0 -0.29 116 116
FCER1G 0.032 0.019 -10000 0 -10000 0 0
FCER1A -0.023 0.14 -10000 0 -0.43 56 56
Antigen/IgE/Fc epsilon R1/Fyn -0.016 0.14 -10000 0 -0.26 108 108
MAPK3 0.013 0.11 -10000 0 -0.97 5 5
MAPK1 0.008 0.11 -10000 0 -0.94 5 5
NFKB1 0.036 0.005 -10000 0 -10000 0 0
MAPK8 -0.041 0.22 -10000 0 -0.62 48 48
DUSP1 0.003 0.11 -10000 0 -0.42 34 34
NF-kappa-B/RelA 0.012 0.084 0.16 30 -0.15 41 71
actin cytoskeleton reorganization -0.044 0.18 -10000 0 -0.53 32 32
mol:Glucocorticoid Dexamethasone 0 0 -10000 0 -10000 0 0
PI3K -0.028 0.18 0.26 1 -0.39 63 64
FER -0.046 0.13 -10000 0 -0.31 83 83
RELA 0.035 0.006 -10000 0 -10000 0 0
ITK -0.032 0.11 -10000 0 -0.39 40 40
SOS1 0.035 0.021 -10000 0 -0.42 1 1
PLCG1 -0.042 0.19 0.27 4 -0.46 55 59
cytokine secretion -0.003 0.051 -10000 0 -0.13 13 13
SPHK1 -0.054 0.14 -10000 0 -0.32 85 85
PTK2 -0.046 0.19 -10000 0 -0.57 30 30
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.057 0.17 -10000 0 -0.38 89 89
EDG1 -0.005 0.064 -10000 0 -0.3 23 23
mol:DAG -0.03 0.19 0.29 14 -0.37 83 97
MAP2K2 0.008 0.11 -10000 0 -0.97 5 5
MAP2K1 0.01 0.11 -10000 0 -0.96 5 5
MAP2K7 0.035 0.021 -10000 0 -0.42 1 1
KLRG1/SHP2 -0.024 0.12 0.21 3 -0.36 34 37
MAP2K4 -0.098 0.36 -10000 0 -0.92 76 76
Fc epsilon R1/FcgammaRIIB -0.026 0.17 -10000 0 -0.31 116 116
mol:Choline -0.003 0.18 0.31 75 -0.3 61 136
SHC/Grb2/SOS1 -0.011 0.14 -10000 0 -0.3 72 72
FYN 0.027 0.054 -10000 0 -0.42 7 7
DOK1 0.027 0.061 -10000 0 -0.42 9 9
PXN -0.045 0.18 -10000 0 -0.52 30 30
HCLS1 -0.05 0.14 -10000 0 -0.32 87 87
PRKCB -0.016 0.15 0.25 18 -0.28 82 100
FCGR2B 0.001 0.11 -10000 0 -0.42 30 30
IGHE 0.001 0.008 -10000 0 -10000 0 0
KLRG1/SHIP -0.042 0.12 -10000 0 -0.32 46 46
LCP2 0.024 0.067 -10000 0 -0.42 11 11
PLA2G4A -0.052 0.14 -10000 0 -0.32 87 87
RASA1 0.029 0.05 -10000 0 -0.42 6 6
mol:Phosphatidic acid -0.003 0.18 0.31 75 -0.3 61 136
IKK complex 0.01 0.11 0.23 43 -0.2 34 77
WIPF1 0 0 -10000 0 -10000 0 0
Wnt signaling

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.067 0.15 -9999 0 -0.29 136 136
FZD6 -0.028 0.14 -9999 0 -0.42 60 60
WNT6 0.03 0.031 -9999 0 -0.42 2 2
WNT4 -0.019 0.14 -9999 0 -0.42 58 58
FZD3 0.007 0.095 -9999 0 -0.42 23 23
WNT5A -0.025 0.15 -9999 0 -0.42 63 63
WNT11 0.027 0.032 -9999 0 -0.42 2 2
IL12-mediated signaling events

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 -0.003 0.1 -10000 0 -0.32 20 20
TBX21 -0.26 0.57 -10000 0 -1.3 101 101
B2M 0.024 0.063 -10000 0 -0.42 9 9
TYK2 0.014 0.043 -10000 0 -10000 0 0
IL12RB1 0.013 0.043 -10000 0 -10000 0 0
GADD45B -0.18 0.44 -10000 0 -1 87 87
IL12RB2 -0.01 0.1 -10000 0 -0.43 26 26
GADD45G -0.17 0.43 -10000 0 -1 87 87
natural killer cell activation -0.005 0.022 -10000 0 -0.039 122 122
RELB 0.029 0.05 -10000 0 -0.42 6 6
RELA 0.035 0.006 -10000 0 -10000 0 0
IL18 0 0.11 -10000 0 -0.42 32 32
IL2RA 0.004 0.11 -10000 0 -0.42 31 31
IFNG -0.007 0.12 -10000 0 -0.42 38 38
STAT3 (dimer) -0.14 0.37 -10000 0 -0.79 101 101
HLA-DRB5 0.016 0.077 -10000 0 -0.42 14 14
FASLG -0.18 0.5 -10000 0 -1.1 89 89
NF kappa B2 p52/RelB -0.16 0.44 -10000 0 -0.94 100 100
CD4 0.028 0.021 -10000 0 -10000 0 0
SOCS1 0.032 0.023 -10000 0 -0.42 1 1
EntrezGene:6955 -0.003 0.012 -10000 0 -0.028 79 79
CD3D 0.008 0.078 -10000 0 -0.43 14 14
CD3E 0.024 0.026 -10000 0 -10000 0 0
CD3G -0.028 0.14 -10000 0 -0.43 54 54
IL12Rbeta2/JAK2 0.004 0.096 -10000 0 -0.33 26 26
CCL3 -0.17 0.43 -10000 0 -1 89 89
CCL4 -0.18 0.45 -10000 0 -1 90 90
HLA-A 0.017 0.086 -10000 0 -0.42 18 18
IL18/IL18R -0.001 0.16 -10000 0 -0.34 84 84
NOS2 -0.18 0.43 -10000 0 -0.87 114 114
IL12/IL12R/TYK2/JAK2/SPHK2 -0.008 0.11 -10000 0 -0.34 20 20
IL1R1 -0.22 0.5 -10000 0 -1.1 102 102
IL4 0.034 0.052 -10000 0 -0.42 5 5
JAK2 0.011 0.051 -10000 0 -0.46 2 2
EntrezGene:6957 -0.003 0.012 -10000 0 -0.029 70 70
TCR/CD3/MHC I/CD8 -0.073 0.28 -10000 0 -0.74 54 54
RAB7A -0.13 0.34 -10000 0 -0.74 104 104
lysosomal transport -0.12 0.32 -10000 0 -0.69 104 104
FOS -0.24 0.5 -10000 0 -1.1 111 111
STAT4 (dimer) -0.15 0.42 -10000 0 -0.89 101 101
STAT5A (dimer) -0.18 0.44 -10000 0 -0.96 100 100
GZMA -0.17 0.42 -10000 0 -0.92 102 102
GZMB -0.26 0.56 -10000 0 -1.3 107 107
HLX 0 0 -10000 0 -10000 0 0
LCK -0.21 0.5 -10000 0 -1.1 105 105
TCR/CD3/MHC II/CD4 -0.058 0.17 -10000 0 -0.37 89 89
IL2/IL2R 0.043 0.11 -10000 0 -0.29 46 46
MAPK14 -0.18 0.44 -10000 0 -0.96 102 102
CCR5 -0.16 0.4 -10000 0 -0.82 113 113
IL1B -0.021 0.13 -10000 0 -0.44 40 40
STAT6 -0.055 0.2 -10000 0 -0.6 34 34
STAT4 0.01 0.1 -10000 0 -0.42 27 27
STAT3 0.028 0.031 -10000 0 -0.42 2 2
STAT1 0.02 0.075 -10000 0 -0.42 14 14
NFKB1 0.036 0.005 -10000 0 -10000 0 0
NFKB2 0.035 0.021 -10000 0 -0.42 1 1
IL12B 0.01 0.063 -10000 0 -0.42 6 6
CD8A 0 0.008 -10000 0 -0.036 21 21
CD8B -0.001 0.009 -10000 0 -0.043 21 21
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity 0.003 0.1 0.32 20 -10000 0 20
IL2RB 0.011 0.097 -10000 0 -0.42 24 24
proteasomal ubiquitin-dependent protein catabolic process -0.13 0.37 -10000 0 -0.79 101 101
IL2RG 0.031 0.041 -10000 0 -0.42 4 4
IL12 0.015 0.076 -10000 0 -0.33 10 10
STAT5A 0.027 0.037 -10000 0 -0.42 3 3
CD247 -0.002 0.011 -10000 0 -0.027 69 69
IL2 0.032 0.036 -10000 0 -0.42 3 3
SPHK2 0.035 0.007 -10000 0 -10000 0 0
FRAP1 0.035 0.007 -10000 0 -10000 0 0
IL12A 0.006 0.059 -10000 0 -0.42 5 5
IL12/IL12R/TYK2/JAK2 -0.21 0.53 -10000 0 -1.1 102 102
MAP2K3 -0.18 0.46 -10000 0 -0.99 103 103
RIPK2 0.028 0.015 -10000 0 -10000 0 0
MAP2K6 -0.18 0.45 -10000 0 -0.96 105 105
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA 0.019 0.064 -10000 0 -0.42 9 9
IL18RAP -0.021 0.15 -10000 0 -0.43 58 58
IL12Rbeta1/TYK2 0.027 0.056 -10000 0 -10000 0 0
EOMES -0.048 0.28 -10000 0 -1.1 30 30
STAT1 (dimer) -0.15 0.38 -10000 0 -0.8 106 106
T cell proliferation -0.11 0.3 -10000 0 -0.62 108 108
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0.016 0.091 -10000 0 -0.43 20 20
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.11 0.33 -10000 0 -0.67 110 110
ATF2 -0.16 0.4 -10000 0 -0.89 97 97
FAS signaling pathway (CD95)

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.024 0.082 0.19 84 -0.19 6 90
RFC1 0.021 0.074 0.19 72 -0.19 5 77
PRKDC 0.044 0.1 0.21 120 -0.2 5 125
RIPK1 0.036 0.008 -10000 0 -10000 0 0
CASP7 -0.007 0.14 -10000 0 -0.68 18 18
FASLG/FAS/FADD/FAF1 0.003 0.091 0.2 37 -0.26 28 65
MAP2K4 -0.025 0.17 0.44 2 -0.44 46 48
mol:ceramide -0.013 0.11 -10000 0 -0.36 34 34
GSN 0.019 0.086 0.19 78 -0.22 14 92
FASLG/FAS/FADD/FAF1/Caspase 8 0.006 0.11 0.23 3 -0.32 29 32
FAS 0.003 0.11 -10000 0 -0.42 29 29
BID -0.017 0.053 0.26 12 -0.27 7 19
MAP3K1 -0.009 0.14 0.3 4 -0.47 22 26
MAP3K7 0.033 0.011 -10000 0 -10000 0 0
RB1 0.019 0.071 0.19 70 -0.2 5 75
CFLAR 0.032 0.046 -10000 0 -0.42 5 5
HGF/MET 0.016 0.12 -10000 0 -0.26 77 77
ARHGDIB 0.016 0.09 0.2 73 -0.23 17 90
FADD 0.025 0.021 -10000 0 -10000 0 0
actin filament polymerization -0.018 0.087 0.22 16 -0.19 73 89
NFKB1 0.004 0.1 -10000 0 -0.63 8 8
MAPK8 -0.044 0.21 0.51 2 -0.5 68 70
DFFA 0.023 0.078 0.19 81 -0.19 6 87
DNA fragmentation during apoptosis 0.022 0.08 0.19 76 -0.19 6 82
FAS/FADD/MET 0.034 0.077 -10000 0 -0.26 27 27
CFLAR/RIP1 0.049 0.038 -10000 0 -0.3 5 5
FAIM3 0.015 0.078 -10000 0 -0.42 15 15
FAF1 0.028 0.03 -10000 0 -0.42 1 1
PARP1 0.028 0.098 0.22 84 -0.21 8 92
DFFB 0.022 0.08 0.19 80 -0.19 6 86
CHUK -0.008 0.11 -10000 0 -0.58 10 10
FASLG -0.011 0.12 -10000 0 -0.42 36 36
FAS/FADD 0.02 0.077 -10000 0 -0.3 23 23
HGF 0.028 0.057 -10000 0 -0.42 8 8
LMNA 0.024 0.1 0.34 26 -0.22 6 32
CASP6 0.02 0.081 0.19 79 -0.21 9 88
CASP10 0.03 0.02 -10000 0 -10000 0 0
CASP3 0.032 0.092 0.23 81 -0.22 6 87
PTPN13 -0.03 0.16 -10000 0 -0.42 72 72
CASP8 -0.013 0.057 0.33 13 -10000 0 13
IL6 -0.1 0.41 -10000 0 -1.2 63 63
MET 0.03 0.041 -10000 0 -0.42 4 4
ICAD/CAD 0.018 0.073 0.17 69 -10000 0 69
FASLG/FAS/FADD/FAF1/Caspase 10 -0.014 0.11 -10000 0 -0.36 34 34
activation of caspase activity by cytochrome c -0.017 0.053 0.26 12 -0.27 7 19
PAK2 0.021 0.077 0.19 81 -0.19 9 90
BCL2 -0.056 0.18 -10000 0 -0.42 99 99
Stabilization and expansion of the E-cadherin adherens junction

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization -0.013 0.083 -10000 0 -0.21 68 68
epithelial cell differentiation 0.026 0.094 -10000 0 -0.22 57 57
CYFIP2 -0.006 0.13 -10000 0 -0.42 45 45
ENAH -0.028 0.075 0.3 2 -0.31 8 10
EGFR -0.015 0.13 -10000 0 -0.42 49 49
EPHA2 0.032 0.036 -10000 0 -0.42 3 3
MYO6 -0.036 0.077 0.18 7 -0.22 69 76
CTNNB1 0.025 0.067 -10000 0 -0.42 11 11
ABI1/Sra1/Nap1 0.041 0.09 -10000 0 -0.26 40 40
AQP5 -0.095 0.17 -10000 0 -0.45 83 83
CTNND1 0.034 0.022 -10000 0 -0.42 1 1
mol:PI-4-5-P2 -0.032 0.07 0.18 6 -0.21 58 64
regulation of calcium-dependent cell-cell adhesion -0.032 0.069 0.18 5 -0.21 60 65
EGF -0.069 0.19 -10000 0 -0.42 110 110
NCKAP1 0.035 0.021 -10000 0 -0.42 1 1
AQP3 -0.094 0.17 -10000 0 -0.45 84 84
cortical microtubule organization 0.026 0.094 -10000 0 -0.22 57 57
GO:0000145 -0.033 0.065 0.16 6 -0.2 58 64
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.031 0.097 -10000 0 -0.22 57 57
MLLT4 0.02 0.078 -10000 0 -0.42 15 15
ARF6/GDP -0.041 0.067 -10000 0 -0.22 56 56
ARF6 0.034 0.029 -10000 0 -0.42 2 2
Ephrin A1/EPHA2/NCK1/GIT1 0.053 0.072 -10000 0 -0.23 20 20
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP -0.026 0.093 0.18 1 -0.34 18 19
PVRL2 0.026 0.064 -10000 0 -0.42 10 10
ZYX -0.034 0.074 0.18 8 -0.21 64 72
ARF6/GTP 0.059 0.077 -10000 0 -0.24 20 20
CDH1 -0.011 0.13 -10000 0 -0.42 45 45
EGFR/EGFR/EGF/EGF -0.057 0.14 -10000 0 -0.22 191 191
RhoA/GDP 0.023 0.099 -10000 0 -0.22 64 64
actin cytoskeleton organization -0.04 0.074 0.16 7 -0.21 70 77
IGF-1R heterotetramer -0.042 0.17 -10000 0 -0.42 84 84
GIT1 0.034 0.022 -10000 0 -0.42 1 1
IGF1R -0.042 0.17 -10000 0 -0.42 84 84
IGF1 -0.038 0.16 -10000 0 -0.42 78 78
DIAPH1 0.002 0.2 -10000 0 -0.56 51 51
Wnt receptor signaling pathway -0.026 0.094 0.22 57 -10000 0 57
RHOA 0.026 0.061 -10000 0 -0.42 9 9
RhoA/GTP -0.043 0.068 -10000 0 -0.22 60 60
CTNNA1 0.035 0.021 -10000 0 -0.42 1 1
VCL -0.041 0.075 0.17 7 -0.22 70 77
EFNA1 0.014 0.08 -10000 0 -0.42 16 16
LPP -0.038 0.071 0.17 8 -0.21 60 68
Ephrin A1/EPHA2 0.01 0.092 -10000 0 -0.22 57 57
SEC6/SEC8 -0.048 0.069 -10000 0 -0.21 75 75
MGAT3 -0.032 0.07 0.18 5 -0.21 60 65
HGF/MET 0.016 0.093 -10000 0 -0.21 66 66
HGF 0.028 0.057 -10000 0 -0.42 8 8
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN -0.013 0.084 -10000 0 -0.22 68 68
actin cable formation 0.016 0.11 0.26 12 -0.29 10 22
KIAA1543 -0.037 0.07 0.17 1 -0.22 54 55
KIFC3 -0.031 0.068 0.18 6 -0.21 52 58
NCK1 0.034 0.021 -10000 0 -0.42 1 1
EXOC3 0.036 0.002 -10000 0 -10000 0 0
ACTN1 -0.034 0.075 0.18 8 -0.21 65 73
NCK1/GIT1 0.049 0.025 -10000 0 -0.29 2 2
mol:GDP 0.026 0.094 -10000 0 -0.22 57 57
EXOC4 0.034 0.021 -10000 0 -0.42 1 1
STX4 -0.034 0.062 -10000 0 -0.21 57 57
PIP5K1C -0.032 0.071 0.18 6 -0.21 58 64
LIMA1 0 0 -10000 0 -10000 0 0
ABI1 0.035 0.008 -10000 0 -10000 0 0
ROCK1 -0.009 0.1 0.3 5 -0.32 7 12
adherens junction assembly -0.044 0.12 0.27 1 -0.48 15 16
IGF-1R heterotetramer/IGF1 -0.055 0.15 -10000 0 -0.24 175 175
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.032 0.076 -10000 0 -0.3 24 24
MET 0.03 0.041 -10000 0 -0.42 4 4
PLEKHA7 -0.031 0.07 0.18 8 -0.21 58 66
mol:GTP 0.051 0.071 -10000 0 -0.23 20 20
establishment of epithelial cell apical/basal polarity -0.044 0.072 0.14 13 -0.2 64 77
cortical actin cytoskeleton stabilization -0.013 0.083 -10000 0 -0.21 68 68
regulation of cell-cell adhesion -0.04 0.074 0.16 7 -0.21 70 77
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton -0.013 0.084 -10000 0 -0.22 68 68
IL23-mediated signaling events

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.16 0.54 -10000 0 -1.3 78 78
IL23A -0.13 0.49 -10000 0 -1.1 71 71
NF kappa B1 p50/RelA/I kappa B alpha -0.099 0.48 -10000 0 -1.1 71 71
positive regulation of T cell mediated cytotoxicity -0.14 0.52 -10000 0 -1.2 68 68
ITGA3 -0.13 0.48 -10000 0 -1.1 73 73
IL17F -0.049 0.33 0.47 5 -0.69 70 75
IL12B 0.02 0.075 -10000 0 -0.44 6 6
STAT1 (dimer) -0.14 0.5 -10000 0 -1.2 69 69
CD4 -0.1 0.45 -10000 0 -1.1 63 63
IL23 -0.12 0.47 -10000 0 -1.1 70 70
IL23R -0.001 0.22 -10000 0 -1.3 11 11
IL1B -0.15 0.53 -10000 0 -1.3 74 74
T-helper cell lineage commitment 0 0 -10000 0 -10000 0 0
IL24 -0.077 0.46 -10000 0 -1.1 57 57
TYK2 0.02 0.046 -10000 0 -10000 0 0
STAT4 0.01 0.1 -10000 0 -0.42 27 27
STAT3 0.029 0.032 -10000 0 -0.42 2 2
IL18RAP -0.022 0.15 -10000 0 -0.42 58 58
IL12RB1 0.02 0.046 -10000 0 -10000 0 0
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
IL12Rbeta1/TYK2 0.031 0.059 -10000 0 -10000 0 0
IL23R/JAK2 0.012 0.22 -10000 0 -1.2 11 11
positive regulation of chronic inflammatory response -0.14 0.52 -10000 0 -1.2 68 68
natural killer cell activation 0 0.012 0.081 7 -10000 0 7
JAK2 0.023 0.063 -10000 0 -0.46 2 2
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
NFKB1 0.036 0.007 -10000 0 -10000 0 0
RELA 0.036 0.007 -10000 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.11 0.45 -10000 0 -1 70 70
ALOX12B -0.11 0.45 -10000 0 -1.1 66 66
CXCL1 -0.17 0.55 -10000 0 -1.2 101 101
T cell proliferation -0.14 0.52 -10000 0 -1.2 68 68
NFKBIA 0.034 0.03 -10000 0 -0.42 2 2
IL17A -0.027 0.26 -10000 0 -0.53 70 70
PI3K -0.12 0.49 -10000 0 -1.1 71 71
IFNG -0.006 0.05 0.14 6 -0.13 45 51
STAT3 (dimer) -0.12 0.46 -10000 0 -1.1 70 70
IL18R1 0.015 0.09 -10000 0 -0.42 20 20
IL23/IL23R/JAK2/TYK2/SOCS3 -0.035 0.29 0.51 1 -0.67 46 47
IL18/IL18R -0.009 0.16 -10000 0 -0.34 84 84
macrophage activation -0.006 0.021 -10000 0 -0.044 63 63
TNF -0.13 0.48 -10000 0 -1.1 72 72
STAT3/STAT4 -0.13 0.49 -10000 0 -1.2 71 71
STAT4 (dimer) -0.14 0.52 -10000 0 -1.2 71 71
IL18 -0.001 0.11 -10000 0 -0.42 32 32
IL19 -0.077 0.46 -10000 0 -1.1 58 58
STAT5A (dimer) -0.14 0.49 -10000 0 -1.2 68 68
STAT1 0.02 0.075 -10000 0 -0.42 14 14
SOCS3 0.028 0.046 -10000 0 -0.42 5 5
CXCL9 -0.2 0.58 -10000 0 -1.2 109 109
MPO -0.097 0.45 -10000 0 -1.1 62 62
positive regulation of humoral immune response -0.14 0.52 -10000 0 -1.2 68 68
IL23/IL23R/JAK2/TYK2 -0.15 0.56 -10000 0 -1.3 68 68
IL6 -0.17 0.56 -10000 0 -1.2 93 93
STAT5A 0.027 0.037 -10000 0 -0.42 3 3
IL2 0.029 0.039 -10000 0 -0.42 3 3
positive regulation of tyrosine phosphorylation of STAT protein 0 0.012 0.081 7 -10000 0 7
CD3E -0.11 0.45 -10000 0 -1.1 63 63
keratinocyte proliferation -0.14 0.52 -10000 0 -1.2 68 68
NOS2 -0.11 0.45 -10000 0 -1 70 70
Noncanonical Wnt signaling pathway

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0.03 0.036 -10000 0 -0.42 3 3
GNB1/GNG2 -0.048 0.17 -10000 0 -0.38 63 63
mol:DAG -0.056 0.15 -10000 0 -0.35 61 61
PLCG1 -0.059 0.15 0.2 3 -0.36 62 65
YES1 -0.066 0.15 -10000 0 -0.41 54 54
FZD3 0.007 0.095 -10000 0 -0.42 23 23
FZD6 -0.028 0.14 -10000 0 -0.42 60 60
G protein -0.035 0.17 0.29 10 -0.36 58 68
MAP3K7 -0.057 0.12 0.24 2 -0.32 54 56
mol:Ca2+ -0.054 0.14 -10000 0 -0.34 61 61
mol:IP3 -0.056 0.15 -10000 0 -0.35 61 61
NLK -0.036 0.25 -10000 0 -0.82 45 45
GNB1 0.032 0.045 -10000 0 -0.42 5 5
CAMK2A -0.056 0.14 0.25 2 -0.32 60 62
MAP3K7IP1 0.034 0.009 -10000 0 -10000 0 0
Noncanonical Wnts/FZD -0.067 0.15 -10000 0 -0.29 136 136
CSNK1A1 0.036 0.006 -10000 0 -10000 0 0
GNAS -0.064 0.14 -10000 0 -0.39 52 52
GO:0007205 -0.059 0.14 0.26 2 -0.35 59 61
WNT6 0.03 0.031 -10000 0 -0.42 2 2
WNT4 -0.019 0.14 -10000 0 -0.42 58 58
NFAT1/CK1 alpha -0.047 0.16 0.29 2 -0.38 52 54
GNG2 0.034 0.021 -10000 0 -0.42 1 1
WNT5A -0.025 0.15 -10000 0 -0.42 63 63
WNT11 0.027 0.032 -10000 0 -0.42 2 2
CDC42 -0.062 0.15 0.19 2 -0.39 53 55
TCR signaling in naïve CD8+ T cells

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC 0.004 0.17 0.24 39 -0.34 68 107
FYN -0.038 0.2 0.29 4 -0.44 71 75
LAT/GRAP2/SLP76 -0.021 0.17 0.24 6 -0.37 71 77
IKBKB 0.03 0.014 -10000 0 -10000 0 0
AKT1 -0.026 0.15 0.25 14 -0.31 80 94
B2M 0.026 0.062 -10000 0 -0.43 9 9
IKBKG 0 0.055 0.13 19 -0.13 26 45
MAP3K8 0.004 0.11 -10000 0 -0.42 32 32
mol:Ca2+ -0.017 0.021 0.093 2 -0.058 66 68
integrin-mediated signaling pathway 0.03 0.048 -10000 0 -0.25 12 12
LAT/GRAP2/SLP76/VAV1/PI3K Class IA -0.052 0.2 0.26 2 -0.43 84 86
TRPV6 -0.028 0.22 1.2 9 -0.62 1 10
CD28 0 0.12 -10000 0 -0.42 37 37
SHC1 -0.022 0.2 0.24 45 -0.39 83 128
receptor internalization -0.069 0.2 0.17 1 -0.4 124 125
PRF1 -0.054 0.22 -10000 0 -0.88 22 22
KRAS 0.028 0.054 -10000 0 -0.42 7 7
GRB2 0.033 0.011 -10000 0 -10000 0 0
COT/AKT1 -0.015 0.14 0.25 11 -0.29 67 78
LAT -0.042 0.19 0.24 13 -0.39 91 104
EntrezGene:6955 0 0.002 -10000 0 -0.016 7 7
CD3D 0.016 0.077 -10000 0 -0.43 14 14
CD3E 0.032 0.015 -10000 0 -10000 0 0
CD3G -0.021 0.14 -10000 0 -0.42 54 54
RASGRP2 -0.001 0.043 -10000 0 -0.17 27 27
RASGRP1 -0.043 0.17 0.32 2 -0.36 77 79
HLA-A 0.018 0.086 -10000 0 -0.43 18 18
RASSF5 0.019 0.064 -10000 0 -0.42 10 10
RAP1A/GTP/RAPL 0.03 0.048 -10000 0 -0.25 12 12
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.016 0.067 0.14 32 -0.12 31 63
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.022 0.071 -10000 0 -0.18 53 53
PRKCA -0.01 0.09 0.18 9 -0.22 46 55
GRAP2 0.032 0.023 -10000 0 -0.42 1 1
mol:IP3 -0.022 0.14 0.21 30 -0.31 63 93
EntrezGene:6957 0 0.003 0.011 2 -0.021 7 9
TCR/CD3/MHC I/CD8 -0.031 0.14 -10000 0 -0.36 65 65
ORAI1 0.007 0.16 0.59 1 -1 9 10
CSK -0.045 0.18 0.26 2 -0.41 79 81
B7 family/CD28 -0.027 0.22 0.29 1 -0.47 75 76
CHUK 0.026 0.067 -10000 0 -0.42 11 11
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.06 0.21 0.26 1 -0.42 103 104
PTPN6 -0.053 0.19 0.24 4 -0.42 81 85
VAV1 -0.059 0.2 0.26 2 -0.41 98 100
Monovalent TCR/CD3 -0.018 0.11 -10000 0 -0.3 61 61
CBL 0.032 0.012 -10000 0 -10000 0 0
LCK -0.046 0.21 0.32 2 -0.48 71 73
PAG1 -0.031 0.19 0.24 11 -0.42 72 83
RAP1A 0.031 0.045 -10000 0 -0.42 5 5
TCR/CD3/MHC I/CD8/LCK -0.062 0.21 0.28 1 -0.42 104 105
CD80 0.034 0.022 -10000 0 -0.42 1 1
CD86 0.017 0.09 -10000 0 -0.42 20 20
PDK1/CARD11/BCL10/MALT1 -0.013 0.09 -10000 0 -0.22 53 53
HRAS 0.032 0.036 -10000 0 -0.42 3 3
GO:0035030 -0.052 0.17 0.25 1 -0.4 76 77
CD8A 0 0.003 0.011 2 -0.018 7 9
CD8B 0 0.004 0.011 3 -0.017 12 15
PTPRC 0.006 0.095 -10000 0 -0.42 23 23
PDK1/PKC theta -0.028 0.18 0.32 17 -0.38 76 93
CSK/PAG1 -0.025 0.18 0.23 11 -0.42 64 75
SOS1 0.035 0.021 -10000 0 -0.42 1 1
peptide-MHC class I 0.033 0.088 -10000 0 -0.36 23 23
GRAP2/SLP76 -0.034 0.2 0.29 1 -0.4 86 87
STIM1 0.008 0.11 1.3 3 -10000 0 3
RAS family/GTP 0.013 0.085 0.18 5 -0.18 38 43
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.072 0.21 -10000 0 -0.41 123 123
mol:DAG -0.042 0.11 0.12 1 -0.27 74 75
RAP1A/GDP 0.011 0.034 0.077 15 -0.068 19 34
PLCG1 0.034 0.008 -10000 0 -10000 0 0
CD247 0 0.002 -10000 0 -0.016 7 7
cytotoxic T cell degranulation -0.051 0.21 -10000 0 -0.82 23 23
RAP1A/GTP 0 0.018 -10000 0 -0.065 31 31
mol:PI-3-4-5-P3 -0.04 0.17 0.25 2 -0.37 83 85
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.021 0.18 0.23 22 -0.39 66 88
NRAS 0.029 0.054 -10000 0 -0.42 7 7
ZAP70 0.034 0.022 -10000 0 -0.42 1 1
GRB2/SOS1 0.048 0.023 -10000 0 -0.3 1 1
LAT/GRAP2/SLP76/VAV1 -0.031 0.17 0.24 3 -0.39 69 72
MALT1 0.031 0.041 -10000 0 -0.42 4 4
TRAF6 0.035 0.021 -10000 0 -0.42 1 1
CD8 heterodimer 0.001 0.006 0.02 3 -0.027 7 10
CARD11 0.028 0.054 -10000 0 -0.42 7 7
PRKCB -0.033 0.077 0.11 2 -0.19 78 80
PRKCE -0.012 0.097 0.18 10 -0.23 50 60
PRKCQ -0.045 0.19 0.29 3 -0.42 80 83
LCP2 0.024 0.067 -10000 0 -0.42 11 11
BCL10 0.035 0.008 -10000 0 -10000 0 0
regulation of survival gene product expression -0.019 0.13 0.24 14 -0.27 78 92
IKK complex 0.013 0.061 0.17 31 -0.11 15 46
RAS family/GDP -0.004 0.015 -10000 0 -0.046 25 25
MAP3K14 -0.014 0.1 0.2 13 -0.23 60 73
PDPK1 -0.021 0.14 0.28 18 -0.3 75 93
TCR/CD3/MHC I/CD8/Fyn -0.061 0.2 -10000 0 -0.43 92 92
IL27-mediated signaling events

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.035 0.021 -10000 0 -0.42 1 1
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response 0.099 0.24 0.62 67 -0.53 2 69
IL27/IL27R/JAK1 -0.088 0.34 0.89 2 -1.1 37 39
TBX21 -0.096 0.3 0.64 20 -0.58 96 116
IL12B 0.026 0.052 -10000 0 -0.42 6 6
IL12A 0.003 0.031 -10000 0 -0.3 5 5
IL6ST -0.05 0.16 -10000 0 -0.4 87 87
IL27RA/JAK1 -0.063 0.33 0.44 2 -1.2 35 37
IL27 -0.036 0.16 -10000 0 -0.42 73 73
TYK2 0.029 0.029 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.013 0.087 0.2 13 -0.24 55 68
T-helper 2 cell differentiation 0.099 0.24 0.62 67 -0.53 2 69
T cell proliferation during immune response 0.099 0.24 0.62 67 -0.53 2 69
MAPKKK cascade -0.099 0.24 0.53 2 -0.62 67 69
STAT3 0.028 0.031 -10000 0 -0.42 2 2
STAT2 0.036 0.005 -10000 0 -10000 0 0
STAT1 0.022 0.077 -10000 0 -0.42 14 14
IL12RB1 0.036 0.005 -10000 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 -0.081 0.29 0.68 19 -0.6 75 94
IL27/IL27R/JAK2/TYK2 -0.1 0.25 0.53 2 -0.63 67 69
positive regulation of T cell mediated cytotoxicity -0.099 0.24 0.53 2 -0.62 67 69
STAT1 (dimer) -0.1 0.39 0.57 30 -0.94 60 90
JAK2 0.024 0.038 -10000 0 -0.43 2 2
JAK1 0.035 0.036 -10000 0 -0.39 3 3
STAT2 (dimer) -0.084 0.24 0.47 2 -0.6 64 66
T cell proliferation -0.11 0.25 0.48 2 -0.62 72 74
IL12/IL12R/TYK2/JAK2 0.001 0.2 -10000 0 -0.9 18 18
IL17A -0.013 0.087 0.2 13 -0.24 55 68
mast cell activation 0.099 0.24 0.62 67 -0.53 2 69
IFNG -0.01 0.05 0.14 5 -0.13 50 55
T cell differentiation -0.005 0.01 0.026 10 -0.025 76 86
STAT3 (dimer) -0.075 0.24 0.47 2 -0.59 64 66
STAT5A (dimer) -0.076 0.24 0.47 2 -0.6 63 65
STAT4 (dimer) -0.094 0.26 0.47 2 -0.6 71 73
STAT4 0.01 0.1 -10000 0 -0.42 27 27
T cell activation -0.002 0.032 0.12 32 -10000 0 32
IL27R/JAK2/TYK2 -0.08 0.32 -10000 0 -1.1 36 36
GATA3 -0.2 0.52 0.82 9 -1.3 91 100
IL18 -0.013 0.074 -10000 0 -0.3 32 32
positive regulation of mast cell cytokine production -0.073 0.23 0.46 2 -0.57 64 66
IL27/EBI3 -0.008 0.13 0.23 5 -0.31 76 81
IL27RA -0.091 0.33 -10000 0 -1.3 35 35
IL6 -0.018 0.14 -10000 0 -0.42 52 52
STAT5A 0.027 0.037 -10000 0 -0.42 3 3
monocyte differentiation 0 0.002 -10000 0 -0.013 1 1
IL2 0.022 0.15 0.47 35 -1.2 3 38
IL1B -0.017 0.082 -10000 0 -0.3 40 40
EBI3 0.026 0.053 -10000 0 -0.43 5 5
TNF 0.002 0.041 -10000 0 -0.3 9 9
Nongenotropic Androgen signaling

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.007 0.004 -10000 0 -10000 0 0
GNB1/GNG2 0.006 0.12 -10000 0 -0.24 102 102
regulation of S phase of mitotic cell cycle -0.026 0.11 -10000 0 -0.23 100 100
GNAO1 0.03 0.014 -10000 0 -10000 0 0
HRAS 0.032 0.036 -10000 0 -0.42 3 3
SHBG/T-DHT 0.022 0.008 -10000 0 -10000 0 0
PELP1 0.032 0.011 -10000 0 -10000 0 0
AKT1 0.007 0.019 -10000 0 -0.3 2 2
MAP2K1 -0.056 0.097 0.22 4 -0.32 21 25
T-DHT/AR -0.037 0.13 -10000 0 -0.3 99 99
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.001 0.002 -10000 0 -0.006 73 73
GNAI2 0.028 0.054 -10000 0 -0.42 7 7
GNAI3 0.035 0.006 -10000 0 -10000 0 0
GNAI1 0.017 0.087 -10000 0 -0.42 19 19
mol:GDP -0.073 0.15 -10000 0 -0.37 99 99
cell proliferation -0.075 0.17 0.29 2 -0.43 76 78
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
FOS -0.12 0.28 -10000 0 -0.78 75 75
mol:Ca2+ -0.009 0.024 -10000 0 -0.062 58 58
MAPK3 -0.06 0.14 0.28 3 -0.34 68 71
MAPK1 -0.045 0.13 0.21 1 -0.34 50 51
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
mol:IP3 0 0.002 -10000 0 -0.004 73 73
cAMP biosynthetic process 0.003 0.017 -10000 0 -10000 0 0
GNG2 0.034 0.021 -10000 0 -0.42 1 1
potassium channel inhibitor activity 0 0.002 -10000 0 -0.004 73 73
HRAS/GTP -0.006 0.12 -10000 0 -0.22 99 99
actin cytoskeleton reorganization 0.039 0.051 -10000 0 -0.21 17 17
SRC 0.033 0.03 -10000 0 -0.42 2 2
voltage-gated calcium channel activity 0 0.002 -10000 0 -0.004 73 73
PI3K 0.033 0.056 -10000 0 -0.25 17 17
apoptosis 0.063 0.17 0.43 77 -10000 0 77
T-DHT/AR/PELP1 -0.015 0.12 -10000 0 -0.25 99 99
HRAS/GDP -0.052 0.16 -10000 0 -0.36 101 101
CREB1 -0.069 0.18 -10000 0 -0.46 77 77
RAC1-CDC42/GTP 0.05 0.056 -10000 0 -0.21 17 17
AR -0.054 0.18 -10000 0 -0.42 99 99
GNB1 0.032 0.045 -10000 0 -0.42 5 5
RAF1 -0.035 0.1 0.35 1 -0.22 94 95
RAC1-CDC42/GDP -0.03 0.16 -10000 0 -0.35 98 98
T-DHT/AR/PELP1/Src 0.001 0.12 -10000 0 -0.23 98 98
MAP2K2 -0.057 0.098 0.21 5 -0.32 23 28
T-DHT/AR/PELP1/Src/PI3K -0.027 0.11 -10000 0 -0.24 100 100
GNAZ 0.023 0.07 -10000 0 -0.42 12 12
SHBG 0.032 0.012 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP -0.037 0.13 -10000 0 -0.4 37 37
mol:T-DHT 0 0.001 0.002 2 -0.002 44 46
RAC1 0.035 0.006 -10000 0 -10000 0 0
GNRH1 0.006 0.014 -10000 0 -0.3 1 1
Gi family/GTP -0.028 0.084 -10000 0 -0.23 47 47
CDC42 0.035 0.008 -10000 0 -10000 0 0
IL6-mediated signaling events

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.075 0.28 -10000 0 -0.74 49 49
CRP -0.044 0.3 0.57 3 -0.77 41 44
cell cycle arrest -0.095 0.34 0.49 1 -0.8 65 66
TIMP1 -0.069 0.3 -10000 0 -0.79 51 51
IL6ST -0.049 0.17 -10000 0 -0.42 88 88
Rac1/GDP -0.05 0.19 0.28 1 -0.42 65 66
AP1 0.013 0.18 -10000 0 -0.51 25 25
GAB2 0.033 0.014 -10000 0 -10000 0 0
TNFSF11 -0.14 0.4 -10000 0 -0.98 79 79
HSP90B1 0 0.12 -10000 0 -0.83 8 8
GAB1 0.028 0.061 -10000 0 -0.42 9 9
MAPK14 -0.045 0.17 -10000 0 -0.52 33 33
AKT1 0.03 0.081 -10000 0 -0.42 5 5
FOXO1 0.037 0.08 -10000 0 -0.4 5 5
MAP2K6 -0.05 0.16 0.24 1 -0.42 55 56
mol:GTP 0 0.002 -10000 0 -10000 0 0
MAP2K4 -0.061 0.21 0.33 2 -0.46 69 71
MITF -0.054 0.17 0.24 1 -0.4 65 66
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.036 0.005 -10000 0 -10000 0 0
A2M -0.053 0.33 -10000 0 -1.3 32 32
CEBPB 0.027 0.05 -10000 0 -0.42 6 6
GRB2/SOS1/GAB family/SHP2 0.005 0.12 0.3 1 -0.43 17 18
STAT3 -0.11 0.37 0.5 1 -0.89 64 65
STAT1 -0.01 0.17 -10000 0 -0.88 17 17
CEBPD -0.097 0.37 0.59 1 -0.91 67 68
PIK3CA 0.034 0.022 -10000 0 -0.42 1 1
PI3K 0.038 0.066 -10000 0 -0.3 17 17
JUN -0.001 0.12 -10000 0 -0.42 39 39
PIAS3/MITF -0.045 0.17 -10000 0 -0.4 59 59
MAPK11 -0.044 0.16 -10000 0 -0.52 32 32
STAT3 (dimer)/FOXO1 -0.052 0.28 0.46 2 -0.66 51 53
GRB2/SOS1/GAB family -0.017 0.17 0.3 1 -0.43 37 38
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.062 0.17 -10000 0 -0.38 78 78
GRB2 0.034 0.011 -10000 0 -10000 0 0
JAK2 0.032 0.03 -10000 0 -0.42 2 2
LBP -0.031 0.23 0.45 1 -0.62 36 37
PIK3R1 0.02 0.08 -10000 0 -0.42 16 16
JAK1 0.031 0.039 -10000 0 -0.42 3 3
MYC -0.067 0.37 0.59 2 -0.91 59 61
FGG -0.076 0.29 -10000 0 -0.75 48 48
macrophage differentiation -0.095 0.34 0.49 1 -0.8 65 66
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.023 0.16 -10000 0 -0.25 132 132
JUNB -0.075 0.28 -10000 0 -0.76 42 42
FOS -0.031 0.15 -10000 0 -0.42 66 66
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.06 0.17 0.27 1 -0.4 71 72
STAT1/PIAS1 -0.046 0.19 0.3 2 -0.42 66 68
GRB2/SOS1/GAB family/SHP2/PI3K 0.031 0.081 -10000 0 -0.36 10 10
STAT3 (dimer) -0.1 0.36 0.49 1 -0.87 65 66
PRKCD -0.072 0.24 0.36 1 -0.56 68 69
IL6R 0.021 0.06 -10000 0 -0.43 8 8
SOCS3 -0.042 0.19 0.43 1 -0.73 19 20
gp130 (dimer)/JAK1/JAK1/LMO4 -0.027 0.15 -10000 0 -0.26 135 135
Rac1/GTP -0.053 0.2 0.28 1 -0.43 69 70
HCK 0.018 0.087 -10000 0 -0.42 19 19
MAPKKK cascade 0.021 0.14 -10000 0 -0.55 18 18
bone resorption -0.13 0.37 -10000 0 -0.89 80 80
IRF1 -0.09 0.32 -10000 0 -0.83 53 53
mol:GDP -0.056 0.18 0.24 1 -0.41 69 70
SOS1 0.036 0.022 -10000 0 -0.42 1 1
VAV1 -0.057 0.18 0.24 1 -0.41 70 71
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.043 0.18 -10000 0 -0.52 40 40
PTPN11 0.016 0.091 -10000 0 -1.1 3 3
IL6/IL6RA 0.004 0.1 -10000 0 -0.3 47 47
gp130 (dimer)/TYK2/TYK2/LMO4 -0.022 0.14 -10000 0 -0.25 133 133
gp130 (dimer)/JAK2/JAK2/LMO4 -0.024 0.15 -10000 0 -0.26 134 134
IL6 -0.021 0.14 -10000 0 -0.42 52 52
PIAS3 0.035 0.006 -10000 0 -10000 0 0
PTPRE 0.02 0.07 -10000 0 -0.41 12 12
PIAS1 0.035 0.007 -10000 0 -10000 0 0
RAC1 0.036 0.006 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.053 0.13 0.23 1 -0.31 69 70
LMO4 -0.019 0.14 -10000 0 -0.42 53 53
STAT3 (dimer)/PIAS3 -0.09 0.34 -10000 0 -0.82 61 61
MCL1 0.038 0.094 -10000 0 -0.78 2 2
LPA receptor mediated events

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.031 0.072 -10000 0 -0.21 34 34
NF kappa B1 p50/RelA/I kappa B alpha 0.021 0.095 0.27 6 -0.27 13 19
AP1 -0.034 0.12 -10000 0 -0.25 100 100
mol:PIP3 -0.031 0.091 -10000 0 -0.22 88 88
AKT1 -0.005 0.1 0.25 3 -0.31 26 29
PTK2B -0.042 0.1 0.14 1 -0.22 112 113
RHOA -0.015 0.1 -10000 0 -0.32 35 35
PIK3CB 0.031 0.045 -10000 0 -0.42 5 5
mol:Ca2+ -0.01 0.091 0.19 41 -0.2 53 94
MAGI3 0.013 0.099 -10000 0 -0.42 25 25
RELA 0.035 0.006 -10000 0 -10000 0 0
apoptosis 0.003 0.054 -10000 0 -0.18 39 39
HRAS/GDP 0.024 0.025 -10000 0 -0.3 3 3
positive regulation of microtubule depolymerization -0.075 0.12 0.18 3 -0.24 129 132
NF kappa B1 p50/RelA -0.02 0.082 -10000 0 -0.21 63 63
endothelial cell migration -0.01 0.12 -10000 0 -0.51 27 27
ADCY4 -0.016 0.089 -10000 0 -0.27 44 44
ADCY5 -0.016 0.086 -10000 0 -0.25 47 47
ADCY6 -0.014 0.083 -10000 0 -0.25 46 46
ADCY7 -0.015 0.089 -10000 0 -0.27 42 42
ADCY1 -0.014 0.084 -10000 0 -0.26 44 44
ADCY2 -0.026 0.1 -10000 0 -0.26 67 67
ADCY3 -0.015 0.085 -10000 0 -0.25 46 46
ADCY8 -0.013 0.075 -10000 0 -0.25 37 37
ADCY9 -0.016 0.081 -10000 0 -0.23 50 50
GSK3B -0.042 0.098 0.16 1 -0.21 107 108
arachidonic acid secretion -0.018 0.09 -10000 0 -0.26 49 49
GNG2 0.034 0.021 -10000 0 -0.42 1 1
TRIP6 0.009 0.071 -10000 0 -0.36 17 17
GNAO1 0.006 0.055 -10000 0 -0.22 27 27
HRAS 0.032 0.036 -10000 0 -0.42 3 3
NFKBIA -0.008 0.091 0.24 8 -0.26 19 27
GAB1 0.027 0.061 -10000 0 -0.42 9 9
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly 0.022 0.2 -10000 0 -0.92 22 22
JUN -0.001 0.12 -10000 0 -0.42 39 39
LPA/LPA2/NHERF2 -0.004 0.077 -10000 0 -0.19 64 64
TIAM1 0 0.23 -10000 0 -1.1 22 22
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
mol:IP3 -0.009 0.09 0.19 41 -0.21 50 91
PLCB3 0.01 0.09 0.19 46 -0.23 42 88
FOS -0.031 0.15 -10000 0 -0.42 66 66
positive regulation of mitosis -0.018 0.09 -10000 0 -0.26 49 49
LPA/LPA1-2-3 -0.007 0.05 -10000 0 -0.17 42 42
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0 -10000 0 -10000 0 0
BCAR1 0.03 0.014 -10000 0 -10000 0 0
stress fiber formation -0.006 0.082 -10000 0 -0.27 23 23
GNAZ -0.001 0.072 -10000 0 -0.21 49 49
EGFR/PI3K-beta/Gab1 -0.023 0.098 -10000 0 -0.22 89 89
positive regulation of dendritic cell cytokine production -0.007 0.05 -10000 0 -0.17 42 42
LPA/LPA2/MAGI-3 0.005 0.065 -10000 0 -0.17 49 49
ARHGEF1 0.027 0.077 0.19 54 -0.21 22 76
GNAI2 0.001 0.069 -10000 0 -0.21 45 45
GNAI3 0.006 0.058 -10000 0 -0.19 38 38
GNAI1 -0.005 0.082 -10000 0 -0.23 54 54
LPA/LPA3 -0.005 0.025 -10000 0 -0.086 42 42
LPA/LPA2 -0.004 0.025 -10000 0 -0.085 42 42
LPA/LPA1 -0.01 0.067 -10000 0 -0.22 42 42
HB-EGF/EGFR -0.026 0.13 -10000 0 -0.28 91 91
HBEGF -0.02 0.099 -10000 0 -0.3 56 56
mol:DAG -0.009 0.09 0.19 41 -0.21 50 91
cAMP biosynthetic process -0.02 0.09 0.2 3 -0.26 46 49
NFKB1 0.036 0.005 -10000 0 -10000 0 0
SRC 0.033 0.029 -10000 0 -0.42 2 2
GNB1 0.032 0.045 -10000 0 -0.42 5 5
LYN 0.005 0.094 0.24 20 -0.24 17 37
GNAQ -0.004 0.02 -10000 0 -0.07 42 42
LPAR2 0 0.001 -10000 0 -10000 0 0
LPAR3 0 0 -10000 0 -10000 0 0
LPAR1 -0.008 0.039 -10000 0 -0.13 42 42
IL8 -0.072 0.18 -10000 0 -0.42 88 88
PTK2 0.011 0.042 -10000 0 -0.16 26 26
Rac1/GDP 0.026 0.004 -10000 0 -10000 0 0
CASP3 0.003 0.054 -10000 0 -0.18 39 39
EGFR -0.015 0.13 -10000 0 -0.42 49 49
PLCG1 -0.002 0.042 -10000 0 -0.12 47 47
PLD2 0.01 0.053 -10000 0 -0.17 38 38
G12/G13 0.03 0.063 -10000 0 -0.18 35 35
PI3K-beta -0.019 0.1 -10000 0 -0.34 28 28
cell migration 0.008 0.068 -10000 0 -0.26 22 22
SLC9A3R2 -0.004 0.12 -10000 0 -0.42 40 40
PXN -0.007 0.083 -10000 0 -0.28 23 23
HRAS/GTP -0.019 0.092 -10000 0 -0.27 49 49
RAC1 0.035 0.006 -10000 0 -10000 0 0
MMP9 -0.013 0.14 -10000 0 -0.42 52 52
PRKCE 0.03 0.05 -10000 0 -0.42 6 6
PRKCD -0.011 0.088 0.18 41 -0.21 41 82
Gi(beta/gamma) -0.009 0.088 -10000 0 -0.25 45 45
mol:LPA -0.008 0.039 -10000 0 -0.13 42 42
TRIP6/p130 Cas/FAK1/Paxillin 0.009 0.081 -10000 0 -0.29 17 17
MAPKKK cascade -0.018 0.09 -10000 0 -0.26 49 49
contractile ring contraction involved in cytokinesis -0.016 0.1 -10000 0 -0.32 37 37
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 -0.014 0.074 -10000 0 -0.2 57 57
GNA15 0.007 0.035 -10000 0 -0.11 28 28
GNA12 0.035 0.007 -10000 0 -10000 0 0
GNA13 0.029 0.037 -10000 0 -0.42 3 3
MAPT -0.077 0.12 0.18 3 -0.25 129 132
GNA11 0.008 0.03 -10000 0 -0.097 28 28
Rac1/GTP 0.021 0.22 -10000 0 -0.98 22 22
MMP2 -0.01 0.12 -10000 0 -0.52 27 27
Signaling mediated by p38-gamma and p38-delta

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K -0.016 0.036 -10000 0 -0.26 11 11
SNTA1 0.032 0.041 -10000 0 -0.42 4 4
response to hypoxia 0 0 -10000 0 -10000 0 0
STMN1 -0.022 0.05 -10000 0 -0.26 22 22
MAPK12 0.004 0.085 0.21 41 -0.23 34 75
CCND1 -0.056 0.16 -10000 0 -0.42 81 81
p38 gamma/SNTA1 0.026 0.09 0.21 51 -0.22 39 90
MAP2K3 0.032 0.023 -10000 0 -0.42 1 1
PKN1 0.033 0.035 -10000 0 -0.42 3 3
G2/M transition checkpoint 0.004 0.084 0.21 41 -0.23 34 75
MAP2K6 0.013 0.096 0.24 46 -0.24 34 80
MAPT -0.054 0.13 0.27 6 -0.28 105 111
MAPK13 0.006 0.052 -10000 0 -0.3 14 14
hyperosmotic response 0 0 -10000 0 -10000 0 0
ZAK 0.005 0.064 -10000 0 -0.29 23 23
Syndecan-4-mediated signaling events

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.027 0.18 -10000 0 -0.46 62 62
Syndecan-4/Syndesmos -0.033 0.2 -10000 0 -0.49 61 61
positive regulation of JNK cascade -0.045 0.22 -10000 0 -0.48 76 76
Syndecan-4/ADAM12 -0.051 0.23 -10000 0 -0.51 81 81
CCL5 -0.014 0.14 -10000 0 -0.42 52 52
Rac1/GDP 0.026 0.004 -10000 0 -10000 0 0
DNM2 0.036 0.005 -10000 0 -10000 0 0
ITGA5 0.034 0.029 -10000 0 -0.42 2 2
SDCBP 0.023 0.058 -10000 0 -0.42 8 8
PLG 0.022 0.04 -10000 0 -0.31 3 3
ADAM12 -0.014 0.14 -10000 0 -0.42 53 53
mol:GTP 0 0 -10000 0 -10000 0 0
NUDT16L1 0.028 0.046 -10000 0 -0.42 5 5
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
Syndecan-4/PKC alpha -0.032 0.019 -10000 0 -10000 0 0
Syndecan-4/Laminin alpha1 -0.033 0.21 -10000 0 -0.5 66 66
Syndecan-4/CXCL12/CXCR4 -0.048 0.23 -10000 0 -0.52 76 76
Syndecan-4/Laminin alpha3 -0.055 0.22 -10000 0 -0.51 68 68
MDK 0.018 0.085 -10000 0 -0.42 18 18
Syndecan-4/FZD7 -0.049 0.22 -10000 0 -0.5 75 75
Syndecan-4/Midkine -0.039 0.21 -10000 0 -0.5 67 67
FZD7 -0.006 0.13 -10000 0 -0.42 43 43
Syndecan-4/FGFR1/FGF -0.033 0.2 -10000 0 -0.47 64 64
THBS1 0.001 0.12 -10000 0 -0.42 37 37
integrin-mediated signaling pathway -0.04 0.21 -10000 0 -0.48 75 75
positive regulation of MAPKKK cascade -0.045 0.22 -10000 0 -0.48 76 76
Syndecan-4/TACI -0.034 0.21 -10000 0 -0.5 66 66
CXCR4 0.007 0.11 -10000 0 -0.42 30 30
cell adhesion 0.012 0.1 0.2 46 -0.27 41 87
Syndecan-4/Dynamin -0.031 0.21 -10000 0 -0.5 66 66
Syndecan-4/TSP1 -0.045 0.22 -10000 0 -0.5 73 73
Syndecan-4/GIPC -0.031 0.21 -10000 0 -0.49 66 66
Syndecan-4/RANTES -0.053 0.22 -10000 0 -0.51 70 70
ITGB1 0.032 0.036 -10000 0 -0.42 3 3
LAMA1 0.034 0.009 -10000 0 -10000 0 0
LAMA3 -0.019 0.14 -10000 0 -0.42 58 58
RAC1 0.035 0.006 -10000 0 -10000 0 0
PRKCA 0.087 0.26 0.8 57 -10000 0 57
Syndecan-4/alpha-Actinin -0.034 0.22 -10000 0 -0.51 67 67
TFPI 0.034 0.008 -10000 0 -10000 0 0
F2 0.031 0.024 -10000 0 -10000 0 0
alpha5/beta1 Integrin 0.048 0.037 -10000 0 -0.3 5 5
positive regulation of cell adhesion -0.061 0.2 -10000 0 -0.5 68 68
ACTN1 0.027 0.061 -10000 0 -0.42 9 9
TNC 0.004 0.11 -10000 0 -0.42 31 31
Syndecan-4/CXCL12 -0.049 0.22 -10000 0 -0.51 74 74
FGF6 0.027 0.057 -10000 0 -0.42 8 8
RHOA 0.026 0.061 -10000 0 -0.42 9 9
CXCL12 -0.008 0.13 -10000 0 -0.42 47 47
TNFRSF13B 0.032 0.012 -10000 0 -10000 0 0
FGF2 -0.001 0.11 -10000 0 -0.42 34 34
FGFR1 0.02 0.064 -10000 0 -0.42 10 10
Syndecan-4/PI-4-5-P2 -0.058 0.19 -10000 0 -0.49 66 66
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.019 0.13 -10000 0 -0.4 51 51
cell migration -0.015 0.015 -10000 0 -10000 0 0
PRKCD 0.024 0.039 -10000 0 -0.3 3 3
vasculogenesis -0.043 0.21 -10000 0 -0.48 73 73
SDC4 -0.057 0.21 -10000 0 -0.52 66 66
Syndecan-4/Tenascin C -0.043 0.22 -10000 0 -0.5 75 75
Syndecan-4/PI-4-5-P2/PKC alpha -0.026 0.016 -10000 0 -10000 0 0
Syndecan-4/Syntenin -0.034 0.2 -10000 0 -0.5 61 61
MMP9 -0.013 0.14 -10000 0 -0.42 52 52
Rac1/GTP 0.012 0.1 0.2 46 -0.28 41 87
cytoskeleton organization -0.031 0.19 -10000 0 -0.48 61 61
GIPC1 0.033 0.035 -10000 0 -0.42 3 3
Syndecan-4/TFPI -0.034 0.21 -10000 0 -0.5 66 66
E-cadherin signaling in keratinocytes

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation -0.012 0.089 0.22 2 -0.27 23 25
adherens junction organization -0.045 0.13 -10000 0 -0.28 86 86
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP -0.013 0.11 0.27 4 -0.26 33 37
FMN1 -0.036 0.12 -10000 0 -0.26 86 86
mol:IP3 -0.016 0.076 -10000 0 -0.23 25 25
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.035 0.13 -10000 0 -0.27 86 86
CTNNB1 0.026 0.067 -10000 0 -0.42 11 11
AKT1 -0.017 0.093 0.19 1 -0.28 21 22
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.062 0.19 -10000 0 -0.43 73 73
CTNND1 0.035 0.022 -10000 0 -0.42 1 1
mol:PI-4-5-P2 -0.032 0.12 0.22 1 -0.26 79 80
VASP -0.039 0.12 -10000 0 -0.27 83 83
ZYX -0.038 0.12 -10000 0 -0.26 86 86
JUB -0.047 0.13 -10000 0 -0.28 87 87
EGFR(dimer) -0.041 0.14 0.23 1 -0.27 102 103
E-cadherin/beta catenin-gamma catenin 0.015 0.099 -10000 0 -0.24 58 58
mol:PI-3-4-5-P3 -0.001 0.11 0.23 2 -0.26 28 30
PIK3CA 0.034 0.022 -10000 0 -0.42 1 1
PI3K -0.001 0.11 0.23 2 -0.26 28 30
FYN -0.017 0.092 0.22 2 -0.28 26 28
mol:Ca2+ -0.015 0.074 -10000 0 -0.22 25 25
JUP 0.03 0.042 -10000 0 -0.42 4 4
PIK3R1 0.02 0.08 -10000 0 -0.42 16 16
mol:DAG -0.016 0.076 -10000 0 -0.23 25 25
CDH1 -0.011 0.13 -10000 0 -0.42 45 45
RhoA/GDP -0.016 0.11 0.26 3 -0.27 33 36
establishment of polarity of embryonic epithelium -0.037 0.12 0.22 1 -0.26 83 84
SRC 0.033 0.029 -10000 0 -0.42 2 2
RAC1 0.035 0.006 -10000 0 -10000 0 0
RHOA 0.026 0.061 -10000 0 -0.42 9 9
EGFR -0.015 0.13 -10000 0 -0.42 49 49
CASR -0.013 0.078 0.22 2 -0.23 22 24
RhoA/GTP -0.001 0.09 0.21 2 -0.25 18 20
AKT2 -0.016 0.093 0.19 2 -0.28 19 21
actin cable formation -0.037 0.12 0.2 6 -0.26 83 89
apoptosis 0.009 0.099 0.27 26 -0.24 5 31
CTNNA1 0.036 0.022 -10000 0 -0.43 1 1
mol:GDP -0.03 0.1 0.22 2 -0.27 34 36
PIP5K1A -0.034 0.12 -10000 0 -0.26 79 79
PLCG1 -0.016 0.077 -10000 0 -0.23 25 25
Rac1/GTP -0.03 0.14 -10000 0 -0.3 55 55
homophilic cell adhesion 0 0.003 -10000 0 -10000 0 0
Ephrin B reverse signaling

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 0.017 0.08 -10000 0 -0.42 16 16
EPHB2 0.033 0.03 -10000 0 -0.42 2 2
EFNB1 0.015 0.029 -10000 0 -0.3 4 4
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP 0.073 0.065 -10000 0 -0.23 17 17
Ephrin B2/EPHB1-2 0.044 0.067 -10000 0 -0.24 23 23
neuron projection morphogenesis 0.048 0.056 -10000 0 -0.22 17 17
Ephrin B1/EPHB1-2/Tiam1 0.064 0.064 -10000 0 -0.24 17 17
DNM1 0.034 0.035 -10000 0 -0.42 3 3
cell-cell signaling 0 0.003 -10000 0 -10000 0 0
MAP2K4 -0.082 0.21 -10000 0 -0.55 79 79
YES1 -0.11 0.3 -10000 0 -0.8 79 79
Ephrin B1/EPHB1-2/NCK2 0.069 0.051 -10000 0 -0.22 12 12
PI3K -0.049 0.23 -10000 0 -0.56 79 79
mol:GDP 0.062 0.063 -10000 0 -0.24 17 17
ITGA2B 0.034 0.01 -10000 0 -10000 0 0
endothelial cell proliferation 0.02 0.081 -10000 0 -0.26 35 35
FYN -0.11 0.3 -10000 0 -0.8 79 79
MAP3K7 -0.082 0.22 -10000 0 -0.59 76 76
FGR -0.1 0.3 -10000 0 -0.78 79 79
TIAM1 0.028 0.057 -10000 0 -0.42 8 8
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
RGS3 0.036 0.005 -10000 0 -10000 0 0
cell adhesion -0.057 0.21 -10000 0 -0.52 79 79
LYN -0.1 0.3 -10000 0 -0.79 79 79
Ephrin B1/EPHB1-2/Src Family Kinases -0.1 0.28 -10000 0 -0.74 79 79
Ephrin B1/EPHB1-2 -0.089 0.24 -10000 0 -0.64 78 78
SRC -0.1 0.3 -10000 0 -0.79 79 79
ITGB3 0.029 0.046 -10000 0 -0.42 5 5
EPHB1 0.027 0.05 -10000 0 -0.42 6 6
EPHB4 0.016 0.091 -10000 0 -0.42 21 21
RAC1 0.035 0.006 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.021 0.081 -10000 0 -0.26 35 35
alphaIIb/beta3 Integrin 0.046 0.035 -10000 0 -0.3 4 4
BLK -0.12 0.3 -10000 0 -0.8 79 79
HCK -0.11 0.3 -10000 0 -0.79 79 79
regulation of stress fiber formation -0.067 0.05 0.22 12 -10000 0 12
MAPK8 -0.08 0.2 -10000 0 -0.53 79 79
Ephrin B1/EPHB1-2/RGS3 0.069 0.051 -10000 0 -0.22 12 12
endothelial cell migration -0.079 0.19 -10000 0 -0.51 75 75
NCK2 0.036 0.005 -10000 0 -10000 0 0
PTPN13 -0.046 0.2 -10000 0 -0.54 72 72
regulation of focal adhesion formation -0.067 0.05 0.22 12 -10000 0 12
chemotaxis -0.066 0.05 0.22 12 -10000 0 12
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
Rac1/GTP 0.062 0.061 -10000 0 -0.23 17 17
angiogenesis -0.09 0.23 -10000 0 -0.63 79 79
LCK -0.12 0.3 -10000 0 -0.8 79 79
Arf6 signaling events

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.015 0.032 -10000 0 -0.25 6 6
ARNO/beta Arrestin1-2 0.014 0.069 -10000 0 -0.19 42 42
EGFR -0.015 0.13 -10000 0 -0.42 49 49
EPHA2 0.032 0.036 -10000 0 -0.42 3 3
USP6 0.032 0.012 -10000 0 -10000 0 0
IQSEC1 0.034 0.021 -10000 0 -0.42 1 1
EGFR/EGFR/EGF/EGF -0.061 0.16 -10000 0 -0.3 152 152
ARRB2 0.011 0.043 -10000 0 -0.3 9 9
mol:GTP 0.006 0.02 0.11 5 -0.11 2 7
ARRB1 0.027 0.05 -10000 0 -0.42 6 6
FBXO8 0.035 0.007 -10000 0 -10000 0 0
TSHR 0.029 0.05 -10000 0 -0.42 6 6
EGF -0.069 0.19 -10000 0 -0.42 110 110
somatostatin receptor activity 0 0 0 2 -0.001 70 72
ARAP2 0 0 0 2 0 69 71
mol:GDP -0.029 0.1 -10000 0 -0.26 56 56
mol:PI-3-4-5-P3 0 0 0 3 -0.001 69 72
ITGA2B 0.034 0.01 -10000 0 -10000 0 0
ARF6 0.033 0.029 -10000 0 -0.42 2 2
Ephrin A1/EPHA2/NCK1/GIT1 0.053 0.072 -10000 0 -0.23 20 20
ADAP1 0 0 0 3 0 40 43
KIF13B 0.022 0.051 -10000 0 -0.42 6 6
HGF/MET 0.042 0.055 -10000 0 -0.3 12 12
PXN 0.036 0.004 -10000 0 -10000 0 0
ARF6/GTP -0.034 0.1 0.17 2 -0.24 65 67
EGFR/EGFR/EGF/EGF/ARFGEP100 -0.035 0.15 -10000 0 -0.26 151 151
ADRB2 0.003 0.11 -10000 0 -0.42 33 33
receptor agonist activity 0 0 0 3 0 52 55
actin filament binding 0 0 0 2 0 77 79
SRC 0.033 0.029 -10000 0 -0.42 2 2
ITGB3 0.029 0.046 -10000 0 -0.42 5 5
GNAQ 0 0 0.001 4 -0.001 52 56
EFA6/PI-4-5-P2 0 0 0.001 5 -0.001 47 52
ARF6/GDP 0.004 0.075 0.2 2 -0.26 15 17
ARF6/GDP/GULP/ACAP1 -0.017 0.13 -10000 0 -0.28 63 63
alphaIIb/beta3 Integrin/paxillin/GIT1 0.079 0.043 -10000 0 -0.23 5 5
ACAP1 0 0 0 1 -10000 0 1
ACAP2 0 0 0 2 0 71 73
LHCGR/beta Arrestin2 0.018 0.06 -10000 0 -0.38 9 9
EFNA1 0.014 0.08 -10000 0 -0.42 16 16
HGF 0.028 0.057 -10000 0 -0.42 8 8
CYTH3 0 0 0.001 4 -0.001 51 55
CYTH2 -0.001 0.002 -10000 0 -0.004 80 80
NCK1 0.034 0.021 -10000 0 -0.42 1 1
fibronectin binding 0 0 0 3 0 48 51
endosomal lumen acidification 0 0 0 3 0 64 67
microtubule-based process 0 0 -10000 0 -10000 0 0
GULP1 0 0.12 -10000 0 -0.42 39 39
GNAQ/ARNO -0.001 0.003 0.007 5 -0.006 43 48
mol:Phosphatidic acid 0 0 0 2 0 71 73
PIP3-E 0.029 0.037 -10000 0 -0.42 3 3
MET 0.03 0.041 -10000 0 -0.42 4 4
GNA14 -0.009 0.13 -10000 0 -0.42 43 43
GNA15 0.03 0.046 -10000 0 -0.42 5 5
GIT1 0.034 0.022 -10000 0 -0.42 1 1
mol:PI-4-5-P2 0 0 0.001 3 -0.001 52 55
GNA11 0.033 0.036 -10000 0 -0.42 3 3
LHCGR 0.027 0.061 -10000 0 -0.42 9 9
AGTR1 -0.047 0.16 -10000 0 -0.42 80 80
desensitization of G-protein coupled receptor protein signaling pathway 0.018 0.06 -10000 0 -0.38 9 9
IPCEF1/ARNO -0.024 0.12 -10000 0 -0.2 150 150
alphaIIb/beta3 Integrin 0.046 0.035 -10000 0 -0.3 4 4
E-cadherin signaling in the nascent adherens junction

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN -0.07 0.16 -10000 0 -0.41 66 66
KLHL20 -0.025 0.09 0.25 1 -0.25 17 18
CYFIP2 -0.006 0.13 -10000 0 -0.42 45 45
Rac1/GDP -0.035 0.12 0.27 4 -0.26 60 64
ENAH -0.065 0.16 -10000 0 -0.35 110 110
AP1M1 0.035 0.021 -10000 0 -0.42 1 1
RAP1B 0.033 0.03 -10000 0 -0.42 2 2
RAP1A 0.031 0.045 -10000 0 -0.42 5 5
CTNNB1 0.025 0.067 -10000 0 -0.42 11 11
CDC42/GTP -0.013 0.083 -10000 0 -0.23 13 13
ABI1/Sra1/Nap1 -0.046 0.054 -10000 0 -0.16 40 40
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin 0.03 0.1 -10000 0 -0.23 58 58
RAPGEF1 -0.073 0.15 0.24 2 -0.36 80 82
CTNND1 0.034 0.022 -10000 0 -0.42 1 1
regulation of calcium-dependent cell-cell adhesion -0.074 0.18 -10000 0 -0.35 144 144
CRK -0.069 0.16 -10000 0 -0.39 81 81
E-cadherin/gamma catenin/alpha catenin 0.018 0.098 -10000 0 -0.26 49 49
alphaE/beta7 Integrin 0.044 0.039 -10000 0 -0.3 5 5
IQGAP1 0.035 0.008 -10000 0 -10000 0 0
NCKAP1 0.035 0.021 -10000 0 -0.42 1 1
Rap1/GTP/I-afadin 0.047 0.064 -10000 0 -0.23 22 22
DLG1 -0.082 0.18 -10000 0 -0.34 146 146
ChemicalAbstracts:7440-70-2 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 -0.031 0.056 -10000 0 -0.15 60 60
MLLT4 0.02 0.078 -10000 0 -0.42 15 15
ARF6/GTP/NME1/Tiam1 0.056 0.045 -10000 0 -0.24 9 9
PI3K -0.036 0.074 -10000 0 -0.2 57 57
ARF6 0.033 0.029 -10000 0 -0.42 2 2
mol:Ca2+ 0 0 -10000 0 -10000 0 0
E-cadherin/gamma catenin 0.004 0.1 -10000 0 -0.3 48 48
TIAM1 0.028 0.057 -10000 0 -0.42 8 8
E-cadherin(dimer)/Ca2+ 0.03 0.097 -10000 0 -0.22 57 57
AKT1 -0.024 0.053 0.17 3 -0.17 5 8
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
CDH1 -0.012 0.13 -10000 0 -0.42 45 45
RhoA/GDP -0.036 0.12 0.27 4 -0.27 63 67
actin cytoskeleton organization -0.017 0.068 0.18 2 -0.18 16 18
CDC42/GDP -0.033 0.12 0.27 4 -0.26 60 64
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin -0.01 0.077 -10000 0 -0.22 56 56
ITGB7 0.036 0.005 -10000 0 -10000 0 0
RAC1 0.035 0.006 -10000 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin 0.033 0.1 -10000 0 -0.23 57 57
E-cadherin/Ca2+/beta catenin/alpha catenin 0.018 0.087 -10000 0 -0.22 56 56
mol:GDP -0.054 0.12 0.27 4 -0.3 64 68
CDC42/GTP/IQGAP1 0.045 0.014 -10000 0 -10000 0 0
JUP 0.028 0.042 -10000 0 -0.42 4 4
p120 catenin/RhoA/GDP -0.031 0.13 0.28 3 -0.28 63 66
RAC1/GTP/IQGAP1 0.046 0.013 -10000 0 -10000 0 0
PIP5K1C/AP1M1 0.049 0.033 -10000 0 -0.3 4 4
RHOA 0.026 0.061 -10000 0 -0.42 9 9
CDC42 0.035 0.008 -10000 0 -10000 0 0
CTNNA1 0.035 0.021 -10000 0 -0.42 1 1
positive regulation of S phase of mitotic cell cycle -0.03 0.077 0.15 1 -0.18 80 81
NME1 0.033 0.01 -10000 0 -10000 0 0
clathrin coat assembly 0 0 -10000 0 -10000 0 0
TJP1 -0.08 0.18 -10000 0 -0.4 83 83
regulation of cell-cell adhesion -0.018 0.069 -10000 0 -0.17 54 54
WASF2 -0.016 0.042 0.12 2 -0.11 12 14
Rap1/GTP -0.015 0.091 0.25 1 -0.25 13 14
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.036 0.1 -10000 0 -0.23 53 53
CCND1 -0.038 0.094 0.17 1 -0.23 80 81
VAV2 -0.068 0.18 -10000 0 -0.51 18 18
RAP1/GDP -0.02 0.1 0.26 1 -0.26 17 18
adherens junction assembly -0.078 0.17 -10000 0 -0.39 85 85
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
ABI1 0.035 0.008 -10000 0 -10000 0 0
PIP5K1C 0.033 0.036 -10000 0 -0.42 3 3
regulation of heterotypic cell-cell adhesion 0.028 0.11 -10000 0 -0.22 62 62
E-cadherin/beta catenin -0.024 0.1 -10000 0 -0.29 63 63
mol:GTP 0 0 -10000 0 -10000 0 0
SRC -0.081 0.18 -10000 0 -0.4 87 87
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
Rac1/GTP -0.076 0.13 -10000 0 -0.38 32 32
E-cadherin/beta catenin/alpha catenin 0.02 0.1 -10000 0 -0.25 56 56
ITGAE 0.028 0.046 -10000 0 -0.42 5 5
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.076 0.19 -10000 0 -0.36 143 143
IL2 signaling events mediated by PI3K

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.015 0.12 -10000 0 -0.43 23 23
UGCG -0.09 0.27 -10000 0 -0.73 73 73
AKT1/mTOR/p70S6K/Hsp90/TERT -0.062 0.19 0.31 1 -0.38 99 100
mol:GTP 0 0.001 -10000 0 -10000 0 0
mol:glucosylceramide -0.088 0.26 -10000 0 -0.71 74 74
mol:DAG -0.006 0.029 0.17 12 -10000 0 12
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.079 0.23 0.34 1 -0.44 115 116
FRAP1 -0.1 0.26 0.36 1 -0.5 115 116
FOXO3 -0.049 0.21 0.36 1 -0.5 54 55
AKT1 -0.054 0.22 0.37 1 -0.54 54 55
GAB2 0.029 0.015 -10000 0 -10000 0 0
SMPD1 -0.005 0.13 -10000 0 -0.68 16 16
SGMS1 -0.004 0.035 0.058 2 -0.077 51 53
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP -0.008 0.048 -10000 0 -0.25 17 17
CALM1 0.035 0.007 -10000 0 -10000 0 0
cell proliferation -0.041 0.19 0.25 5 -0.37 95 100
EIF3A 0 0 -10000 0 -10000 0 0
PI3K 0.034 0.066 -10000 0 -0.3 17 17
RPS6KB1 -0.043 0.16 -10000 0 -0.8 14 14
mol:sphingomyelin -0.006 0.029 0.17 12 -10000 0 12
natural killer cell activation -0.002 0.004 -10000 0 -0.015 17 17
JAK3 0.035 0.008 -10000 0 -10000 0 0
PIK3R1 0.018 0.08 -10000 0 -0.42 16 16
JAK1 0.032 0.036 -10000 0 -0.42 3 3
NFKB1 0.036 0.005 -10000 0 -10000 0 0
MYC -0.027 0.29 0.49 2 -0.95 35 37
MYB -0.23 0.5 -10000 0 -1.2 104 104
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K -0.021 0.15 -10000 0 -0.37 47 47
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 -0.025 0.16 -10000 0 -0.69 15 15
mol:PI-3-4-5-P3 -0.02 0.15 -10000 0 -0.37 47 47
Rac1/GDP 0.008 0.051 -10000 0 -0.23 17 17
T cell proliferation -0.018 0.14 0.29 3 -0.34 46 49
SHC1 0.026 0.026 -10000 0 -0.42 1 1
RAC1 0.035 0.006 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity -0.01 0.028 -10000 0 -0.065 103 103
PRKCZ -0.021 0.15 -10000 0 -0.36 46 46
NF kappa B1 p50/RelA -0.069 0.24 0.36 1 -0.45 107 108
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K -0.013 0.13 -10000 0 -0.42 32 32
HSP90AA1 0 0 -10000 0 -10000 0 0
RELA 0.035 0.006 -10000 0 -10000 0 0
IL2RA 0.002 0.11 -10000 0 -0.42 31 31
IL2RB 0.011 0.097 -10000 0 -0.42 24 24
TERT 0.032 0.03 -10000 0 -0.42 2 2
E2F1 -0.072 0.2 -10000 0 -0.43 113 113
SOS1 0.032 0.023 -10000 0 -0.43 1 1
RPS6 0.034 0.022 -10000 0 -0.42 1 1
mol:cAMP 0.004 0.013 0.031 100 -10000 0 100
PTPN11 0.032 0.012 -10000 0 -10000 0 0
IL2RG 0.029 0.042 -10000 0 -0.42 4 4
actin cytoskeleton organization -0.018 0.14 0.29 3 -0.34 46 49
GRB2 0.031 0.013 -10000 0 -10000 0 0
IL2 0.031 0.037 -10000 0 -0.42 3 3
PIK3CA 0.032 0.024 -10000 0 -0.42 1 1
Rac1/GTP 0.033 0.064 -10000 0 -0.22 17 17
LCK -0.019 0.14 -10000 0 -0.42 54 54
BCL2 -0.18 0.38 -10000 0 -0.82 118 118
E-cadherin signaling events

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
E-cadherin/beta catenin-gamma catenin 0.014 0.1 -9999 0 -0.26 58 58
E-cadherin/beta catenin 0.004 0.11 -9999 0 -0.3 55 55
CTNNB1 0.025 0.067 -9999 0 -0.42 11 11
JUP 0.028 0.042 -9999 0 -0.42 4 4
CDH1 -0.011 0.13 -9999 0 -0.42 45 45
ErbB4 signaling events

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF -0.06 0.29 -10000 0 -0.92 46 46
epithelial cell differentiation -0.027 0.25 -10000 0 -0.72 48 48
ITCH 0.035 0.039 -10000 0 -0.11 6 6
WWP1 -0.087 0.39 -10000 0 -1.4 42 42
FYN 0.027 0.054 -10000 0 -0.42 7 7
EGFR -0.015 0.13 -10000 0 -0.42 49 49
PRL 0.034 0.022 -10000 0 -0.42 1 1
neuron projection morphogenesis -0.019 0.21 0.34 8 -0.64 43 51
PTPRZ1 0.023 0.061 -10000 0 -0.42 9 9
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC -0.028 0.22 -10000 0 -0.71 43 43
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta -0.064 0.25 -10000 0 -0.87 43 43
ADAM17 0.036 0.037 -10000 0 -10000 0 0
ErbB4/ErbB4 -0.079 0.3 -10000 0 -1 45 45
ErbB4/ErbB4/neuregulin 3/neuregulin 3 -0.062 0.29 -10000 0 -0.9 47 47
NCOR1 0.032 0.012 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn -0.054 0.25 -10000 0 -0.82 43 43
GRIN2B -0.062 0.22 0.25 1 -0.75 43 44
ErbB4/ErbB2/betacellulin -0.069 0.26 -10000 0 -0.72 56 56
STAT1 0.02 0.075 -10000 0 -0.42 14 14
HBEGF 0.029 0.05 -10000 0 -0.42 6 6
PRLR -0.001 0.12 -10000 0 -0.42 40 40
E4ICDs/ETO2 -0.1 0.32 -10000 0 -0.84 62 62
axon guidance -0.068 0.28 -10000 0 -0.91 45 45
NEDD4 0.025 0.076 -10000 0 -0.42 11 11
Prolactin receptor/Prolactin receptor/Prolactin 0.022 0.094 -10000 0 -0.3 39 39
CBFA2T3 -0.047 0.16 -10000 0 -0.42 81 81
ErbB4/ErbB2/HBEGF -0.05 0.26 -10000 0 -0.78 49 49
MAPK3 -0.016 0.22 0.35 8 -0.66 43 51
STAT1 (dimer) -0.064 0.29 -10000 0 -0.9 47 47
MAPK1 -0.016 0.22 0.35 8 -0.66 43 51
JAK2 0.032 0.03 -10000 0 -0.42 2 2
ErbB4/ErbB2/neuregulin 1 beta -0.063 0.25 -10000 0 -0.77 50 50
NRG1 0.013 0.021 -10000 0 -10000 0 0
NRG3 0.028 0.054 -10000 0 -0.42 7 7
NRG2 0.025 0.061 -10000 0 -0.42 9 9
NRG4 0.033 0.022 -10000 0 -0.42 1 1
heart development -0.068 0.28 -10000 0 -0.91 45 45
neural crest cell migration -0.062 0.25 -10000 0 -0.75 50 50
ERBB2 0.006 0.058 -10000 0 -0.3 15 15
WWOX/E4ICDs -0.071 0.28 -10000 0 -0.92 46 46
SHC1 0.028 0.025 -10000 0 -0.42 1 1
ErbB4/EGFR/neuregulin 4 -0.065 0.28 -10000 0 -0.84 48 48
apoptosis 0.059 0.28 0.83 50 -10000 0 50
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta -0.062 0.29 -10000 0 -0.91 47 47
ErbB4/ErbB2/epiregulin -0.053 0.26 -10000 0 -0.77 50 50
ErbB4/ErbB4/betacellulin/betacellulin -0.079 0.29 -10000 0 -0.85 53 53
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 -0.031 0.28 -10000 0 -0.71 58 58
MDM2 -0.068 0.29 0.28 14 -0.92 45 59
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta -0.044 0.23 -10000 0 -0.77 43 43
STAT5A -0.041 0.28 0.33 7 -0.89 43 50
ErbB4/EGFR/neuregulin 1 beta -0.07 0.25 -10000 0 -0.79 46 46
DLG4 0.032 0.012 -10000 0 -10000 0 0
GRB2/SHC 0.038 0.029 -10000 0 -0.3 1 1
E4ICDs/TAB2/NCoR1 -0.048 0.28 -10000 0 -0.86 46 46
STAT5A (dimer) -0.019 0.28 -10000 0 -0.81 48 48
MAP3K7IP2 0.032 0.03 -10000 0 -0.42 2 2
STAT5B (dimer) -0.045 0.28 -10000 0 -0.87 46 46
LRIG1 0.006 0.11 -10000 0 -0.42 31 31
EREG 0.025 0.051 -10000 0 -0.42 6 6
BTC -0.009 0.13 -10000 0 -0.42 47 47
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta -0.07 0.28 -10000 0 -0.92 45 45
ERBB4 -0.08 0.3 -10000 0 -1 45 45
STAT5B 0.03 0.024 -10000 0 -0.42 1 1
YAP1 -0.024 0.15 -10000 0 -0.41 48 48
GRB2 0.033 0.011 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 -0.048 0.26 -10000 0 -0.76 50 50
glial cell differentiation 0.047 0.27 0.85 46 -10000 0 46
WWOX 0.027 0.016 -10000 0 -10000 0 0
cell proliferation -0.077 0.26 0.34 1 -0.79 49 50
TCGA08_p53

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A -0.002 0.05 -10000 0 -0.3 14 14
TP53 -0.025 0.091 0.26 1 -0.26 58 59
Senescence -0.028 0.093 0.25 1 -0.25 66 67
Apoptosis -0.028 0.093 0.25 1 -0.25 66 67
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 0.004 0.061 0.26 25 -10000 0 25
MDM4 0.026 0.032 -10000 0 -0.42 2 2
Canonical Wnt signaling pathway

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.053 0.052 0.23 21 -0.42 1 22
AES 0.052 0.042 0.2 22 -10000 0 22
FBXW11 0.033 0.029 -10000 0 -0.42 2 2
mol:GTP 0.001 0.002 -10000 0 -10000 0 0
LRP6/FZD1 0.04 0.055 -10000 0 -0.3 12 12
SMAD4 0.029 0.054 -10000 0 -0.42 7 7
DKK2 0.006 0.11 -10000 0 -0.42 31 31
TLE1 0.022 0.12 0.22 21 -0.42 33 54
MACF1 0.035 0.021 -10000 0 -0.42 1 1
CTNNB1 -0.003 0.1 0.26 7 -0.37 11 18
WIF1 0.03 0.014 -10000 0 -10000 0 0
beta catenin/RanBP3 0.073 0.21 0.41 115 -0.36 7 122
KREMEN2 -0.09 0.19 -10000 0 -0.42 129 129
DKK1 -0.027 0.14 -10000 0 -0.42 60 60
beta catenin/beta TrCP1 0.011 0.11 0.28 5 -0.37 10 15
FZD1 0.028 0.057 -10000 0 -0.42 8 8
AXIN2 -0.047 0.4 0.6 52 -1.3 32 84
AXIN1 0.037 0.002 -10000 0 -10000 0 0
RAN 0.036 0.005 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.044 0.066 -10000 0 -0.59 4 4
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.008 0.17 0.3 7 -0.44 41 48
Axin1/APC/GSK3 0.033 0.051 0.32 1 -0.31 1 2
Axin1/APC/GSK3/beta catenin/Macf1 0.021 0.081 0.33 3 -0.36 5 8
HNF1A 0.017 0.045 0.18 22 -10000 0 22
CTBP1 0.05 0.046 0.23 18 -10000 0 18
MYC 0.028 0.47 0.59 112 -1.3 37 149
RANBP3 0.036 0.007 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 -0.044 0.15 -10000 0 -0.26 154 154
NKD1 0.027 0.037 -10000 0 -0.42 3 3
TCF4 0.031 0.1 0.22 18 -0.4 22 40
TCF3 0.048 0.052 0.22 18 -0.42 2 20
WNT1/LRP6/FZD1/Axin1 0.076 0.058 -10000 0 -0.23 13 13
Ran/GTP 0.028 0.006 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0.09 0.26 0.51 108 -0.47 12 120
LEF1 0.038 0.085 0.23 19 -0.4 13 32
DVL1 0.03 0.049 -10000 0 -0.28 3 3
CSNK2A1 0.035 0.006 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES -0.045 0.19 -10000 0 -0.52 41 41
DKK1/LRP6/Kremen 2 -0.06 0.16 -10000 0 -0.27 169 169
LRP6 0.029 0.046 -10000 0 -0.42 5 5
CSNK1A1 0.053 0.048 0.24 19 -10000 0 19
NLK 0.029 0.026 -10000 0 -0.43 1 1
CCND1 -0.15 0.6 0.58 69 -1.4 86 155
WNT1 0.035 0.021 -10000 0 -0.42 1 1
GSK3A 0.036 0.005 -10000 0 -10000 0 0
GSK3B 0.036 0.005 -10000 0 -10000 0 0
FRAT1 0.029 0.054 -10000 0 -0.42 7 7
PPP2R5D 0.028 0.065 0.24 1 -0.29 14 15
APC -0.012 0.059 0.2 18 -0.22 16 34
WNT1/LRP6/FZD1 0.022 0.051 -10000 0 -0.23 8 8
CREBBP 0.048 0.044 0.22 17 -10000 0 17
Coregulation of Androgen receptor activity

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 -0.009 0.14 -9999 0 -0.42 51 51
SVIL 0.022 0.078 -9999 0 -0.42 15 15
ZNF318 0.033 0.006 -9999 0 -10000 0 0
JMJD2C 0.04 0.011 -9999 0 -10000 0 0
T-DHT/AR/Ubc9 -0.036 0.12 -9999 0 -0.25 106 106
CARM1 0.035 0.021 -9999 0 -0.42 1 1
PRDX1 0.033 0.036 -9999 0 -0.42 3 3
PELP1 0.032 0.011 -9999 0 -10000 0 0
CTNNB1 0.026 0.067 -9999 0 -0.42 11 11
AKT1 0.032 0.03 -9999 0 -0.42 2 2
PTK2B 0.028 0.016 -9999 0 -10000 0 0
MED1 -0.001 0 -9999 0 -10000 0 0
MAK 0.025 0.046 -9999 0 -0.42 5 5
response to oxidative stress 0 0 -9999 0 -10000 0 0
HIP1 0.037 0.005 -9999 0 -10000 0 0
GSN 0.023 0.078 -9999 0 -0.42 15 15
NCOA2 0.025 0.047 -9999 0 -0.42 5 5
NCOA6 0.037 0.007 -9999 0 -10000 0 0
DNA-PK 0.054 0.036 -9999 0 -0.26 2 2
NCOA4 0.03 0.05 -9999 0 -0.42 6 6
PIAS3 0.036 0.006 -9999 0 -10000 0 0
cell proliferation -0.014 0.097 -9999 0 -0.56 13 13
XRCC5 0.035 0.004 -9999 0 -10000 0 0
UBE3A 0.036 0.029 -9999 0 -0.42 2 2
T-DHT/AR/SNURF -0.051 0.12 -9999 0 -0.25 112 112
FHL2 -0.11 0.31 -9999 0 -0.9 65 65
RANBP9 0.036 0.008 -9999 0 -10000 0 0
JMJD1A 0.01 0.072 -9999 0 -0.15 86 86
CDK6 0.025 0.058 -9999 0 -0.42 8 8
TGFB1I1 0.018 0.085 -9999 0 -0.42 18 18
T-DHT/AR/CyclinD1 -0.073 0.17 -9999 0 -0.33 134 134
XRCC6 0.033 0.009 -9999 0 -10000 0 0
T-DHT/AR -0.062 0.14 -9999 0 -0.22 210 210
CTDSP1 0.034 0.029 -9999 0 -0.42 2 2
CTDSP2 0.032 0.029 -9999 0 -0.42 2 2
BRCA1 0.023 0.07 -9999 0 -0.42 12 12
TCF4 0.014 0.093 -9999 0 -0.42 22 22
CDKN2A 0.015 0.075 -9999 0 -0.42 14 14
SRF 0.018 0.061 -9999 0 -0.14 60 60
NKX3-1 -0.047 0.1 -9999 0 -0.24 90 90
KLK3 0.021 0.054 -9999 0 -10000 0 0
TMF1 0.035 0.008 -9999 0 -10000 0 0
HNRNPA1 -0.001 0 -9999 0 -10000 0 0
AOF2 0.036 0.008 -9999 0 -10000 0 0
APPL1 0.004 0.02 -9999 0 -0.3 2 2
T-DHT/AR/Caspase 8 -0.038 0.13 -9999 0 -0.25 111 111
AR -0.077 0.18 -9999 0 -0.43 100 100
UBA3 0 0 -9999 0 -10000 0 0
PATZ1 -0.001 0 -9999 0 -10000 0 0
PAWR 0.024 0.072 -9999 0 -0.42 13 13
PRKDC 0.029 0.031 -9999 0 -0.42 2 2
PA2G4 0.035 0.005 -9999 0 -10000 0 0
UBE2I 0.032 0.011 -9999 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 -0.031 0.11 -9999 0 -0.23 106 106
RPS6KA3 0.034 0.041 -9999 0 -0.42 4 4
T-DHT/AR/ARA70 -0.041 0.13 -9999 0 -0.25 116 116
LATS2 0.024 0.061 -9999 0 -0.42 9 9
T-DHT/AR/PRX1 -0.035 0.12 -9999 0 -0.23 114 114
Cyclin D3/CDK11 p58 0.026 0.005 -9999 0 -10000 0 0
VAV3 -0.038 0.17 -9999 0 -0.42 81 81
KLK2 -0.012 0.087 -9999 0 -0.38 15 15
CASP8 0.036 0.004 -9999 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.021 0.12 -9999 0 -0.24 88 88
TMPRSS2 -0.15 0.35 -9999 0 -0.87 91 91
CCND1 -0.041 0.16 -9999 0 -0.42 79 79
PIAS1 0.037 0.007 -9999 0 -10000 0 0
mol:T-DHT -0.013 0.03 -9999 0 -0.064 116 116
CDC2L1 0 0 -9999 0 -10000 0 0
PIAS4 0.035 0.036 -9999 0 -0.42 3 3
T-DHT/AR/CDK6 -0.04 0.13 -9999 0 -0.25 116 116
CMTM2 0.029 0.025 -9999 0 -0.42 1 1
SNURF 0 0 -9999 0 -10000 0 0
ZMIZ1 -0.013 0.03 -9999 0 -0.065 116 116
CCND3 0.035 0.007 -9999 0 -10000 0 0
TGIF1 -0.001 0 -9999 0 -10000 0 0
FKBP4 0.031 0.046 -9999 0 -0.42 5 5
PLK2 and PLK4 events

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 -0.005 0.12 -9999 0 -0.42 41 41
PLK4 0.03 0.05 -9999 0 -0.42 6 6
regulation of centriole replication -0.013 0.091 -9999 0 -0.3 46 46
Syndecan-2-mediated signaling events

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.006 0.11 -10000 0 -0.3 52 52
EPHB2 0.032 0.03 -10000 0 -0.42 2 2
Syndecan-2/TACI 0.011 0.064 -10000 0 -0.24 28 28
LAMA1 0.034 0.009 -10000 0 -10000 0 0
Syndecan-2/alpha2 ITGB1 0.019 0.14 -10000 0 -0.25 86 86
HRAS 0.032 0.036 -10000 0 -0.42 3 3
Syndecan-2/CASK -0.005 0.057 -10000 0 -0.24 28 28
ITGA5 0.034 0.029 -10000 0 -0.42 2 2
BAX -0.008 0.052 -10000 0 -10000 0 0
EPB41 0.034 0.021 -10000 0 -0.42 1 1
positive regulation of cell-cell adhesion 0.008 0.065 -10000 0 -0.23 33 33
LAMA3 -0.019 0.14 -10000 0 -0.42 58 58
EZR 0 0 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
CAV2 0.013 0.095 -10000 0 -0.42 23 23
Syndecan-2/MMP2 0 0.089 -10000 0 -0.29 40 40
RP11-540L11.1 0 0 -10000 0 -10000 0 0
alpha2 ITGB1 0.015 0.1 -10000 0 -0.3 48 48
dendrite morphogenesis 0.012 0.065 -10000 0 -0.24 29 29
Syndecan-2/GM-CSF 0.011 0.066 -10000 0 -0.24 30 30
determination of left/right symmetry -0.005 0.069 -10000 0 -0.29 28 28
Syndecan-2/PKC delta 0.012 0.067 -10000 0 -0.24 30 30
GNB2L1 0.034 0.035 -10000 0 -0.42 3 3
MAPK3 0.033 0.09 0.2 82 -0.22 27 109
MAPK1 0.037 0.095 0.2 94 -0.22 29 123
Syndecan-2/RACK1 0.025 0.067 -10000 0 -0.22 31 31
NF1 0.032 0.03 -10000 0 -0.42 2 2
FGFR/FGF/Syndecan-2 -0.005 0.069 -10000 0 -0.29 28 28
ITGA2 -0.01 0.13 -10000 0 -0.42 48 48
MAPK8 -0.005 0.059 -10000 0 -0.24 29 29
Syndecan-2/alpha2/beta1 Integrin 0.043 0.11 -10000 0 -0.24 50 50
Syndecan-2/Kininogen 0.013 0.065 -10000 0 -0.25 28 28
ITGB1 0.032 0.036 -10000 0 -0.42 3 3
SRC 0.037 0.093 0.19 88 -0.22 29 117
Syndecan-2/CASK/Protein 4.1 0.012 0.059 -10000 0 -0.22 29 29
extracellular matrix organization 0.013 0.065 -10000 0 -0.24 28 28
actin cytoskeleton reorganization -0.006 0.1 -10000 0 -0.3 52 52
Syndecan-2/Caveolin-2/Ras 0.016 0.092 -10000 0 -0.27 41 41
Syndecan-2/Laminin alpha3 -0.013 0.1 -10000 0 -0.26 68 68
Syndecan-2/RasGAP 0.034 0.075 -10000 0 -0.21 35 35
alpha5/beta1 Integrin 0.048 0.037 -10000 0 -0.3 5 5
PRKCD 0.033 0.03 -10000 0 -0.42 2 2
Syndecan-2 dimer 0.012 0.066 -10000 0 -0.24 29 29
GO:0007205 0.003 0.001 -10000 0 -10000 0 0
DNA mediated transformation 0 0 -10000 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.019 0.067 -10000 0 -0.21 33 33
RHOA 0.026 0.061 -10000 0 -0.42 9 9
SDCBP 0.023 0.058 -10000 0 -0.42 8 8
TNFRSF13B 0.032 0.012 -10000 0 -10000 0 0
RASA1 0.029 0.05 -10000 0 -0.42 6 6
alpha2/beta1 Integrin 0.015 0.1 -10000 0 -0.3 48 48
Syndecan-2/Synbindin 0.011 0.064 -10000 0 -0.24 28 28
TGFB1 0.035 0.021 -10000 0 -0.42 1 1
CASP3 0.034 0.093 0.2 88 -0.22 29 117
FN1 -0.01 0.14 -10000 0 -0.42 50 50
Syndecan-2/IL8 -0.007 0.094 -10000 0 -0.27 53 53
SDC2 -0.005 0.069 -10000 0 -0.29 28 28
KNG1 0.035 0.008 -10000 0 -10000 0 0
Syndecan-2/Neurofibromin 0.011 0.067 -10000 0 -0.25 30 30
TRAPPC4 0.032 0.012 -10000 0 -10000 0 0
CSF2 0.031 0.036 -10000 0 -0.42 3 3
Syndecan-2/TGFB1 0.013 0.065 -10000 0 -0.25 28 28
Syndecan-2/Syntenin/PI-4-5-P2 0.009 0.065 -10000 0 -0.23 33 33
Syndecan-2/Ezrin 0.009 0.064 -10000 0 -0.22 34 34
PRKACA 0.036 0.095 0.2 93 -0.22 30 123
angiogenesis -0.007 0.094 -10000 0 -0.27 53 53
MMP2 0.005 0.1 -10000 0 -0.42 27 27
IL8 -0.004 0.12 -10000 0 -0.42 37 37
calcineurin-NFAT signaling pathway 0.011 0.064 -10000 0 -0.24 28 28
Signaling events mediated by PTP1B

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.028 0.057 -10000 0 -0.42 8 8
Jak2/Leptin Receptor -0.035 0.14 -10000 0 -0.39 41 41
PTP1B/AKT1 -0.045 0.14 0.26 3 -0.31 70 73
FYN 0.027 0.054 -10000 0 -0.42 7 7
p210 bcr-abl/PTP1B -0.062 0.14 0.28 3 -0.33 73 76
EGFR -0.024 0.14 -10000 0 -0.43 49 49
EGF/EGFR -0.091 0.18 0.29 2 -0.32 158 160
CSF1 0.034 0.021 -10000 0 -0.42 1 1
AKT1 0.033 0.03 -10000 0 -0.43 2 2
INSR 0.034 0.029 -10000 0 -0.42 2 2
PTP1B/N-cadherin -0.056 0.15 0.3 2 -0.35 69 71
Insulin Receptor/Insulin -0.008 0.13 0.31 2 -0.33 39 41
HCK 0.018 0.087 -10000 0 -0.42 19 19
CRK 0.032 0.023 -10000 0 -0.42 1 1
TYK2 -0.061 0.14 0.3 4 -0.33 68 72
EGF -0.073 0.19 -10000 0 -0.43 110 110
YES1 0.029 0.05 -10000 0 -0.42 6 6
CAV1 -0.071 0.15 0.27 3 -0.34 79 82
TXN 0.033 0.007 -10000 0 -10000 0 0
PTP1B/IRS1/GRB2 -0.056 0.16 0.3 2 -0.33 87 89
cell migration 0.062 0.14 0.33 73 -0.28 3 76
STAT3 0.028 0.032 -10000 0 -0.42 2 2
PRLR 0.001 0.12 -10000 0 -0.4 42 42
ITGA2B 0.033 0.01 -10000 0 -10000 0 0
CSF1R 0.035 0.006 -10000 0 -10000 0 0
Prolactin Receptor/Prolactin 0.028 0.098 -10000 0 -0.3 41 41
FGR 0.035 0.008 -10000 0 -10000 0 0
PTP1B/p130 Cas -0.045 0.14 0.3 1 -0.33 67 68
Crk/p130 Cas -0.038 0.14 0.3 1 -0.33 62 63
DOK1 -0.054 0.14 0.26 3 -0.38 53 56
JAK2 -0.043 0.14 -10000 0 -0.4 41 41
Jak2/Leptin Receptor/Leptin -0.038 0.14 0.25 1 -0.39 38 39
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
PTPN1 -0.062 0.14 0.28 3 -0.34 73 76
LYN 0.03 0.014 -10000 0 -10000 0 0
CDH2 0.013 0.091 -10000 0 -0.42 21 21
SRC -0.003 0.12 -10000 0 -0.63 14 14
ITGB3 0.028 0.046 -10000 0 -0.42 5 5
CAT1/PTP1B -0.085 0.2 0.32 2 -0.46 77 79
CAPN1 0.025 0.065 -10000 0 -0.43 10 10
CSK 0.034 0.022 -10000 0 -0.42 1 1
PI3K -0.003 0.14 0.28 2 -0.34 42 44
mol:H2O2 -0.001 0.006 -10000 0 -10000 0 0
STAT3 (dimer) -0.033 0.14 -10000 0 -0.37 36 36
negative regulation of transcription -0.042 0.14 -10000 0 -0.4 41 41
FCGR2A 0.018 0.07 -10000 0 -0.42 12 12
FER 0.032 0.022 -10000 0 -0.43 1 1
alphaIIb/beta3 Integrin 0.044 0.035 -10000 0 -0.31 4 4
BLK 0.022 0.038 -10000 0 -0.42 3 3
Insulin Receptor/Insulin/Shc 0.053 0.04 -10000 0 -0.26 3 3
RHOA 0.025 0.062 -10000 0 -0.43 9 9
LEPR 0.026 0.058 -10000 0 -0.42 8 8
BCAR1 0.03 0.014 -10000 0 -10000 0 0
p210 bcr-abl/Grb2 0.033 0.01 -10000 0 -10000 0 0
mol:NADPH -0.002 0.004 -10000 0 -10000 0 0
TRPV6 -0.068 0.21 0.26 1 -0.5 70 71
PRL 0.036 0.026 -10000 0 -0.26 3 3
SOCS3 0.006 0.19 -10000 0 -1.3 10 10
SPRY2 0.005 0.11 -10000 0 -0.43 29 29
Insulin Receptor/Insulin/IRS1 0.032 0.11 -10000 0 -0.27 55 55
CSF1/CSF1R -0.035 0.15 0.3 2 -0.33 62 64
Ras protein signal transduction 0.055 0.17 0.62 39 -10000 0 39
IRS1 -0.014 0.14 -10000 0 -0.42 54 54
INS 0.034 0.022 -10000 0 -0.43 1 1
LEP 0.001 0.11 -10000 0 -0.42 32 32
STAT5B -0.052 0.14 0.25 2 -0.34 61 63
STAT5A -0.054 0.14 0.25 2 -0.34 64 66
GRB2 0.033 0.011 -10000 0 -10000 0 0
PDGFB-D/PDGFRB -0.05 0.15 0.3 2 -0.34 73 75
CSN2 0.022 0.11 -10000 0 -1.4 2 2
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
LAT -0.009 0.12 -10000 0 -0.53 19 19
YBX1 0.037 0.043 -10000 0 -0.38 5 5
LCK -0.017 0.14 -10000 0 -0.42 54 54
SHC1 0.028 0.025 -10000 0 -0.42 1 1
NOX4 -0.023 0.15 -10000 0 -0.43 58 58
Integrins in angiogenesis

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.025 0.025 -10000 0 -0.3 3 3
alphaV beta3 Integrin 0.031 0.1 -10000 0 -0.26 51 51
PTK2 0.01 0.12 0.36 5 -0.42 18 23
IGF1R -0.042 0.17 -10000 0 -0.42 84 84
PI4KB 0 0 -10000 0 -10000 0 0
MFGE8 0.017 0.085 -10000 0 -0.42 18 18
SRC 0.033 0.029 -10000 0 -0.42 2 2
CDKN1B -0.008 0.12 -10000 0 -0.46 29 29
VEGFA 0 0 -10000 0 -10000 0 0
ILK 0.015 0.063 -10000 0 -0.48 5 5
ROCK1 0.036 0.006 -10000 0 -10000 0 0
AKT1 0.002 0.073 0.21 3 -0.31 17 20
PTK2B 0.006 0.059 0.21 9 -0.24 20 29
alphaV/beta3 Integrin/JAM-A 0.058 0.1 -10000 0 -0.23 42 42
CBL 0.032 0.012 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.051 0.073 -10000 0 -0.27 23 23
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.037 0.19 -10000 0 -0.31 151 151
VEGF/Rho/ROCK/alphaV/beta3 Integrin 0.006 0.07 -10000 0 -0.23 27 27
alphaV/beta3 Integrin/Syndecan-1 0.029 0.11 -10000 0 -0.27 56 56
PI4KA 0 0 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.079 0.21 -10000 0 -0.32 191 191
PI4 Kinase 0 0 -10000 0 -10000 0 0
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
alphaV/beta3 Integrin/Osteopontin -0.019 0.15 -10000 0 -0.27 124 124
RPS6KB1 -0.12 0.17 0.52 1 -0.44 78 79
TLN1 0.035 0.021 -10000 0 -0.42 1 1
MAPK3 -0.045 0.19 -10000 0 -0.56 50 50
GPR124 0.017 0.073 -10000 0 -0.42 13 13
MAPK1 -0.049 0.2 -10000 0 -0.54 58 58
PXN 0.036 0.004 -10000 0 -10000 0 0
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
alphaV/beta3 Integrin/Tumstatin 0.053 0.073 -10000 0 -0.28 21 21
cell adhesion 0.024 0.1 -10000 0 -0.27 47 47
ANGPTL3 0.031 0.041 -10000 0 -0.42 4 4
VEGFR2 homodimer/VEGFA homodimer/Src 0.044 0.029 -10000 0 -0.25 4 4
IGF-1R heterotetramer -0.042 0.17 -10000 0 -0.42 84 84
Rac1/GDP 0.026 0.004 -10000 0 -10000 0 0
TGFBR2 0.033 0.036 -10000 0 -0.42 3 3
ITGB3 0.029 0.046 -10000 0 -0.42 5 5
IGF1 -0.038 0.16 -10000 0 -0.42 78 78
RAC1 0.035 0.006 -10000 0 -10000 0 0
regulation of cell-matrix adhesion 0.035 0.086 -10000 0 -0.3 26 26
apoptosis 0.022 0.077 -10000 0 -0.42 15 15
CD47 0.019 0.085 -10000 0 -0.42 18 18
alphaV/beta3 Integrin/CD47 0.042 0.089 -10000 0 -0.26 37 37
VCL 0.035 0.021 -10000 0 -0.42 1 1
alphaV/beta3 Integrin/Del1 -0.009 0.14 -10000 0 -0.28 104 104
CSF1 0.034 0.021 -10000 0 -0.42 1 1
PIK3C2A 0.011 0.08 -10000 0 -0.54 8 8
PI4 Kinase/Pyk2 0.004 0.075 -10000 0 -0.21 50 50
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.051 0.067 -10000 0 -0.25 20 20
FAK1/Vinculin 0.026 0.12 0.35 5 -0.34 18 23
alphaV beta3/Integrin/ppsTEM5 0.035 0.086 -10000 0 -0.3 26 26
RHOA 0.026 0.061 -10000 0 -0.42 9 9
VTN 0.035 0.008 -10000 0 -10000 0 0
BCAR1 0.03 0.014 -10000 0 -10000 0 0
FGF2 -0.001 0.11 -10000 0 -0.42 34 34
F11R -0.005 0.072 -10000 0 -0.3 28 28
alphaV/beta3 Integrin/Lactadherin 0.044 0.092 -10000 0 -0.31 27 27
alphaV/beta3 Integrin/TGFBR2 0.052 0.071 -10000 0 -0.27 21 21
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.06 0.066 -10000 0 -0.23 15 15
HSP90AA1 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.051 0.063 -10000 0 -0.24 20 20
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.01 0.14 -10000 0 -0.42 50 50
alphaV/beta3 Integrin/Pyk2 0.035 0.065 -10000 0 -0.24 20 20
SDC1 -0.003 0.13 -10000 0 -0.42 42 42
VAV3 -0.05 0.087 0.18 1 -0.24 83 84
PTPN11 0.036 0.004 -10000 0 -10000 0 0
IRS1 -0.014 0.14 -10000 0 -0.42 54 54
FAK1/Paxillin 0.025 0.12 0.35 5 -0.34 18 23
cell migration 0.019 0.11 0.32 6 -0.32 16 22
ITGAV 0.022 0.078 -10000 0 -0.42 15 15
PI3K 0.058 0.11 -10000 0 -0.22 50 50
SPP1 -0.073 0.19 -10000 0 -0.42 115 115
KDR 0.033 0.035 -10000 0 -0.42 3 3
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.022 0.077 -10000 0 -0.42 15 15
COL4A3 0.033 0.036 -10000 0 -0.42 3 3
angiogenesis -0.036 0.2 -10000 0 -0.56 52 52
Rac1/GTP -0.012 0.097 -10000 0 -0.22 86 86
EDIL3 -0.056 0.18 -10000 0 -0.42 97 97
cell proliferation 0.052 0.071 -10000 0 -0.27 21 21
Cellular roles of Anthrax toxin

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 0.006 0.11 -10000 0 -0.42 32 32
ANTXR2 0.022 0.078 -10000 0 -0.42 15 15
negative regulation of myeloid dendritic cell antigen processing and presentation -0.006 0.017 -10000 0 -0.063 40 40
monocyte activation -0.017 0.12 -10000 0 -0.37 56 56
MAP2K2 0.004 0.1 -10000 0 -0.63 12 12
MAP2K1 -0.009 0.015 -10000 0 -0.089 5 5
MAP2K7 -0.009 0.018 -10000 0 -0.11 7 7
MAP2K6 -0.013 0.041 0.13 3 -0.21 17 20
CYAA -0.025 0.066 -10000 0 -0.24 40 40
MAP2K4 -0.008 0.018 -10000 0 -0.12 5 5
IL1B -0.026 0.07 0.16 2 -0.21 54 56
Channel 0.021 0.085 -10000 0 -0.26 40 40
NLRP1 -0.006 0.016 -10000 0 -0.058 40 40
CALM1 0.035 0.007 -10000 0 -10000 0 0
negative regulation of phagocytosis 0 0.074 -10000 0 -0.43 13 13
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.006 0.017 0.063 40 -10000 0 40
MAPK3 -0.007 0.023 0.13 6 -0.11 6 12
MAPK1 -0.009 0.018 -10000 0 -0.11 7 7
PGR -0.074 0.1 -10000 0 -0.22 169 169
PA/Cellular Receptors 0.021 0.093 -10000 0 -0.28 40 40
apoptosis -0.006 0.017 -10000 0 -0.063 40 40
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) 0.021 0.081 -10000 0 -0.24 40 40
macrophage activation 0.001 0.051 0.17 35 -0.2 2 37
TNF 0.026 0.061 -10000 0 -0.42 9 9
VCAM1 -0.018 0.13 -10000 0 -0.37 56 56
platelet activation 0 0.074 -10000 0 -0.43 13 13
MAPKKK cascade 0.001 0.032 0.12 6 -0.089 14 20
IL18 -0.02 0.064 0.14 1 -0.24 34 35
negative regulation of macrophage activation -0.006 0.017 -10000 0 -0.063 40 40
LEF -0.006 0.017 -10000 0 -0.063 40 40
CASP1 -0.008 0.031 -10000 0 -0.085 61 61
mol:cAMP 0 0.075 -10000 0 -0.44 13 13
necrosis -0.006 0.017 -10000 0 -0.063 40 40
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) 0.021 0.08 -10000 0 -0.24 40 40
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
amb2 Integrin signaling

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 0.018 0.11 -10000 0 -0.31 43 43
alphaM/beta2 Integrin/GPIbA 0.035 0.084 -10000 0 -0.29 22 22
alphaM/beta2 Integrin/proMMP-9 0.01 0.12 -10000 0 -0.29 60 60
PLAUR 0.009 0.11 -10000 0 -0.42 29 29
HMGB1 0.025 0.031 -10000 0 -10000 0 0
alphaM/beta2 Integrin/Talin 0.037 0.087 -10000 0 -0.3 23 23
AGER 0.025 0.037 -10000 0 -0.42 1 1
RAP1A 0.031 0.045 -10000 0 -0.42 5 5
SELPLG 0.025 0.07 -10000 0 -0.42 12 12
mol:LDL 0 0 -10000 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 0.043 0.12 -10000 0 -0.24 56 56
mol:GTP 0 0 -10000 0 -10000 0 0
MMP9 -0.013 0.14 -10000 0 -0.42 52 52
CYR61 -0.004 0.12 -10000 0 -0.42 40 40
TLN1 0.035 0.021 -10000 0 -0.42 1 1
Rap1/GTP 0.011 0.13 -10000 0 -0.36 35 35
RHOA 0.026 0.061 -10000 0 -0.42 9 9
P-selectin oligomer -0.039 0.16 -10000 0 -0.42 73 73
MYH2 -0.016 0.14 0.23 1 -0.42 33 34
MST1R -0.005 0.13 -10000 0 -0.42 44 44
leukocyte activation during inflammatory response 0.041 0.079 -10000 0 -0.25 23 23
APOB 0.036 0.004 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
complement component iC3b receptor activity 0 0 -10000 0 -10000 0 0
MMP2 0.005 0.1 -10000 0 -0.42 27 27
JAM3 0.014 0.087 -10000 0 -0.42 19 19
GP1BA 0.03 0.014 -10000 0 -10000 0 0
alphaM/beta2 Integrin/CTGF 0.018 0.12 -10000 0 -0.32 45 45
alphaM/beta2 Integrin -0.01 0.13 -10000 0 -0.38 37 37
JAM3 homodimer 0.014 0.087 -10000 0 -0.42 19 19
ICAM2 0.027 0.046 -10000 0 -0.42 5 5
ICAM1 0.018 0.085 -10000 0 -0.42 18 18
phagocytosis triggered by activation of immune response cell surface activating receptor -0.009 0.13 -10000 0 -0.38 37 37
cell adhesion 0.034 0.083 -10000 0 -0.29 22 22
NFKB1 0 0.15 0.39 1 -0.37 52 53
THY1 0.015 0.085 -10000 0 -0.42 18 18
RhoA/GDP 0.02 0.043 -10000 0 -0.3 9 9
Lipoprotein(a) 0.045 0.019 -10000 0 -0.25 1 1
alphaM/beta2 Integrin/LRP/tPA 0.016 0.12 -10000 0 -0.26 61 61
IL6 -0.049 0.23 0.36 2 -0.6 65 67
ITGB2 0.006 0.098 -10000 0 -0.44 21 21
elevation of cytosolic calcium ion concentration 0.015 0.15 -10000 0 -0.35 61 61
alphaM/beta2 Integrin/JAM2/JAM3 0.026 0.13 -10000 0 -0.31 48 48
JAM2 0.012 0.099 -10000 0 -0.42 25 25
alphaM/beta2 Integrin/ICAM1 0.04 0.13 -10000 0 -0.27 64 64
alphaM/beta2 Integrin/uPA/Plg 0.026 0.13 -10000 0 -0.28 58 58
RhoA/GTP -0.03 0.14 -10000 0 -0.44 37 37
positive regulation of phagocytosis 0.004 0.14 -10000 0 -0.41 36 36
Ron/MSP 0.02 0.1 -10000 0 -0.3 44 44
alphaM/beta2 Integrin/uPAR/uPA 0.017 0.15 -10000 0 -0.35 61 61
alphaM/beta2 Integrin/uPAR 0.024 0.11 -10000 0 -0.33 39 39
PLAU -0.013 0.14 -10000 0 -0.42 52 52
PLAT -0.021 0.14 -10000 0 -0.42 51 51
actin filament polymerization -0.013 0.14 0.24 3 -0.4 33 36
MST1 0.034 0.008 -10000 0 -10000 0 0
alphaM/beta2 Integrin/lipoprotein(a) 0.047 0.083 -10000 0 -0.25 23 23
TNF -0.015 0.16 0.35 2 -0.41 51 53
RAP1B 0.033 0.03 -10000 0 -0.42 2 2
alphaM/beta2 Integrin/uPA 0.013 0.13 -10000 0 -0.31 56 56
fibrinolysis 0.024 0.12 -10000 0 -0.28 58 58
HCK 0.018 0.087 -10000 0 -0.42 19 19
dendritic cell antigen processing and presentation -0.009 0.13 -10000 0 -0.38 37 37
VTN 0.035 0.008 -10000 0 -10000 0 0
alphaM/beta2 Integrin/CYR61 0.019 0.12 -10000 0 -0.3 47 47
LPA 0.033 0.022 -10000 0 -0.42 1 1
LRP1 0.035 0.021 -10000 0 -0.42 1 1
cell migration -0.011 0.13 -10000 0 -0.28 76 76
FN1 -0.01 0.14 -10000 0 -0.42 50 50
alphaM/beta2 Integrin/Thy1 0.024 0.1 -10000 0 -0.29 37 37
MPO 0.032 0.013 -10000 0 -10000 0 0
KNG1 0.035 0.008 -10000 0 -10000 0 0
RAP1/GDP 0.041 0.037 -10000 0 -0.25 7 7
ROCK1 -0.019 0.14 -10000 0 -0.42 37 37
ELA2 0.035 0.008 -10000 0 -10000 0 0
PLG 0.032 0.03 -10000 0 -0.42 2 2
CTGF 0.002 0.11 -10000 0 -0.42 34 34
alphaM/beta2 Integrin/Hck 0.03 0.11 -10000 0 -0.37 28 28
ITGAM 0.022 0.053 -10000 0 -0.43 5 5
alphaM/beta2 Integrin/P-Selectin/PSGL1 0.003 0.14 -10000 0 -0.28 77 77
HP 0.027 0.037 -10000 0 -0.42 3 3
leukocyte adhesion 0 0.15 -10000 0 -0.4 42 42
SELP -0.039 0.16 -10000 0 -0.42 73 73
Reelin signaling pathway

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.048 0.017 -10000 0 -10000 0 0
VLDLR -0.007 0.12 -10000 0 -0.42 42 42
CRKL 0.031 0.041 -10000 0 -0.42 4 4
LRPAP1 0.035 0.007 -10000 0 -10000 0 0
FYN 0.027 0.054 -10000 0 -0.42 7 7
ITGA3 0.023 0.07 -10000 0 -0.42 12 12
RELN/VLDLR/Fyn 0.027 0.1 -10000 0 -0.27 51 51
MAPK8IP1/MKK7/MAP3K11/JNK1 0.07 0.07 -10000 0 -0.22 15 15
AKT1 -0.017 0.088 -10000 0 -0.23 57 57
MAP2K7 0.035 0.021 -10000 0 -0.42 1 1
RAPGEF1 0.036 0.004 -10000 0 -10000 0 0
DAB1 0.035 0.007 -10000 0 -10000 0 0
RELN/LRP8/DAB1 0.039 0.081 -10000 0 -0.23 40 40
LRPAP1/LRP8 0.024 0.089 -10000 0 -0.3 35 35
RELN/LRP8/DAB1/Fyn 0.045 0.09 -10000 0 -0.22 46 46
DAB1/alpha3/beta1 Integrin 0.016 0.12 -10000 0 -0.22 85 85
long-term memory 0.049 0.1 -10000 0 -0.22 55 55
DAB1/LIS1 0.032 0.12 -10000 0 -0.22 80 80
DAB1/CRLK/C3G 0.021 0.11 -10000 0 -0.22 82 82
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
DAB1/NCK2 0.039 0.12 -10000 0 -0.22 80 80
ARHGEF2 0.022 0.055 -10000 0 -0.42 7 7
mol:Src family inhibitors PP1 and PP2 0 0 -10000 0 -10000 0 0
GRIN2A 0.033 0.011 -10000 0 -10000 0 0
CDK5R1 0.033 0.01 -10000 0 -10000 0 0
RELN 0.03 0.046 -10000 0 -0.42 5 5
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
RELN/LRP8/Fyn 0.031 0.096 -10000 0 -0.26 46 46
GRIN2A/RELN/LRP8/DAB1/Fyn 0.056 0.094 -10000 0 -0.22 41 41
MAPK8 0.033 0.035 -10000 0 -0.42 3 3
RELN/VLDLR/DAB1 0.032 0.088 -10000 0 -0.23 46 46
ITGB1 0.032 0.036 -10000 0 -0.42 3 3
MAP1B -0.027 0.12 0.32 5 -0.25 96 101
RELN/LRP8 0.039 0.089 -10000 0 -0.25 40 40
GRIN2B/RELN/LRP8/DAB1/Fyn 0.047 0.11 -10000 0 -0.23 61 61
PI3K 0.036 0.065 -10000 0 -0.3 17 17
mol:PP2 0 0 -10000 0 -10000 0 0
alpha3/beta1 Integrin 0.04 0.059 -10000 0 -0.32 12 12
RAP1A -0.042 0.097 0.34 7 -0.43 3 10
PAFAH1B1 0.032 0.023 -10000 0 -0.42 1 1
MAPK8IP1 0.034 0.029 -10000 0 -0.42 2 2
CRLK/C3G 0.047 0.034 -10000 0 -0.3 4 4
GRIN2B 0.018 0.082 -10000 0 -0.42 17 17
NCK2 0.036 0.005 -10000 0 -10000 0 0
neuron differentiation 0.018 0.083 -10000 0 -0.32 9 9
neuron adhesion -0.041 0.11 0.35 7 -0.39 6 13
LRP8 -0.001 0.12 -10000 0 -0.42 35 35
GSK3B -0.015 0.092 0.19 5 -0.23 55 60
RELN/VLDLR/DAB1/Fyn 0.039 0.097 -10000 0 -0.23 51 51
MAP3K11 0.034 0.029 -10000 0 -0.42 2 2
RELN/VLDLR/DAB1/P13K -0.007 0.095 -10000 0 -0.24 60 60
CDK5 0.035 0.007 -10000 0 -10000 0 0
MAPT -0.068 0.18 0.77 6 -0.38 96 102
neuron migration -0.024 0.12 0.3 11 -0.33 18 29
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 0.017 0.082 -10000 0 -0.32 9 9
RELN/VLDLR 0.025 0.12 -10000 0 -0.24 80 80
TCGA08_retinoblastoma

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0.021 0.068 -10000 0 -0.39 12 12
CDKN2C 0.024 0.064 -10000 0 -0.37 12 12
CDKN2A 0.019 0.071 -10000 0 -0.39 14 14
CCND2 0.003 0.047 0.18 27 -0.13 2 29
RB1 -0.011 0.062 0.24 2 -0.21 38 40
CDK4 0.007 0.057 0.22 30 -10000 0 30
CDK6 0.004 0.058 0.21 28 -0.17 6 34
G1/S progression 0.018 0.073 0.2 57 -0.26 3 60
Caspase cascade in apoptosis

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 -0.005 0.11 0.24 1 -0.46 10 11
ACTA1 -0.016 0.12 0.23 12 -0.31 44 56
NUMA1 -0.014 0.12 -10000 0 -0.42 16 16
SPTAN1 -0.021 0.12 0.24 8 -0.31 47 55
LIMK1 -0.033 0.13 0.24 3 -0.33 49 52
BIRC3 -0.008 0.12 -10000 0 -0.42 40 40
BIRC2 0.032 0.012 -10000 0 -10000 0 0
BAX 0.035 0.007 -10000 0 -10000 0 0
CASP10 -0.048 0.091 -10000 0 -0.26 75 75
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
PTK2 -0.011 0.12 0.26 1 -0.49 12 13
DIABLO 0.036 0.004 -10000 0 -10000 0 0
apoptotic nuclear changes -0.02 0.12 0.24 8 -0.3 47 55
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.03 0.05 -10000 0 -0.42 6 6
GSN -0.028 0.12 0.26 5 -0.32 51 56
MADD 0.036 0.005 -10000 0 -10000 0 0
TFAP2A -0.003 0.16 -10000 0 -0.58 32 32
BID -0.022 0.069 -10000 0 -0.17 82 82
MAP3K1 -0.034 0.14 -10000 0 -0.43 49 49
TRADD 0.03 0.014 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.047 0.037 -10000 0 -0.3 5 5
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB -0.03 0.13 0.3 6 -0.33 51 57
CASP9 0.034 0.022 -10000 0 -0.42 1 1
DNA repair -0.022 0.069 0.28 9 -0.18 18 27
neuron apoptosis -0.031 0.2 -10000 0 -0.67 41 41
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis -0.018 0.12 0.25 1 -0.39 20 21
APAF1 0.032 0.041 -10000 0 -0.42 4 4
CASP6 -0.014 0.15 -10000 0 -0.79 15 15
TRAF2 0.034 0.029 -10000 0 -0.42 2 2
ICAD/CAD -0.024 0.11 0.24 4 -0.31 45 49
CASP7 0.031 0.1 0.25 45 -0.32 14 59
KRT18 -0.066 0.22 -10000 0 -0.57 73 73
apoptosis -0.016 0.12 0.26 3 -0.37 24 27
DFFA -0.023 0.12 0.23 5 -0.31 46 51
DFFB -0.023 0.12 0.24 4 -0.31 46 50
PARP1 0.022 0.07 0.18 18 -0.28 9 27
actin filament polymerization 0.033 0.13 0.32 46 -0.29 7 53
TNF 0.026 0.061 -10000 0 -0.42 9 9
CYCS -0.008 0.057 0.15 3 -0.21 10 13
SATB1 -0.028 0.16 -10000 0 -0.71 16 16
SLK -0.023 0.12 0.23 5 -0.3 48 53
p15 BID/BAX -0.002 0.077 -10000 0 -0.25 14 14
CASP2 -0.016 0.1 0.22 4 -0.32 29 33
JNK cascade 0.034 0.14 0.42 49 -10000 0 49
CASP3 -0.021 0.12 0.22 8 -0.32 50 58
LMNB2 -0.009 0.12 -10000 0 -0.45 18 18
RIPK1 0.035 0.007 -10000 0 -10000 0 0
CASP4 0.023 0.061 -10000 0 -0.42 9 9
Mammalian IAPs/DIABLO 0.034 0.082 -10000 0 -0.23 39 39
negative regulation of DNA binding -0.002 0.16 -10000 0 -0.57 33 33
stress fiber formation -0.022 0.12 0.23 5 -0.3 46 51
GZMB -0.033 0.12 -10000 0 -0.31 75 75
CASP1 -0.008 0.1 -10000 0 -0.36 32 32
LMNB1 -0.06 0.16 0.25 1 -0.39 46 47
APP -0.031 0.2 -10000 0 -0.68 41 41
TNFRSF1A 0.033 0.022 -10000 0 -0.42 1 1
response to stress 0 0 -10000 0 -10000 0 0
CASP8 0.009 0.001 -10000 0 -10000 0 0
VIM -0.012 0.13 0.27 3 -0.38 24 27
LMNA -0.008 0.099 0.25 1 -0.31 22 23
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD -0.016 0.11 -10000 0 -0.34 32 32
LRDD 0.035 0.008 -10000 0 -10000 0 0
SREBF1 -0.036 0.13 0.25 3 -0.32 49 52
APAF-1/Caspase 9 0.016 0.11 -10000 0 -0.64 12 12
nuclear fragmentation during apoptosis -0.013 0.12 -10000 0 -0.42 16 16
CFL2 -0.034 0.13 0.29 7 -0.33 46 53
GAS2 -0.031 0.13 0.24 5 -0.32 52 57
positive regulation of apoptosis -0.028 0.12 0.26 1 -0.37 27 28
PRF1 0.027 0.054 -10000 0 -0.42 7 7
Regulation of nuclear SMAD2/3 signaling

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.035 0.036 -10000 0 -0.41 2 2
HSPA8 0.018 0.073 -10000 0 -0.42 13 13
SMAD3/SMAD4/ER alpha -0.034 0.18 -10000 0 -0.29 135 135
AKT1 0.03 0.038 -10000 0 -0.42 2 2
GSC -0.19 0.49 -10000 0 -1.4 74 74
NKX2-5 0.028 0.022 -10000 0 -10000 0 0
muscle cell differentiation 0.012 0.17 0.39 52 -10000 0 52
SMAD2-3/SMAD4/SP1 0.022 0.18 -10000 0 -0.36 62 62
SMAD4 -0.004 0.097 -10000 0 -0.24 43 43
CBFB 0.03 0.014 -10000 0 -10000 0 0
SAP18 0.033 0.01 -10000 0 -10000 0 0
Cbp/p300/MSG1 0.062 0.049 -10000 0 -0.23 4 4
SMAD3/SMAD4/VDR 0.059 0.12 -10000 0 -0.26 32 32
MYC -0.001 0.1 -10000 0 -0.41 29 29
CDKN2B -0.1 0.32 -10000 0 -1.1 35 35
AP1 -0.03 0.18 -10000 0 -0.38 84 84
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.007 0.099 -10000 0 -0.35 18 18
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 -0.007 0.092 -10000 0 -0.27 43 43
SP3 0.028 0.03 -10000 0 -10000 0 0
CREB1 0.035 0.021 -10000 0 -0.42 1 1
FOXH1 0.013 0.059 -10000 0 -0.18 11 11
SMAD3/SMAD4/GR 0.027 0.12 -10000 0 -0.28 43 43
GATA3 -0.044 0.17 -10000 0 -0.41 91 91
SKI/SIN3/HDAC complex/NCoR1 0.015 0.073 -10000 0 -0.31 12 12
MEF2C/TIF2 -0.014 0.13 0.33 1 -0.37 39 40
endothelial cell migration 0.005 0.24 1.2 17 -10000 0 17
MAX 0.035 0.011 -10000 0 -10000 0 0
RBBP7 0.034 0.029 -10000 0 -0.42 2 2
RBBP4 0.034 0.021 -10000 0 -0.42 1 1
RUNX2 0.031 0.041 -10000 0 -0.42 4 4
RUNX3 -0.01 0.13 -10000 0 -0.42 46 46
RUNX1 0.008 0.11 -10000 0 -0.42 29 29
CTBP1 0.035 0.008 -10000 0 -10000 0 0
NR3C1 0.024 0.072 -10000 0 -0.42 13 13
VDR 0.02 0.082 -10000 0 -0.42 17 17
CDKN1A -0.042 0.24 -10000 0 -1.2 17 17
KAT2B 0.001 0.005 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.015 0.14 -10000 0 -0.28 86 86
DCP1A 0.034 0.022 -10000 0 -0.42 1 1
SKI 0.036 0.002 -10000 0 -10000 0 0
SERPINE1 -0.006 0.25 -10000 0 -1.2 17 17
SMAD3/SMAD4/ATF2 0.034 0.11 -10000 0 -0.26 33 33
SMAD3/SMAD4/ATF3 0.015 0.12 -10000 0 -0.3 43 43
SAP30 0.03 0.046 -10000 0 -0.42 5 5
Cbp/p300/PIAS3 0.067 0.051 0.22 2 -0.26 1 3
JUN -0.043 0.18 -10000 0 -0.42 69 69
SMAD3/SMAD4/IRF7 0.032 0.12 -10000 0 -0.28 41 41
TFE3 0.033 0.035 -10000 0 -0.15 5 5
COL1A2 -0.076 0.33 -10000 0 -0.87 70 70
mesenchymal cell differentiation -0.03 0.11 0.28 33 -10000 0 33
DLX1 0.033 0.011 -10000 0 -10000 0 0
TCF3 0.033 0.03 -10000 0 -0.42 2 2
FOS -0.038 0.16 -10000 0 -0.45 66 66
SMAD3/SMAD4/Max 0.033 0.11 -10000 0 -0.26 32 32
Cbp/p300/SNIP1 0.06 0.045 -10000 0 -0.26 4 4
ZBTB17 0.035 0.013 -10000 0 -10000 0 0
LAMC1 -0.007 0.11 -10000 0 -0.4 26 26
TGIF2/HDAC complex/SMAD3/SMAD4 0.028 0.11 -10000 0 -0.27 37 37
IRF7 0.028 0.059 -10000 0 -0.42 8 8
ESR1 -0.082 0.19 -10000 0 -0.41 132 132
HNF4A 0.033 0.03 -10000 0 -0.42 2 2
MEF2C -0.03 0.14 0.34 3 -0.38 45 48
SMAD2-3/SMAD4 0.018 0.13 -10000 0 -0.27 48 48
Cbp/p300/Src-1 0.062 0.049 -10000 0 -0.23 5 5
IGHV3OR16-13 -0.003 0.065 -10000 0 -0.44 8 8
TGIF2/HDAC complex 0.029 0.05 -10000 0 -0.42 6 6
CREBBP 0.034 0.019 -10000 0 -10000 0 0
SKIL 0.028 0.05 -10000 0 -0.42 6 6
HDAC1 0.034 0.021 -10000 0 -0.42 1 1
HDAC2 0.032 0.023 -10000 0 -0.42 1 1
SNIP1 0.032 0.036 -10000 0 -0.42 3 3
GCN5L2 0.031 0.029 -10000 0 -0.42 1 1
SMAD3/SMAD4/TFE3 0.04 0.12 -10000 0 -0.3 39 39
MSG1/HSC70 0.032 0.062 -10000 0 -0.3 15 15
SMAD2 0.011 0.059 -10000 0 -0.14 16 16
SMAD3 0.01 0.091 -10000 0 -0.32 21 21
SMAD3/E2F4-5/DP1/p107/SMAD4 -0.001 0.079 -10000 0 -0.24 30 30
SMAD2/SMAD2/SMAD4 -0.001 0.063 0.26 4 -0.21 19 23
NCOR1 0.032 0.012 -10000 0 -10000 0 0
NCOA2 0.025 0.047 -10000 0 -0.42 5 5
NCOA1 0.031 0.045 -10000 0 -0.42 5 5
MYOD/E2A 0.032 0.077 -10000 0 -0.3 25 25
SMAD2-3/SMAD4/SP1/MIZ-1 0.035 0.18 -10000 0 -0.35 56 56
IFNB1 -0.005 0.096 0.36 1 -0.31 26 27
SMAD3/SMAD4/MEF2C -0.003 0.17 -10000 0 -0.42 44 44
CITED1 0.029 0.031 -10000 0 -0.42 2 2
SMAD2-3/SMAD4/ARC105 0.021 0.12 -10000 0 -0.24 48 48
RBL1 0.033 0.022 -10000 0 -0.42 1 1
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB -0.004 0.12 -10000 0 -0.42 31 31
RUNX1-3/PEBPB2 0.013 0.12 -10000 0 -0.26 70 70
SMAD7 -0.041 0.21 -10000 0 -0.52 56 56
MYC/MIZ-1 0.016 0.082 0.19 5 -0.29 29 34
SMAD3/SMAD4 0.04 0.13 0.32 36 -0.4 17 53
IL10 -0.034 0.12 -10000 0 -0.31 56 56
PIASy/HDAC complex 0.024 0.043 -10000 0 -0.42 3 3
PIAS3 0.036 0.011 -10000 0 -10000 0 0
CDK2 0.035 0.033 -10000 0 -0.42 2 2
IL5 -0.035 0.13 -10000 0 -0.28 93 93
CDK4 0.038 0.017 -10000 0 -10000 0 0
PIAS4 0.024 0.043 -10000 0 -0.42 3 3
ATF3 0.011 0.084 -10000 0 -0.42 18 18
SMAD3/SMAD4/SP1 0.014 0.17 -10000 0 -0.33 71 71
FOXG1 -0.001 0.003 -10000 0 -10000 0 0
FOXO3 0.006 0.03 -10000 0 -0.2 4 4
FOXO1 0.006 0.029 -10000 0 -0.23 3 3
FOXO4 0.006 0.029 -10000 0 -0.23 3 3
heart looping -0.029 0.14 0.34 3 -0.38 45 48
CEBPB 0.025 0.053 -10000 0 -0.42 6 6
SMAD3/SMAD4/DLX1 0.033 0.11 -10000 0 -0.26 31 31
MYOD1 0.014 0.095 -10000 0 -0.42 23 23
SMAD3/SMAD4/HNF4 0.032 0.11 -10000 0 -0.27 32 32
SMAD3/SMAD4/GATA3 -0.011 0.17 -10000 0 -0.3 105 105
SnoN/SIN3/HDAC complex/NCoR1 0.028 0.05 -10000 0 -0.42 6 6
SMAD3/SMAD4/RUNX1-3/PEBPB2 0.017 0.15 -10000 0 -0.27 83 83
SMAD3/SMAD4/SP1-3 0.029 0.18 -10000 0 -0.36 64 64
MED15 0 0 -10000 0 -10000 0 0
SP1 0.009 0.076 -10000 0 -0.19 38 38
SIN3B 0.035 0.005 -10000 0 -10000 0 0
SIN3A 0.035 0.007 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.032 0.15 -10000 0 -0.26 91 91
ITGB5 -0.045 0.18 -10000 0 -0.5 59 59
TGIF/SIN3/HDAC complex/CtBP 0.018 0.061 -10000 0 -0.29 9 9
SMAD3/SMAD4/AR -0.023 0.18 -10000 0 -0.31 115 115
AR -0.053 0.18 -10000 0 -0.42 99 99
negative regulation of cell growth 0.012 0.099 -10000 0 -0.33 22 22
SMAD3/SMAD4/MYOD 0.018 0.12 -10000 0 -0.26 56 56
E2F5 0.011 0.087 -10000 0 -0.42 19 19
E2F4 0.03 0.014 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.045 0.13 -10000 0 -0.22 70 70
SMAD2-3/SMAD4/FOXO1-3a-4 -0.004 0.1 -10000 0 -0.3 42 42
TFDP1 0.032 0.012 -10000 0 -10000 0 0
SMAD3/SMAD4/AP1 -0.007 0.2 -10000 0 -0.43 69 69
SMAD3/SMAD4/RUNX2 0.031 0.11 -10000 0 -0.28 33 33
TGIF2 0.029 0.05 -10000 0 -0.42 6 6
TGIF1 0 0 -10000 0 -10000 0 0
ATF2 0.036 0.003 -10000 0 -10000 0 0
Visual signal transduction: Rods

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.03 0.046 -10000 0 -0.42 5 5
GNAT1/GTP 0.024 0.025 -10000 0 -0.3 3 3
Metarhodopsin II/Arrestin 0.009 0.094 -10000 0 -0.25 57 57
PDE6G/GNAT1/GTP 0.042 0.028 -10000 0 -0.25 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
GNAT1 0.032 0.036 -10000 0 -0.42 3 3
GRK1 0 0 -10000 0 -10000 0 0
CNG Channel -0.015 0.12 -10000 0 -0.22 123 123
mol:Na + 0.025 0.098 -10000 0 -0.25 45 45
mol:ADP 0 0 -10000 0 -10000 0 0
RGS9-1/Gbeta5/R9AP 0.007 0.12 -10000 0 -0.27 73 73
mol:GDP 0 0 -10000 0 -10000 0 0
cGMP/CNG Channel 0.037 0.11 -10000 0 -0.26 42 42
CNGB1 0.03 0.014 -10000 0 -10000 0 0
RDH5 0.033 0.011 -10000 0 -10000 0 0
SAG -0.024 0.14 -10000 0 -0.42 58 58
mol:Ca2+ -0.034 0.087 0.33 6 -0.39 10 16
Na + (4 Units) 0.016 0.093 -10000 0 -0.26 31 31
RGS9 0.017 0.07 -10000 0 -0.42 12 12
GNB1/GNGT1 0.036 0.062 -10000 0 -0.3 16 16
GNAT1/GDP 0.018 0.11 -10000 0 -0.23 76 76
GUCY2D 0.032 0.012 -10000 0 -10000 0 0
GNGT1 0.017 0.067 -10000 0 -0.42 11 11
GUCY2F 0.027 0.064 -10000 0 -0.42 10 10
GNB5 0.025 0.067 -10000 0 -0.42 11 11
mol:GMP (4 units) -0.02 0.1 -10000 0 -0.22 105 105
mol:11-cis-retinal 0.033 0.01 -10000 0 -10000 0 0
mol:cGMP 0.048 0.084 -10000 0 -0.26 29 29
GNB1 0.032 0.045 -10000 0 -0.42 5 5
Rhodopsin 0.051 0.011 -10000 0 -10000 0 0
SLC24A1 0.03 0.046 -10000 0 -0.42 5 5
CNGA1 0.004 0.1 -10000 0 -0.42 28 28
Metarhodopsin II 0.023 0.004 -10000 0 -10000 0 0
mol:Ca ++ 0 0 -10000 0 -10000 0 0
GC1/GCAP Family 0.064 0.077 -10000 0 -0.25 23 23
RGS9BP -0.023 0.15 -10000 0 -0.42 61 61
Metarhodopsin II/Transducin 0.015 0.047 -10000 0 -0.21 20 20
GCAP Family/Ca ++ 0.051 0.068 -10000 0 -0.25 23 23
PDE6A/B -0.027 0.15 -10000 0 -0.3 112 112
mol:Pi 0.006 0.12 -10000 0 -0.27 73 73
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
Transducin 0.05 0.058 -10000 0 -0.23 19 19
PDE6B -0.064 0.19 -10000 0 -0.42 111 111
PDE6A 0.033 0.029 -10000 0 -0.42 2 2
PDE6G 0.034 0.01 -10000 0 -10000 0 0
RHO 0.036 0.006 -10000 0 -10000 0 0
PDE6 -0.015 0.15 -10000 0 -0.24 140 140
GUCA1A 0.022 0.075 -10000 0 -0.42 14 14
GC2/GCAP Family 0.067 0.09 -10000 0 -0.28 29 29
GUCA1C 0.026 0.064 -10000 0 -0.42 10 10
GUCA1B 0.034 0.021 -10000 0 -0.42 1 1
BMP receptor signaling

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS 0.045 0.1 -9999 0 -0.24 49 49
SMAD6-7/SMURF1 0.067 0.025 -9999 0 -0.26 1 1
NOG 0.029 0.037 -9999 0 -0.42 3 3
SMAD9 -0.029 0.16 -9999 0 -0.45 55 55
SMAD4 0.029 0.054 -9999 0 -0.42 7 7
SMAD5 -0.026 0.12 -9999 0 -0.38 28 28
BMP7/USAG1 -0.063 0.16 -9999 0 -0.31 139 139
SMAD5/SKI -0.014 0.13 -9999 0 -0.38 29 29
SMAD1 0.012 0.07 -9999 0 -0.32 6 6
BMP2 0.021 0.073 -9999 0 -0.42 13 13
SMAD1/SMAD1/SMAD4 0.033 0.077 -9999 0 -0.32 2 2
BMPR1A 0.031 0.045 -9999 0 -0.42 5 5
BMPR1B -0.004 0.11 -9999 0 -0.42 30 30
BMPR1A-1B/BAMBI -0.02 0.14 -9999 0 -0.26 120 120
AHSG 0.034 0.008 -9999 0 -10000 0 0
CER1 0.034 0.009 -9999 0 -10000 0 0
BMP2-4/CER1 0.016 0.12 -9999 0 -0.26 71 71
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.015 0.12 -9999 0 -0.36 30 30
BMP2-4 (homodimer) -0.006 0.13 -9999 0 -0.31 74 74
RGMB 0.028 0.057 -9999 0 -0.42 8 8
BMP6/BMPR2/BMPR1A-1B 0.051 0.091 -9999 0 -0.24 41 41
RGMA 0.019 0.073 -9999 0 -0.42 13 13
SMURF1 0.036 0.006 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.03 0.12 -9999 0 -0.36 32 32
BMP2-4/USAG1 -0.075 0.18 -9999 0 -0.29 189 189
SMAD6/SMURF1/SMAD5 -0.013 0.13 -9999 0 -0.38 28 28
SOSTDC1 -0.11 0.2 -9999 0 -0.42 151 151
BMP7/BMPR2/BMPR1A-1B 0.041 0.095 -9999 0 -0.24 45 45
SKI 0.036 0.002 -9999 0 -10000 0 0
BMP6 (homodimer) 0.027 0.05 -9999 0 -0.42 6 6
HFE2 0.026 0.064 -9999 0 -0.42 10 10
ZFYVE16 0.034 0.022 -9999 0 -0.42 1 1
MAP3K7 0.033 0.011 -9999 0 -10000 0 0
BMP2-4/CHRD 0.014 0.12 -9999 0 -0.28 70 70
SMAD5/SMAD5/SMAD4 -0.017 0.13 -9999 0 -0.38 30 30
MAPK1 0.033 0.022 -9999 0 -0.42 1 1
TAK1/TAB family 0.012 0.13 -9999 0 -0.36 24 24
BMP7 (homodimer) 0.016 0.072 -9999 0 -0.42 13 13
NUP214 0.035 0.021 -9999 0 -0.42 1 1
BMP6/FETUA 0.044 0.041 -9999 0 -0.3 6 6
SMAD1/SKI 0.027 0.08 -9999 0 -0.32 7 7
SMAD6 0.035 0.008 -9999 0 -10000 0 0
CTDSP2 0.034 0.029 -9999 0 -0.42 2 2
BMP2-4/FETUA 0.017 0.12 -9999 0 -0.26 69 69
MAP3K7IP1 0.034 0.009 -9999 0 -10000 0 0
GREM1 -0.002 0.12 -9999 0 -0.42 40 40
BMPR2 (homodimer) 0.034 0.029 -9999 0 -0.42 2 2
GADD34/PP1CA 0.06 0.039 -9999 0 -0.26 4 4
BMPR1A-1B (homodimer) 0.02 0.087 -9999 0 -0.3 34 34
CHRDL1 0.03 0.037 -9999 0 -0.42 3 3
ENDOFIN/SMAD1 0.026 0.08 -9999 0 -0.31 7 7
SMAD6-7/SMURF1/SMAD1 0.055 0.086 -9999 0 -0.31 5 5
SMAD6/SMURF1 0.036 0.006 -9999 0 -10000 0 0
BAMBI -0.054 0.17 -9999 0 -0.42 93 93
SMURF2 0.028 0.042 -9999 0 -0.42 4 4
BMP2-4/CHRDL1 0.014 0.12 -9999 0 -0.27 75 75
BMP2-4/GREM1 -0.009 0.15 -9999 0 -0.29 101 101
SMAD7 0.034 0.021 -9999 0 -0.42 1 1
SMAD8A/SMAD8A/SMAD4 -0.023 0.17 -9999 0 -0.44 59 59
SMAD1/SMAD6 0.026 0.08 -9999 0 -0.33 6 6
TAK1/SMAD6 0.048 0.017 -9999 0 -10000 0 0
BMP7 0.016 0.073 -9999 0 -0.42 13 13
BMP6 0.027 0.05 -9999 0 -0.42 6 6
MAP3K7IP2 0.032 0.03 -9999 0 -0.42 2 2
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.018 0.11 -9999 0 -0.33 35 35
PPM1A 0.034 0.021 -9999 0 -0.42 1 1
SMAD1/SMURF2 0.022 0.076 -9999 0 -0.33 5 5
SMAD7/SMURF1 0.05 0.02 -9999 0 -0.3 1 1
CTDSPL 0.029 0.054 -9999 0 -0.42 7 7
PPP1CA 0.031 0.03 -9999 0 -0.42 2 2
XIAP 0 0 -9999 0 -10000 0 0
CTDSP1 0.034 0.029 -9999 0 -0.42 2 2
PPP1R15A 0.034 0.021 -9999 0 -0.42 1 1
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.034 0.14 -9999 0 -0.41 36 36
CHRD 0.029 0.046 -9999 0 -0.42 5 5
BMPR2 0.034 0.029 -9999 0 -0.42 2 2
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.03 0.12 -9999 0 -0.38 31 31
BMP4 -0.028 0.15 -9999 0 -0.42 65 65
FST 0.023 0.064 -9999 0 -0.42 10 10
BMP2-4/NOG 0.012 0.12 -9999 0 -0.26 72 72
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 0.052 0.097 -9999 0 -0.23 45 45
Nectin adhesion pathway

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.028 0.057 -10000 0 -0.42 8 8
alphaV beta3 Integrin 0.036 0.071 -10000 0 -0.31 19 19
PTK2 -0.025 0.14 -10000 0 -0.43 36 36
positive regulation of JNK cascade -0.002 0.13 -10000 0 -0.32 40 40
CDC42/GDP 0.009 0.17 -10000 0 -0.43 42 42
Rac1/GDP 0.01 0.16 -10000 0 -0.41 43 43
RAP1B 0.033 0.03 -10000 0 -0.42 2 2
RAP1A 0.031 0.045 -10000 0 -0.42 5 5
CTNNB1 0.025 0.067 -10000 0 -0.42 11 11
CDC42/GTP 0 0.16 -10000 0 -0.4 40 40
nectin-3/I-afadin 0.022 0.098 -10000 0 -0.32 35 35
RAPGEF1 -0.016 0.16 -10000 0 -0.45 45 45
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.021 0.18 -10000 0 -0.51 46 46
PDGFB-D/PDGFRB 0.028 0.057 -10000 0 -0.42 8 8
TLN1 -0.015 0.074 0.19 4 -0.34 16 20
Rap1/GTP -0.006 0.12 -10000 0 -0.33 44 44
IQGAP1 0.035 0.008 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.047 0.064 -10000 0 -0.23 22 22
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin 0.022 0.098 -10000 0 -0.32 35 35
PVR 0.031 0.041 -10000 0 -0.42 4 4
Necl-5(dimer) 0.031 0.041 -10000 0 -0.42 4 4
mol:GDP -0.012 0.19 -10000 0 -0.51 45 45
MLLT4 0.02 0.078 -10000 0 -0.42 15 15
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
PI3K 0.054 0.12 -10000 0 -0.28 47 47
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.033 0.064 -10000 0 -0.3 16 16
positive regulation of lamellipodium assembly 0.005 0.12 -10000 0 -0.32 41 41
PVRL1 0.03 0.024 -10000 0 -0.42 1 1
PVRL3 0.013 0.097 -10000 0 -0.42 24 24
PVRL2 0.026 0.064 -10000 0 -0.42 10 10
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
CDH1 -0.011 0.13 -10000 0 -0.42 45 45
CLDN1 -0.047 0.17 -10000 0 -0.42 86 86
JAM-A/CLDN1 0.002 0.14 -10000 0 -0.27 87 87
SRC -0.035 0.2 -10000 0 -0.56 48 48
ITGB3 0.029 0.046 -10000 0 -0.42 5 5
nectin-1(dimer)/I-afadin/I-afadin 0.033 0.064 -10000 0 -0.3 16 16
FARP2 -0.017 0.2 -10000 0 -0.53 44 44
RAC1 0.035 0.006 -10000 0 -10000 0 0
CTNNA1 0.035 0.021 -10000 0 -0.42 1 1
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) 0.038 0.097 -10000 0 -0.28 38 38
nectin-1/I-afadin 0.033 0.064 -10000 0 -0.3 16 16
nectin-2/I-afadin 0.032 0.076 -10000 0 -0.3 24 24
RAC1/GTP/IQGAP1/filamentous actin 0.046 0.013 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin 0.035 0.093 -10000 0 -0.28 36 36
CDC42/GTP/IQGAP1/filamentous actin 0.045 0.014 -10000 0 -10000 0 0
F11R 0.026 0.038 -10000 0 -0.42 3 3
positive regulation of filopodium formation -0.002 0.13 -10000 0 -0.32 40 40
alphaV/beta3 Integrin/Talin 0.008 0.11 0.27 1 -0.32 29 30
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.032 0.076 -10000 0 -0.3 24 24
nectin-2(dimer)/I-afadin/I-afadin 0.032 0.076 -10000 0 -0.3 24 24
PIP5K1C -0.011 0.077 -10000 0 -0.24 39 39
VAV2 -0.006 0.19 -10000 0 -0.52 38 38
RAP1/GDP 0.01 0.16 -10000 0 -0.39 44 44
ITGAV 0.022 0.078 -10000 0 -0.42 15 15
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin 0.035 0.1 -10000 0 -0.28 42 42
nectin-3(dimer)/I-afadin/I-afadin 0.022 0.098 -10000 0 -0.32 35 35
Rac1/GTP 0.008 0.15 -10000 0 -0.39 40 40
PTPRM -0.006 0.089 -10000 0 -0.27 40 40
E-cadherin/beta catenin/alpha catenin 0.025 0.12 -10000 0 -0.22 78 78
adherens junction assembly 0 0 -10000 0 -10000 0 0
CDC42 0.035 0.008 -10000 0 -10000 0 0
mTOR signaling pathway

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GBL 0.032 0.023 -10000 0 -0.42 1 1
MKNK1 0.035 0.006 -10000 0 -10000 0 0
mol:PIP3 -0.024 0.1 0.26 5 -0.26 65 70
FRAP1 -0.008 0.11 -10000 0 -0.43 25 25
AKT1 -0.025 0.096 0.2 9 -0.25 58 67
INSR 0.034 0.029 -10000 0 -0.42 2 2
Insulin Receptor/Insulin 0.045 0.026 -10000 0 -0.25 3 3
mol:GTP 0.011 0.097 0.29 2 -0.22 46 48
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA/eIF3/40s Ribosomal subunit -0.006 0.051 -10000 0 -0.19 16 16
TSC2 0.032 0.023 -10000 0 -0.42 1 1
RHEB/GDP 0.004 0.081 -10000 0 -0.2 50 50
TSC1 0.036 0.005 -10000 0 -10000 0 0
Insulin Receptor/IRS1 -0.009 0.11 -10000 0 -0.3 65 65
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA 0.011 0.068 -10000 0 -0.22 15 15
mol:GDP 0 0 -10000 0 -10000 0 0
EIF3A 0 0 -10000 0 -10000 0 0
RPS6KB1 0 0.092 0.24 4 -0.33 16 20
MAP3K5 -0.015 0.086 0.19 7 -0.25 51 58
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
apoptosis -0.015 0.086 0.19 7 -0.25 51 58
mol:LY294002 0 0 0.001 2 -0.001 62 64
EIF4B -0.002 0.085 0.28 2 -0.29 17 19
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.012 0.082 0.26 1 -0.27 16 17
eIF4E/eIF4G1/eIF4A1 0.002 0.075 -10000 0 -0.28 21 21
KIAA1303 0 0 -10000 0 -10000 0 0
PI3K 0.002 0.12 -10000 0 -0.27 75 75
mTOR/RHEB/GTP/Raptor/GBL 0.01 0.061 0.22 3 -0.21 11 14
FKBP1A 0.035 0.007 -10000 0 -10000 0 0
RHEB/GTP 0.02 0.091 0.27 2 -0.27 12 14
mol:Amino Acids 0 0 0.001 2 -0.001 62 64
FKBP12/Rapamycin 0.026 0.006 -10000 0 -10000 0 0
PDPK1 -0.033 0.094 0.17 23 -0.26 60 83
EIF4E 0.036 0.005 -10000 0 -10000 0 0
ASK1/PP5C -0.035 0.22 -10000 0 -0.59 57 57
mTOR/RHEB/GTP/Raptor/GBL/eIF4E 0.017 0.054 -10000 0 -0.38 1 1
TSC1/TSC2 0.013 0.1 0.32 2 -0.24 46 48
tumor necrosis factor receptor activity 0 0 0.001 62 -0.001 2 64
RPS6 0.034 0.022 -10000 0 -0.42 1 1
PPP5C 0.032 0.041 -10000 0 -0.42 4 4
EIF4G1 0.031 0.041 -10000 0 -0.42 4 4
IRS1 -0.031 0.11 -10000 0 -0.32 65 65
INS 0.034 0.021 -10000 0 -0.42 1 1
PTEN 0.027 0.06 -10000 0 -0.42 9 9
PDK2 -0.032 0.1 0.17 27 -0.26 64 91
EIF4EBP1 -0.068 0.32 -10000 0 -1.2 38 38
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
PPP2R5D -0.007 0.1 -10000 0 -0.39 25 25
peptide biosynthetic process 0.017 0.03 0.19 5 -0.23 5 10
RHEB 0.035 0.007 -10000 0 -10000 0 0
EIF4A1 0.032 0.012 -10000 0 -10000 0 0
mol:Rapamycin 0 0.001 0.004 14 -0.003 4 18
EEF2 0.017 0.03 0.19 5 -0.23 5 10
eIF4E/4E-BP1 -0.048 0.3 -10000 0 -1.1 38 38
BCR signaling pathway

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN -0.021 0.16 0.26 4 -0.42 44 48
IKBKB 0.017 0.092 0.33 2 -0.3 4 6
AKT1 0.024 0.11 0.25 35 -0.23 18 53
IKBKG 0.027 0.079 0.24 5 -0.28 6 11
CALM1 -0.01 0.13 0.25 5 -0.41 29 34
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
MAP3K1 -0.02 0.18 0.32 2 -0.48 42 44
MAP3K7 0.033 0.01 -10000 0 -10000 0 0
mol:Ca2+ -0.011 0.14 0.26 5 -0.42 31 36
DOK1 0.027 0.061 -10000 0 -0.42 9 9
AP-1 -0.018 0.1 0.21 2 -0.25 43 45
LYN 0.03 0.014 -10000 0 -10000 0 0
BLNK 0.013 0.099 -10000 0 -0.42 25 25
SHC1 0.028 0.025 -10000 0 -0.42 1 1
BCR complex 0.025 0.074 -10000 0 -0.3 23 23
CD22 -0.018 0.12 0.26 1 -0.44 30 31
CAMK2G -0.009 0.12 0.24 7 -0.4 26 33
CSNK2A1 0.035 0.006 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.004 0.077 -10000 0 -0.24 36 36
GO:0007205 -0.011 0.14 0.26 5 -0.42 31 36
SYK 0.005 0.11 -10000 0 -0.42 34 34
ELK1 -0.012 0.13 0.25 5 -0.42 29 34
NFATC1 0.022 0.13 0.26 22 -0.36 29 51
B-cell antigen/BCR complex 0.025 0.074 -10000 0 -0.3 23 23
PAG1/CSK 0.035 0.051 -10000 0 -0.3 9 9
NFKBIB 0.027 0.05 0.15 8 -0.12 21 29
HRAS 0.003 0.12 0.25 13 -0.34 30 43
NFKBIA 0.028 0.05 0.15 8 -0.12 21 29
NF-kappa-B/RelA/I kappa B beta 0.032 0.045 0.15 9 -0.093 6 15
RasGAP/Csk 0.038 0.1 -10000 0 -0.26 35 35
mol:GDP -0.01 0.14 0.26 5 -0.4 34 39
PTEN 0.027 0.061 -10000 0 -0.42 9 9
CD79B 0.007 0.094 -10000 0 -0.42 23 23
NF-kappa-B/RelA/I kappa B alpha 0.032 0.044 0.14 10 -0.092 4 14
GRB2 0.033 0.011 -10000 0 -10000 0 0
PI3K/BCAP/CD19 -0.01 0.18 0.34 2 -0.5 40 42
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
mol:IP3 -0.012 0.14 0.27 4 -0.42 32 36
CSK 0.034 0.022 -10000 0 -0.42 1 1
FOS -0.036 0.14 0.24 4 -0.39 42 46
CHUK 0.016 0.1 0.25 3 -0.33 18 21
IBTK 0.032 0.03 -10000 0 -0.42 2 2
CARD11/BCL10/MALT1/TAK1 0.01 0.13 0.27 1 -0.4 26 27
PTPN6 -0.01 0.12 0.25 1 -0.48 23 24
RELA 0.036 0.006 -10000 0 -10000 0 0
BCL2A1 0.023 0.035 0.14 3 -0.1 1 4
VAV2 0 0.14 0.26 2 -0.5 26 28
ubiquitin-dependent protein catabolic process 0.03 0.05 0.15 8 -0.12 21 29
BTK -0.012 0.19 -10000 0 -1.1 15 15
CD19 -0.017 0.12 0.26 1 -0.47 26 27
MAP4K1 0.035 0.007 -10000 0 -10000 0 0
CD72 0.009 0.1 -10000 0 -0.42 27 27
PAG1 0.02 0.061 -10000 0 -0.42 9 9
MAPK14 -0.015 0.16 0.28 3 -0.41 42 45
SH3BP5 0.021 0.078 -10000 0 -0.42 15 15
PIK3AP1 -0.02 0.15 0.28 4 -0.45 36 40
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.02 0.16 -10000 0 -0.47 42 42
RAF1 0.003 0.12 0.24 12 -0.33 26 38
RasGAP/p62DOK/SHIP 0.026 0.099 -10000 0 -0.26 40 40
CD79A 0.031 0.023 -10000 0 -0.42 1 1
re-entry into mitotic cell cycle -0.018 0.1 0.21 2 -0.25 43 45
RASA1 0.029 0.05 -10000 0 -0.42 6 6
MAPK3 0.012 0.1 0.24 20 -0.31 16 36
MAPK1 0.002 0.1 0.26 9 -0.31 19 28
CD72/SHP1 0.018 0.16 0.3 16 -0.47 29 45
NFKB1 0.036 0.005 -10000 0 -10000 0 0
MAPK8 -0.016 0.16 0.3 5 -0.41 41 46
actin cytoskeleton organization 0.019 0.14 0.3 13 -0.44 27 40
NF-kappa-B/RelA 0.065 0.087 0.28 8 -0.2 16 24
Calcineurin 0.004 0.13 0.25 1 -0.38 27 28
PI3K -0.025 0.11 -10000 0 -0.39 28 28
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.011 0.15 0.3 4 -0.44 37 41
SOS1 0.035 0.021 -10000 0 -0.42 1 1
Bam32/HPK1 -0.065 0.31 -10000 0 -0.73 79 79
DAPP1 -0.1 0.34 -10000 0 -0.84 77 77
cytokine secretion 0.023 0.13 0.25 24 -0.34 28 52
mol:DAG -0.012 0.14 0.27 4 -0.42 32 36
PLCG2 0.02 0.055 -10000 0 -0.42 7 7
MAP2K1 0.002 0.11 0.24 13 -0.33 21 34
B-cell antigen/BCR complex/FcgammaRIIB 0.02 0.094 -10000 0 -0.29 34 34
mol:PI-3-4-5-P3 0 0.11 0.25 20 -0.3 23 43
ETS1 -0.009 0.11 0.23 7 -0.37 26 33
B-cell antigen/BCR complex/LYN/SYK/BLNK 0.033 0.12 -10000 0 -0.26 55 55
B-cell antigen/BCR complex/LYN -0.013 0.12 0.27 1 -0.45 31 32
MALT1 0.031 0.041 -10000 0 -0.42 4 4
TRAF6 0.035 0.021 -10000 0 -0.42 1 1
RAC1 0.008 0.14 0.33 5 -0.46 27 32
B-cell antigen/BCR complex/LYN/SYK -0.002 0.14 -10000 0 -0.48 27 27
CARD11 -0.013 0.14 0.26 7 -0.44 30 37
FCGR2B 0.001 0.11 -10000 0 -0.42 30 30
PPP3CA 0.027 0.061 -10000 0 -0.42 9 9
BCL10 0.034 0.008 -10000 0 -10000 0 0
IKK complex 0.024 0.05 0.16 18 -0.14 1 19
PTPRC 0.007 0.094 -10000 0 -0.42 23 23
PDPK1 0.005 0.085 0.21 28 -0.22 16 44
PPP3CB 0.035 0.021 -10000 0 -0.42 1 1
PPP3CC 0.024 0.043 -10000 0 -0.42 4 4
POU2F2 0.025 0.032 0.13 5 -0.1 1 6
Aurora B signaling

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex -0.007 0.034 -10000 0 -0.097 60 60
STMN1 0.005 0.051 -10000 0 -0.34 10 10
Aurora B/RasGAP/Survivin 0.028 0.1 -10000 0 -0.28 43 43
Chromosomal passenger complex/Cul3 protein complex -0.044 0.12 -10000 0 -0.35 40 40
BIRC5 -0.004 0.12 -10000 0 -0.44 38 38
DES -0.062 0.26 -10000 0 -0.68 72 72
Aurora C/Aurora B/INCENP 0.053 0.049 -10000 0 -0.24 10 10
Aurora B/TACC1 0.023 0.064 -10000 0 -0.25 23 23
Aurora B/PP2A 0.045 0.034 -10000 0 -0.31 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
CBX5 0.009 0.022 -10000 0 -0.18 6 6
mitotic metaphase/anaphase transition 0.001 0.006 0.014 49 -0.01 1 50
NDC80 0.005 0.025 -10000 0 -0.31 3 3
Cul3 protein complex 0.015 0.12 -10000 0 -0.26 76 76
KIF2C -0.056 0.21 -10000 0 -0.66 49 49
PEBP1 -0.001 0.004 0.01 2 -0.014 38 40
KIF20A 0.004 0.12 -10000 0 -0.42 35 35
mol:GDP 0 0 -10000 0 -10000 0 0
Aurora B/RasGAP 0.04 0.051 -10000 0 -0.31 9 9
SEPT1 0.031 0.023 -10000 0 -0.42 1 1
SMC2 0 0 -10000 0 -10000 0 0
SMC4 0 0 -10000 0 -10000 0 0
NSUN2/NPM1/Nucleolin -0.044 0.18 -10000 0 -0.51 60 60
PSMA3 0.035 0.006 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle 0 0.004 0.009 53 -0.009 7 60
H3F3B 0.014 0.028 -10000 0 -0.29 4 4
AURKB 0.03 0.04 -10000 0 -0.45 3 3
AURKC 0.034 0.021 -10000 0 -0.42 1 1
CDCA8 0.017 0.085 -10000 0 -0.44 16 16
cytokinesis -0.045 0.23 -10000 0 -0.64 49 49
Aurora B/Septin1 -0.026 0.22 -10000 0 -0.62 44 44
AURKA 0 0.004 0.009 53 -0.009 7 60
INCENP 0.025 0.053 -10000 0 -0.44 6 6
KLHL13 -0.034 0.16 -10000 0 -0.42 73 73
BUB1 -0.012 0.14 -10000 0 -0.42 52 52
hSgo1/Aurora B/Survivin 0.025 0.12 -10000 0 -0.34 39 39
EVI5 0.031 0.041 -10000 0 -0.42 4 4
RhoA/GTP -0.021 0.22 -10000 0 -0.58 49 49
SGOL1 0.02 0.08 -10000 0 -0.42 16 16
CENPA -0.039 0.15 -10000 0 -0.31 82 82
NCAPG 0 0 -10000 0 -10000 0 0
Aurora B/HC8 Proteasome 0.045 0.034 -10000 0 -0.31 3 3
NCAPD2 0 0 -10000 0 -10000 0 0
Aurora B/PP1-gamma 0.044 0.043 -10000 0 -0.31 6 6
RHOA 0.026 0.061 -10000 0 -0.42 9 9
NCAPH 0 0 -10000 0 -10000 0 0
NPM1 -0.02 0.12 -10000 0 -0.32 57 57
RASA1 0.029 0.05 -10000 0 -0.42 6 6
KLHL9 0.032 0.03 -10000 0 -0.42 2 2
mitotic prometaphase -0.001 0.004 0.01 2 -0.014 38 40
proteasomal ubiquitin-dependent protein catabolic process 0.045 0.034 -10000 0 -0.31 3 3
PPP1CC 0.033 0.035 -10000 0 -0.42 3 3
Centraspindlin -0.03 0.23 -10000 0 -0.61 52 52
RhoA/GDP 0.02 0.043 -10000 0 -0.3 9 9
NSUN2 -0.017 0.11 -10000 0 -0.3 57 57
MYLK 0.006 0.059 -10000 0 -0.3 17 17
KIF23 0.006 0.11 -10000 0 -0.43 30 30
VIM -0.006 0.072 -10000 0 -0.3 27 27
RACGAP1 0.02 0.085 -10000 0 -0.43 17 17
mitosis 0 0 -10000 0 -10000 0 0
NCL -0.022 0.13 -10000 0 -0.35 51 51
Chromosomal passenger complex -0.048 0.18 -10000 0 -0.46 59 59
Chromosomal passenger complex/EVI5 0.04 0.13 -10000 0 -0.33 48 48
TACC1 0.011 0.089 -10000 0 -0.42 20 20
PPP2R5D 0.035 0.006 -10000 0 -10000 0 0
CUL3 0.032 0.041 -10000 0 -0.42 4 4
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
IL1-mediated signaling events

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.026 0.004 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
MAP3K7IP2 0.032 0.03 -10000 0 -0.42 2 2
ERC1 0 0 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.01 0.11 -10000 0 -0.37 29 29
IRAK/TOLLIP 0.041 0.017 0.18 5 -10000 0 5
IKBKB 0.03 0.014 -10000 0 -10000 0 0
IKBKG 0.036 0 -10000 0 -10000 0 0
IL1 alpha/IL1R2 0.026 0.09 -10000 0 -0.3 35 35
IL1A 0.032 0.041 -10000 0 -0.42 4 4
IL1B -0.023 0.11 -10000 0 -0.34 53 53
IRAK/TRAF6/p62/Atypical PKCs 0.059 0.05 -10000 0 -0.21 12 12
IL1R2 0.004 0.11 -10000 0 -0.42 31 31
IL1R1 -0.005 0.13 -10000 0 -0.42 43 43
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.022 0.12 -10000 0 -0.41 26 26
TOLLIP 0.035 0.007 -10000 0 -10000 0 0
TICAM2 0 0 -10000 0 -10000 0 0
MAP3K3 0.031 0.013 -10000 0 -10000 0 0
TAK1/TAB1/TAB2 0.06 0.034 -10000 0 -0.26 2 2
IKK complex/ELKS 0.025 0.079 0.27 1 -0.32 9 10
JUN -0.028 0.068 0.24 2 -0.45 2 4
MAP3K7 0.033 0.011 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/PI3K 0.006 0.15 -10000 0 -0.28 94 94
IL1 alpha/IL1R1/IL1RAP/MYD88 0.052 0.098 -10000 0 -0.23 50 50
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 0.063 0.1 -10000 0 -0.22 53 53
IL1 beta fragment/IL1R1/IL1RAP -0.011 0.14 -10000 0 -0.29 87 87
NFKB1 0.036 0.005 -10000 0 -10000 0 0
MAPK8 -0.014 0.059 0.28 3 -0.38 1 4
IRAK1 0.018 0.003 -10000 0 -10000 0 0
IL1RN/IL1R1 -0.003 0.13 -10000 0 -0.32 73 73
IRAK4 0.033 0.035 -10000 0 -0.42 3 3
PRKCI 0.025 0.064 -10000 0 -0.42 10 10
TRAF6 0.035 0.021 -10000 0 -0.42 1 1
PI3K 0.036 0.065 -10000 0 -0.3 17 17
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.018 0.13 -10000 0 -0.39 36 36
CHUK 0.026 0.067 -10000 0 -0.42 11 11
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.011 0.14 -10000 0 -0.29 87 87
IL1 beta/IL1R2 -0.019 0.13 -10000 0 -0.3 85 85
IRAK/TRAF6/TAK1/TAB1/TAB2 0.075 0.045 -10000 0 -0.21 3 3
NF kappa B1 p50/RelA -0.004 0.13 -10000 0 -0.26 91 91
IRAK3 0.027 0.046 -10000 0 -0.42 5 5
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 0.001 0.13 -10000 0 -0.27 88 88
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP 0.009 0.084 -10000 0 -0.23 53 53
IL1 alpha/IL1R1/IL1RAP 0.038 0.095 -10000 0 -0.26 46 46
RELA 0.035 0.006 -10000 0 -10000 0 0
MAP3K7IP1 0.034 0.009 -10000 0 -10000 0 0
SQSTM1 0.034 0.021 -10000 0 -0.42 1 1
MYD88 0.031 0.041 -10000 0 -0.42 4 4
IRAK/TRAF6/MEKK3 0.053 0.03 -10000 0 -0.22 1 1
IL1RAP 0.033 0.022 -10000 0 -0.42 1 1
UBE2N 0.035 0.006 -10000 0 -10000 0 0
IRAK/TRAF6 -0.015 0.11 -10000 0 -0.25 73 73
CASP1 0.002 0.11 -10000 0 -0.42 30 30
IL1RN/IL1R2 0.003 0.12 -10000 0 -0.32 62 62
IL1 beta fragment/IL1R1/IL1RAP/MYD88 0.003 0.14 -10000 0 -0.28 88 88
TMEM189-UBE2V1 0 0 -10000 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP 0.003 0.11 -10000 0 -0.32 45 45
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
IL1RN 0.001 0.12 -10000 0 -0.42 37 37
TRAF6/TAK1/TAB1/TAB2 0.071 0.043 -10000 0 -0.21 3 3
MAP2K6 -0.01 0.057 0.27 2 -0.22 13 15
PDGFR-alpha signaling pathway

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.004 0.11 -10000 0 -0.44 29 29
PDGF/PDGFRA/CRKL 0.02 0.088 -10000 0 -0.3 32 32
positive regulation of JUN kinase activity 0.048 0.073 -10000 0 -0.23 22 22
CRKL 0.031 0.041 -10000 0 -0.42 4 4
PDGF/PDGFRA/Caveolin-3 0.022 0.086 -10000 0 -0.3 30 30
AP1 -0.14 0.3 -10000 0 -0.81 78 78
mol:IP3 -0.014 0.08 -10000 0 -0.32 27 27
PLCG1 -0.014 0.08 -10000 0 -0.32 27 27
PDGF/PDGFRA/alphaV Integrin 0.014 0.1 -10000 0 -0.32 42 42
RAPGEF1 0.036 0.004 -10000 0 -10000 0 0
CRK 0.032 0.023 -10000 0 -0.42 1 1
mol:Ca2+ -0.014 0.08 -10000 0 -0.32 27 27
CAV3 0.034 0.021 -10000 0 -0.42 1 1
CAV1 0.027 0.054 -10000 0 -0.42 7 7
SHC/Grb2/SOS1 0.05 0.074 -10000 0 -0.23 22 22
PDGF/PDGFRA/Shf 0.022 0.086 -10000 0 -0.3 30 30
FOS -0.14 0.3 0.31 2 -0.8 78 80
JUN -0.053 0.083 -10000 0 -0.34 36 36
oligodendrocyte development 0.014 0.1 -10000 0 -0.32 42 42
GRB2 0.033 0.011 -10000 0 -10000 0 0
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
mol:DAG -0.014 0.08 -10000 0 -0.32 27 27
PDGF/PDGFRA -0.004 0.11 -10000 0 -0.44 29 29
actin cytoskeleton reorganization 0.02 0.09 -10000 0 -0.3 33 33
SRF 0.018 0.012 -10000 0 -10000 0 0
SHC1 0.028 0.025 -10000 0 -0.42 1 1
PI3K 0.034 0.099 -10000 0 -0.28 40 40
PDGF/PDGFRA/Crk/C3G 0.044 0.079 -10000 0 -0.25 30 30
JAK1 -0.01 0.079 -10000 0 -0.31 30 30
ELK1/SRF -0.026 0.071 0.15 20 -0.26 30 50
SHB 0.031 0.046 -10000 0 -0.42 5 5
SHF 0.033 0.022 -10000 0 -0.42 1 1
CSNK2A1 0.04 0.021 -10000 0 -10000 0 0
GO:0007205 -0.023 0.084 -10000 0 -0.35 28 28
SOS1 0.035 0.021 -10000 0 -0.42 1 1
Ras protein signal transduction 0.048 0.073 -10000 0 -0.23 22 22
PDGF/PDGFRA/SHB 0.02 0.09 -10000 0 -0.3 33 33
PDGF/PDGFRA/Caveolin-1 0.017 0.097 -10000 0 -0.33 33 33
ITGAV 0.022 0.078 -10000 0 -0.42 15 15
ELK1 -0.036 0.08 0.24 2 -0.32 30 32
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
PDGF/PDGFRA/Crk 0.019 0.085 -10000 0 -0.3 30 30
JAK-STAT cascade -0.01 0.079 -10000 0 -0.31 30 30
cell proliferation 0.022 0.086 -10000 0 -0.3 30 30
IFN-gamma pathway

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.045 0.086 -10000 0 -0.22 39 39
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
CRKL 0.031 0.041 -10000 0 -0.42 4 4
STAT1 (dimer)/Cbp/p300 0.035 0.1 0.31 2 -0.31 19 21
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.052 0.051 -10000 0 -0.26 4 4
antigen processing and presentation of peptide antigen via MHC class I -0.016 0.093 -10000 0 -0.25 48 48
CaM/Ca2+ 0.047 0.085 -10000 0 -0.21 39 39
RAP1A 0.031 0.045 -10000 0 -0.42 5 5
STAT1 (dimer)/SHP2 0.017 0.095 0.28 3 -0.24 47 50
AKT1 -0.01 0.093 0.28 11 -0.29 9 20
MAP2K1 -0.022 0.081 0.27 3 -0.28 13 16
MAP3K11 0.005 0.079 0.26 5 -0.21 40 45
IFNGR1 0.03 0.022 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII -0.005 0.13 -10000 0 -0.42 24 24
Rap1/GTP 0.001 0.067 -10000 0 -0.21 30 30
CRKL/C3G 0.047 0.034 -10000 0 -0.3 4 4
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP 0.059 0.093 -10000 0 -0.22 39 39
CEBPB -0.016 0.16 0.33 3 -0.51 30 33
STAT3 0.028 0.031 -10000 0 -0.42 2 2
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 0.054 0.13 -10000 0 -0.84 6 6
STAT1 -0.002 0.09 0.29 3 -0.24 47 50
CALM1 0.035 0.007 -10000 0 -10000 0 0
IFN-gamma (dimer) -0.007 0.12 -10000 0 -0.42 38 38
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
STAT1 (dimer)/PIAS1 0.017 0.093 0.29 3 -0.23 46 49
CEBPB/PTGES2/Cbp/p300 0.005 0.11 -10000 0 -0.33 31 31
mol:Ca2+ 0.042 0.083 -10000 0 -0.21 39 39
MAPK3 -0.015 0.14 0.4 1 -0.67 11 12
STAT1 (dimer) -0.011 0.13 -10000 0 -0.34 48 48
MAPK1 -0.044 0.2 0.4 1 -0.7 35 36
JAK2 0.028 0.036 -10000 0 -0.42 2 2
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
JAK1 0.029 0.04 -10000 0 -0.41 3 3
CAMK2D 0.022 0.075 -10000 0 -0.42 14 14
DAPK1 -0.007 0.13 0.31 2 -0.48 21 23
SMAD7 -0.001 0.058 0.16 8 -0.16 20 28
CBL/CRKL/C3G 0.034 0.084 0.3 2 -0.21 33 35
PI3K 0.036 0.095 -10000 0 -0.22 48 48
IFNG -0.007 0.12 -10000 0 -0.42 38 38
apoptosis -0.061 0.18 0.31 1 -0.42 87 88
CAMK2G 0.036 0.005 -10000 0 -10000 0 0
STAT3 (dimer) 0.028 0.031 -10000 0 -0.42 2 2
CAMK2A 0.035 0.021 -10000 0 -0.42 1 1
CAMK2B -0.012 0.13 -10000 0 -0.42 47 47
FRAP1 -0.016 0.085 0.28 9 -0.28 7 16
PRKCD -0.011 0.092 0.29 10 -0.3 8 18
RAP1B 0.033 0.03 -10000 0 -0.42 2 2
negative regulation of cell growth -0.016 0.093 -10000 0 -0.25 48 48
PTPN2 0.035 0.008 -10000 0 -10000 0 0
EP300 0.032 0.03 -10000 0 -0.42 2 2
IRF1 -0.006 0.1 0.29 8 -0.42 15 23
STAT1 (dimer)/PIASy 0.013 0.094 0.29 3 -0.24 38 41
SOCS1 0.018 0.13 -10000 0 -1.1 6 6
mol:GDP 0.031 0.079 0.28 2 -0.2 34 36
CASP1 -0.012 0.083 0.16 8 -0.24 43 51
PTGES2 0.036 0.005 -10000 0 -10000 0 0
IRF9 0 0.049 0.12 4 -0.15 19 23
mol:PI-3-4-5-P3 0.021 0.086 -10000 0 -0.21 48 48
RAP1/GDP 0.025 0.08 -10000 0 -0.25 15 15
CBL 0.004 0.073 0.29 2 -0.21 37 39
MAP3K1 -0.005 0.089 0.26 5 -0.22 57 62
PIAS1 0.035 0.007 -10000 0 -10000 0 0
PIAS4 0.032 0.036 -10000 0 -0.42 3 3
antigen processing and presentation of peptide antigen via MHC class II -0.016 0.093 -10000 0 -0.25 48 48
PTPN11 0.008 0.08 0.29 4 -0.21 39 43
CREBBP 0.033 0.011 -10000 0 -10000 0 0
RAPGEF1 0.036 0.004 -10000 0 -10000 0 0
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.028 0.025 -10000 0 -0.42 1 1
Caspase 8 (4 units) 0.029 0.13 -10000 0 -0.4 23 23
NEF -0.011 0.049 -10000 0 -0.17 45 45
NFKBIA 0.022 0.05 -10000 0 -0.46 2 2
BIRC3 -0.012 0.14 -10000 0 -0.46 40 40
CYCS -0.005 0.12 0.19 4 -0.33 40 44
RIPK1 0.035 0.007 -10000 0 -10000 0 0
CD247 -0.011 0.049 -10000 0 -0.17 45 45
MAP2K7 0.004 0.18 -10000 0 -0.78 15 15
protein ubiquitination -0.015 0.12 0.22 2 -0.37 23 25
CRADD 0.03 0.05 -10000 0 -0.42 6 6
DAXX 0.036 0.006 -10000 0 -10000 0 0
FAS 0.008 0.11 -10000 0 -0.42 29 29
BID -0.006 0.12 -10000 0 -0.3 57 57
NF-kappa-B/RelA/I kappa B alpha 0.042 0.099 -10000 0 -0.26 39 39
TRADD 0.03 0.014 -10000 0 -10000 0 0
MAP3K5 0.012 0.095 -10000 0 -0.42 23 23
CFLAR 0.031 0.045 -10000 0 -0.42 5 5
FADD 0.029 0.014 -10000 0 -10000 0 0
NF-kappa-B/RelA/I kappa B alpha/ubiquitin 0.042 0.1 -10000 0 -0.26 39 39
MAPK8 0.003 0.16 0.42 1 -0.69 15 16
APAF1 0.032 0.041 -10000 0 -0.42 4 4
TRAF1 0.035 0.021 -10000 0 -0.42 1 1
TRAF2 0.034 0.029 -10000 0 -0.42 2 2
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG 0.002 0.13 -10000 0 -0.31 54 54
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD -0.014 0.14 -10000 0 -0.41 30 30
CHUK -0.019 0.13 -10000 0 -0.4 24 24
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0.055 0.095 -10000 0 -0.24 35 35
TCRz/NEF -0.017 0.083 -10000 0 -0.28 45 45
TNF 0.026 0.061 -10000 0 -0.42 9 9
FASLG -0.022 0.14 -10000 0 -0.52 36 36
NFKB1 0.023 0.041 -10000 0 -0.1 36 36
TNFR1A/BAG4/TNF-alpha 0.048 0.047 -10000 0 -0.25 6 6
CASP6 0.022 0.16 -10000 0 -0.53 24 24
CASP7 -0.041 0.2 0.29 1 -0.47 68 69
RELA 0.023 0.042 -10000 0 -0.1 39 39
CASP2 0.035 0.008 -10000 0 -10000 0 0
CASP3 -0.04 0.19 -10000 0 -0.46 65 65
TNFRSF1A 0.033 0.022 -10000 0 -0.42 1 1
TNFR1A/BAG4 0.039 0.028 -10000 0 -0.3 1 1
CASP8 0.036 0.004 -10000 0 -10000 0 0
CASP9 0.034 0.022 -10000 0 -0.42 1 1
MAP3K14 -0.013 0.13 0.24 2 -0.43 23 25
APAF-1/Caspase 9 -0.014 0.14 -10000 0 -0.34 54 54
BCL2 -0.031 0.16 0.58 1 -0.53 22 23
Arf6 downstream pathway

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR -0.029 0.23 -10000 0 -0.98 28 28
regulation of axonogenesis -0.001 0.058 0.29 12 -10000 0 12
myoblast fusion -0.006 0.11 0.4 31 -10000 0 31
mol:GTP 0.01 0.066 -10000 0 -0.23 32 32
regulation of calcium-dependent cell-cell adhesion -0.047 0.082 0.24 33 -10000 0 33
ARF1/GTP 0.024 0.056 -10000 0 -0.19 24 24
mol:GM1 0 0.047 -10000 0 -0.18 27 27
mol:Choline -0.001 0.057 -10000 0 -0.27 16 16
lamellipodium assembly -0.007 0.12 -10000 0 -0.45 34 34
MAPK3 0.009 0.085 -10000 0 -0.33 29 29
ARF6/GTP/NME1/Tiam1 0.048 0.082 -10000 0 -0.24 33 33
ARF1 0.027 0.025 -10000 0 -0.42 1 1
ARF6/GDP 0.006 0.11 -10000 0 -0.4 31 31
ARF1/GDP 0.008 0.099 -10000 0 -0.36 29 29
ARF6 0.031 0.056 -10000 0 -0.41 3 3
RAB11A 0.034 0.021 -10000 0 -0.42 1 1
TIAM1 0.025 0.06 -10000 0 -0.42 8 8
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 0.009 0.086 -10000 0 -0.34 28 28
actin filament bundle formation -0.016 0.11 0.37 34 -10000 0 34
KALRN 0.001 0.082 -10000 0 -0.31 31 31
RAB11FIP3/RAB11A 0.047 0.043 -10000 0 -0.3 7 7
RhoA/GDP 0.017 0.11 -10000 0 -0.37 34 34
NME1 0.031 0.02 -10000 0 -10000 0 0
Rac1/GDP 0.022 0.11 -10000 0 -0.37 33 33
substrate adhesion-dependent cell spreading 0.01 0.066 -10000 0 -0.23 32 32
cortical actin cytoskeleton organization -0.007 0.13 -10000 0 -0.46 34 34
RAC1 0.035 0.006 -10000 0 -10000 0 0
liver development 0.01 0.066 -10000 0 -0.23 32 32
ARF6/GTP 0.01 0.066 -10000 0 -0.23 32 32
RhoA/GTP 0.025 0.071 -10000 0 -0.21 35 35
mol:GDP -0.009 0.1 -10000 0 -0.39 33 33
ARF6/GTP/RAB11FIP3/RAB11A 0.048 0.067 -10000 0 -0.21 15 15
RHOA 0.026 0.061 -10000 0 -0.42 9 9
PLD1 0.007 0.068 -10000 0 -0.23 32 32
RAB11FIP3 0.031 0.049 -10000 0 -0.42 6 6
tube morphogenesis -0.007 0.12 -10000 0 -0.45 34 34
ruffle organization 0.001 0.058 -10000 0 -0.29 12 12
regulation of epithelial cell migration 0.01 0.066 -10000 0 -0.23 32 32
PLD2 0.012 0.052 -10000 0 -0.2 22 22
PIP5K1A 0.001 0.058 -10000 0 -0.3 12 12
mol:Phosphatidic acid -0.001 0.057 -10000 0 -0.27 16 16
Rac1/GTP -0.007 0.13 -10000 0 -0.46 34 34
Ceramide signaling pathway

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.007 0.054 -10000 0 -0.3 15 15
MAP4K4 -0.024 0.11 0.22 3 -0.3 42 45
BAG4 0.028 0.025 -10000 0 -0.42 1 1
PKC zeta/ceramide -0.008 0.048 0.12 5 -0.22 14 19
NFKBIA 0.033 0.03 -10000 0 -0.42 2 2
BIRC3 -0.008 0.12 -10000 0 -0.42 40 40
BAX 0.011 0.034 -10000 0 -0.37 2 2
RIPK1 0.035 0.007 -10000 0 -10000 0 0
AKT1 0.002 0.082 0.66 7 -0.39 2 9
BAD -0.011 0.05 0.19 2 -0.23 13 15
SMPD1 0.007 0.065 0.18 3 -0.22 19 22
RB1 -0.015 0.057 0.19 1 -0.23 22 23
FADD/Caspase 8 0.011 0.12 0.22 54 -0.33 23 77
MAP2K4 -0.022 0.064 0.19 2 -0.22 35 37
NSMAF 0.027 0.042 -10000 0 -0.42 4 4
response to UV 0 0 -10000 0 -10000 0 0
RAF1 -0.009 0.054 0.19 8 -0.22 12 20
EGF -0.069 0.19 -10000 0 -0.42 110 110
mol:ceramide -0.008 0.052 0.13 10 -0.23 14 24
MADD 0.036 0.005 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid -0.005 0.075 -10000 0 -0.31 28 28
ASAH1 0.009 0.088 -10000 0 -0.42 20 20
negative regulation of cell cycle -0.015 0.057 0.18 2 -0.22 22 24
cell proliferation -0.011 0.092 0.22 2 -0.22 33 35
BID -0.013 0.14 -10000 0 -0.65 15 15
MAP3K1 -0.02 0.066 0.17 2 -0.22 37 39
EIF2A -0.014 0.064 0.21 8 -0.22 23 31
TRADD 0.03 0.014 -10000 0 -10000 0 0
CRADD 0.03 0.05 -10000 0 -0.42 6 6
MAPK3 -0.007 0.053 0.19 7 -0.23 10 17
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 -0.011 0.061 0.19 7 -0.24 12 19
Cathepsin D/ceramide 0.006 0.06 0.15 1 -0.22 19 20
FADD 0.007 0.11 0.22 53 -0.3 26 79
KSR1 -0.009 0.051 0.18 4 -0.23 13 17
MAPK8 -0.012 0.06 0.15 1 -0.21 24 25
PRKRA -0.009 0.051 0.15 7 -0.23 13 20
PDGFA 0.021 0.082 -10000 0 -0.42 17 17
TRAF2 0.034 0.029 -10000 0 -0.42 2 2
IGF1 -0.038 0.16 -10000 0 -0.42 78 78
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.008 0.052 0.13 10 -0.23 14 24
CTSD 0.029 0.046 -10000 0 -0.42 5 5
regulation of nitric oxide biosynthetic process 0.051 0.012 -10000 0 -10000 0 0
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta -0.011 0.098 0.24 2 -0.23 33 35
PRKCD 0.033 0.03 -10000 0 -0.42 2 2
PRKCZ 0 0 -10000 0 -10000 0 0
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine -0.005 0.075 -10000 0 -0.31 28 28
RelA/NF kappa B1 0.051 0.012 -10000 0 -10000 0 0
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0.024 0.072 -10000 0 -0.42 13 13
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD -0.013 0.1 -10000 0 -0.36 26 26
TNFR1A/BAG4/TNF-alpha 0.048 0.047 -10000 0 -0.25 6 6
mol:Sphingosine-1-phosphate 0.007 0.054 -10000 0 -0.3 15 15
MAP2K1 -0.01 0.053 0.18 12 -0.23 9 21
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.035 0.006 -10000 0 -10000 0 0
CYCS 0.031 0.07 0.16 68 -0.2 5 73
TNFRSF1A 0.033 0.022 -10000 0 -0.42 1 1
NFKB1 0.036 0.005 -10000 0 -10000 0 0
TNFR1A/BAG4 0.039 0.028 -10000 0 -0.3 1 1
EIF2AK2 -0.017 0.06 0.17 5 -0.22 26 31
TNF-alpha/TNFR1A/FAN 0.051 0.05 -10000 0 -0.25 8 8
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 0.01 0.091 -10000 0 -0.34 20 20
MAP2K2 -0.011 0.054 0.18 10 -0.22 11 21
SMPD3 -0.026 0.12 0.19 1 -0.3 74 75
TNF 0.026 0.061 -10000 0 -0.42 9 9
PKC zeta/PAR4 0.018 0.051 -10000 0 -0.3 13 13
mol:PHOSPHOCHOLINE 0.037 0.095 0.21 103 -0.2 4 107
NF kappa B1/RelA/I kappa B alpha 0.069 0.057 -10000 0 -0.22 15 15
AIFM1 0.027 0.066 0.15 67 -0.17 8 75
BCL2 -0.057 0.18 -10000 0 -0.42 99 99
Visual signal transduction: Cones

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.047 0.055 -10000 0 -0.23 16 16
RGS9BP -0.023 0.15 -10000 0 -0.42 61 61
mol:GTP 0 0 -10000 0 -10000 0 0
GRK1 0 0 -10000 0 -10000 0 0
mol:Na + 0.024 0.061 -10000 0 -0.26 19 19
mol:ADP 0.008 0.019 -10000 0 -0.3 2 2
GNAT2 0.019 0.085 -10000 0 -0.42 18 18
RGS9-1/Gbeta5/R9AP 0.007 0.12 -10000 0 -0.27 73 73
mol:GDP 0 0 -10000 0 -10000 0 0
PDE6H/GNAT2/GTP 0.026 0.076 -10000 0 -0.27 30 30
GRK7 0.034 0.029 -10000 0 -0.42 2 2
CNGB3 0.022 0.051 -10000 0 -0.42 6 6
Cone Metarhodopsin II/X-Arrestin 0.027 0.001 -10000 0 -10000 0 0
mol:Ca2+ 0.04 0.089 0.2 91 -0.24 20 111
Cone PDE6 0.02 0.13 -10000 0 -0.24 84 84
Cone Metarhodopsin II 0.022 0.016 -10000 0 -0.22 2 2
Na + (4 Units) 0.038 0.064 -10000 0 -0.24 20 20
GNAT2/GDP 0.011 0.12 -10000 0 -0.24 85 85
GNB5 0.025 0.067 -10000 0 -0.42 11 11
mol:GMP (4 units) 0.005 0.078 0.19 16 -0.25 34 50
Cone Transducin 0.051 0.059 -10000 0 -0.24 16 16
SLC24A2 0.032 0.036 -10000 0 -0.42 3 3
GNB3/GNGT2 0.048 0.023 -10000 0 -0.3 1 1
GNB3 0.034 0.009 -10000 0 -10000 0 0
GNAT2/GTP 0.015 0.06 -10000 0 -0.3 18 18
CNGA3 0.018 0.078 -10000 0 -0.42 15 15
ARR3 0.036 0.002 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
cGMP/Cone CNG Channel 0.025 0.061 -10000 0 -0.26 19 19
mol:Pi 0.006 0.12 -10000 0 -0.27 73 73
Cone CNG Channel 0.034 0.099 -10000 0 -0.25 44 44
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
mol:K + 0.032 0.036 -10000 0 -0.42 3 3
RGS9 0.017 0.07 -10000 0 -0.42 12 12
PDE6C 0.03 0.05 -10000 0 -0.42 6 6
GNGT2 0.033 0.03 -10000 0 -0.42 2 2
mol:cGMP (4 units) 0 0 -10000 0 -10000 0 0
PDE6H 0.021 0.075 -10000 0 -0.42 14 14
Presenilin action in Notch and Wnt signaling

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.041 0.11 -10000 0 -0.46 18 18
HDAC1 0.04 0.028 -10000 0 -0.42 1 1
AES 0.037 0.009 -10000 0 -10000 0 0
FBXW11 0.033 0.029 -10000 0 -0.42 2 2
DTX1 0.033 0.035 -10000 0 -0.42 3 3
LRP6/FZD1 0.041 0.055 -10000 0 -0.3 12 12
TLE1 0.006 0.11 -10000 0 -0.42 33 33
AP1 -0.025 0.11 -10000 0 -0.27 75 75
NCSTN 0.028 0.025 -10000 0 -0.42 1 1
ADAM10 0.033 0.03 -10000 0 -0.42 2 2
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 -0.037 0.15 -10000 0 -0.64 10 10
NICD/RBPSUH 0.005 0.097 -10000 0 -0.46 18 18
WIF1 0.03 0.014 -10000 0 -10000 0 0
NOTCH1 0.014 0.099 -10000 0 -0.48 18 18
PSENEN 0.035 0.006 -10000 0 -10000 0 0
KREMEN2 -0.09 0.19 -10000 0 -0.42 129 129
DKK1 -0.027 0.14 -10000 0 -0.42 60 60
beta catenin/beta TrCP1 0.012 0.1 0.26 2 -0.35 16 18
APH1B 0.025 0.067 -10000 0 -0.42 11 11
APH1A 0.031 0.036 -10000 0 -0.42 3 3
AXIN1 0.015 0.053 0.26 1 -0.39 2 3
CtBP/CBP/TCF1/TLE1/AES 0.027 0.089 0.29 3 -0.24 28 31
PSEN1 0.032 0.041 -10000 0 -0.42 4 4
FOS -0.031 0.15 -10000 0 -0.42 66 66
JUN -0.001 0.12 -10000 0 -0.42 39 39
MAP3K7 0.036 0.014 -10000 0 -10000 0 0
CTNNB1 -0.004 0.097 0.23 5 -0.37 15 20
MAPK3 0.032 0.023 -10000 0 -0.42 1 1
DKK2/LRP6/Kremen 2 -0.044 0.15 -10000 0 -0.26 154 154
HNF1A 0.002 0.006 -10000 0 -10000 0 0
CTBP1 0.036 0.01 -10000 0 -10000 0 0
MYC -0.083 0.35 -10000 0 -1.3 35 35
NKD1 0.028 0.038 -10000 0 -0.42 3 3
FZD1 0.028 0.057 -10000 0 -0.42 8 8
NOTCH1 precursor/Deltex homolog 1 0.042 0.11 -10000 0 -0.47 18 18
apoptosis -0.025 0.11 -10000 0 -0.26 75 75
Delta 1/NOTCHprecursor 0.04 0.11 -10000 0 -0.46 18 18
DLL1 0.034 0.01 -10000 0 -10000 0 0
PPARD 0.006 0.11 -10000 0 -0.9 6 6
Gamma Secretase 0.069 0.068 -10000 0 -0.22 13 13
APC -0.001 0.1 0.26 1 -0.44 20 21
DVL1 0.025 0.028 -10000 0 -0.26 2 2
CSNK2A1 0.035 0.007 -10000 0 -10000 0 0
MAP3K7IP1 0.037 0.012 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.061 0.16 -10000 0 -0.27 169 169
LRP6 0.029 0.046 -10000 0 -0.42 5 5
CSNK1A1 0.035 0.006 -10000 0 -10000 0 0
NLK 0.029 0.025 -10000 0 -0.24 1 1
CCND1 -0.2 0.5 -10000 0 -1.3 84 84
WNT1 0.035 0.021 -10000 0 -0.42 1 1
Axin1/APC/beta catenin 0.021 0.1 0.34 2 -0.45 9 11
DKK2 0.006 0.11 -10000 0 -0.42 31 31
NOTCH1 precursor/DVL1 0.037 0.1 -10000 0 -0.51 11 11
GSK3B 0.036 0.005 -10000 0 -10000 0 0
FRAT1 0.03 0.054 -10000 0 -0.42 7 7
NOTCH/Deltex homolog 1 0.043 0.11 -10000 0 -0.47 18 18
PPP2R5D 0.012 0.068 0.23 3 -0.32 17 20
MAPK1 0.033 0.022 -10000 0 -0.42 1 1
WNT1/LRP6/FZD1 0.071 0.058 -10000 0 -0.23 13 13
RBPJ 0 0 -10000 0 -10000 0 0
CREBBP 0.026 0.02 -10000 0 -10000 0 0
Glypican 1 network

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer 0.019 0.11 -10000 0 -0.27 53 53
fibroblast growth factor receptor signaling pathway 0.018 0.1 -10000 0 -0.27 53 53
LAMA1 0.034 0.009 -10000 0 -10000 0 0
PRNP 0.028 0.057 -10000 0 -0.42 8 8
GPC1/SLIT2 0.013 0.11 -10000 0 -0.31 52 52
SMAD2 0.005 0.064 0.19 6 -0.24 29 35
GPC1/PrPc/Cu2+ 0.03 0.069 -10000 0 -0.26 26 26
GPC1/Laminin alpha1 0.036 0.068 -10000 0 -0.3 19 19
TDGF1 0.034 0.008 -10000 0 -10000 0 0
CRIPTO/GPC1 0.037 0.068 -10000 0 -0.3 19 19
APP/GPC1 0.016 0.1 -10000 0 -0.3 47 47
mol:NO 0 0 -10000 0 -10000 0 0
YES1 0.005 0.06 -10000 0 -0.26 25 25
FLT1 0.026 0.058 -10000 0 -0.42 8 8
GPC1/TGFB/TGFBR1/TGFBR2 0.049 0.081 -10000 0 -0.26 30 30
SERPINC1 0.028 0.025 -10000 0 -0.42 1 1
FYN 0.005 0.057 -10000 0 -0.26 23 23
FGR 0.009 0.053 -10000 0 -0.26 19 19
positive regulation of MAPKKK cascade -0.025 0.12 -10000 0 -0.35 38 38
SLIT2 0.003 0.12 -10000 0 -0.42 35 35
GPC1/NRG 0.028 0.068 -10000 0 -0.3 19 19
NRG1 0.028 0.015 -10000 0 -10000 0 0
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.027 0.07 -10000 0 -0.26 26 26
LYN 0.009 0.045 -10000 0 -0.25 14 14
mol:Spermine -0.003 0.058 -10000 0 -0.3 19 19
cell growth 0.018 0.1 -10000 0 -0.27 53 53
BMP signaling pathway -0.018 0.087 0.42 19 -10000 0 19
SRC 0.008 0.055 -10000 0 -0.27 19 19
TGFBR1 0.027 0.061 -10000 0 -0.42 9 9
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A 0.013 0.08 -10000 0 -0.42 16 16
GPC1 0.018 0.087 -10000 0 -0.42 19 19
TGFBR1 (dimer) 0.027 0.06 -10000 0 -0.42 9 9
VEGFA 0 0 -10000 0 -10000 0 0
BLK 0.006 0.046 -10000 0 -0.25 15 15
HCK 0.001 0.068 -10000 0 -0.26 33 33
FGF2 -0.001 0.11 -10000 0 -0.42 34 34
FGFR1 0.02 0.064 -10000 0 -0.42 10 10
VEGFR1 homodimer 0.026 0.057 -10000 0 -0.42 8 8
TGFBR2 0.033 0.036 -10000 0 -0.42 3 3
cell death 0.016 0.1 -10000 0 -0.3 47 47
ATIII/GPC1 0.03 0.065 -10000 0 -0.3 17 17
PLA2G2A/GPC1 0.022 0.09 -10000 0 -0.3 34 34
LCK -0.019 0.095 -10000 0 -0.26 68 68
neuron differentiation 0.028 0.068 -10000 0 -0.3 19 19
PrPc/Cu2+ 0.021 0.04 -10000 0 -0.3 8 8
APP 0.008 0.11 -10000 0 -0.42 29 29
TGFBR2 (dimer) 0.033 0.036 -10000 0 -0.42 3 3
PLK1 signaling events

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion -0.001 0.047 0.2 23 -0.12 5 28
BUB1B -0.019 0.097 0.12 1 -0.3 43 44
PLK1 0.003 0.033 0.091 10 -0.09 19 29
PLK1S1 0.002 0.019 0.054 10 -0.049 17 27
KIF2A 0.003 0.03 0.08 10 -0.081 19 29
regulation of mitotic centrosome separation 0.003 0.033 0.09 10 -0.089 19 29
GOLGA2 0.036 0.005 -10000 0 -10000 0 0
Hec1/SPC24 -0.008 0.019 -10000 0 -0.071 25 25
WEE1 -0.006 0.094 -10000 0 -0.35 27 27
cytokinesis -0.022 0.14 -10000 0 -0.45 39 39
PP2A-alpha B56 -0.036 0.28 -10000 0 -0.7 72 72
AURKA 0.002 0.02 0.06 11 -0.055 5 16
PICH/PLK1 -0.018 0.095 -10000 0 -0.33 35 35
CENPE -0.012 0.068 0.2 3 -0.25 31 34
RhoA/GTP 0.02 0.043 -10000 0 -0.3 9 9
positive regulation of microtubule depolymerization 0.003 0.03 0.08 10 -0.08 19 29
PPP2CA 0.031 0.045 -10000 0 -0.42 5 5
FZR1 0.035 0.006 -10000 0 -10000 0 0
TPX2 -0.008 0.078 -10000 0 -0.27 39 39
PAK1 0.014 0.086 -10000 0 -0.43 18 18
SPC24 0 0 -10000 0 -10000 0 0
FBXW11 0.033 0.029 -10000 0 -0.42 2 2
CLSPN 0.004 0.057 -10000 0 -0.28 18 18
GORASP1 0.034 0.022 -10000 0 -0.42 1 1
metaphase 0.002 0.006 0.019 46 -10000 0 46
mol:GTP 0 0 -10000 0 -10000 0 0
NLP 0.002 0.019 0.054 10 -0.049 17 27
G2 phase of mitotic cell cycle -0.001 0.002 0.011 2 -10000 0 2
STAG2 0.036 0 -10000 0 -10000 0 0
GRASP65/GM130/RAB1/GTP 0.007 0.11 -10000 0 -0.51 20 20
spindle elongation 0.003 0.033 0.09 10 -0.089 19 29
ODF2 0.036 0.005 -10000 0 -10000 0 0
BUB1 -0.074 0.29 -10000 0 -0.75 74 74
TPT1 -0.009 0.063 -10000 0 -0.19 52 52
CDC25C -0.014 0.11 -10000 0 -0.36 42 42
CDC25B 0.028 0.045 -10000 0 -0.44 4 4
SGOL1 0.001 0.047 0.12 5 -0.2 23 28
RHOA 0.026 0.061 -10000 0 -0.42 9 9
CCNB1/CDK1 0.028 0.13 -10000 0 -0.37 41 41
CDC14B 0.005 0.024 -10000 0 -0.3 3 3
CDC20 0.017 0.087 -10000 0 -0.42 19 19
PLK1/PBIP1 -0.005 0.056 0.096 1 -0.21 28 29
mitosis 0 0.003 0.013 10 -10000 0 10
FBXO5 -0.003 0.05 0.13 9 -0.2 10 19
CDC2 0.014 0.097 -10000 0 -0.44 22 22
NDC80 0 0 -10000 0 -10000 0 0
metaphase plate congression 0.004 0.054 -10000 0 -0.25 20 20
ERCC6L -0.013 0.11 -10000 0 -0.35 41 41
NLP/gamma Tubulin 0.007 0.028 0.072 15 -0.083 10 25
microtubule cytoskeleton organization -0.009 0.063 -10000 0 -0.19 52 52
G2/M transition DNA damage checkpoint 0 0.003 0.011 19 -10000 0 19
PPP1R12A 0.036 0.005 -10000 0 -10000 0 0
interphase 0 0.003 0.011 19 -10000 0 19
PLK1/PRC1-2 0.014 0.11 -10000 0 -0.33 42 42
GRASP65/GM130/RAB1/GTP/PLK1 0.05 0.048 -10000 0 -0.19 2 2
RAB1A 0.035 0.021 -10000 0 -0.42 1 1
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA 0.003 0.025 0.069 13 -0.069 13 26
mitotic prometaphase -0.001 0.004 0.018 20 -10000 0 20
proteasomal ubiquitin-dependent protein catabolic process 0.015 0.054 -10000 0 -0.39 3 3
microtubule-based process 0.006 0.078 -10000 0 -0.25 36 36
Golgi organization 0.003 0.033 0.09 10 -0.089 19 29
Cohesin/SA2 0.021 0.035 -10000 0 -0.11 1 1
PPP1CB/MYPT1 0.052 0.009 -10000 0 -10000 0 0
KIF20A 0.003 0.12 -10000 0 -0.42 35 35
APC/C/CDC20 0.013 0.064 0.12 2 -0.25 20 22
PPP2R1A 0.035 0.007 -10000 0 -10000 0 0
chromosome segregation -0.005 0.055 0.095 1 -0.21 28 29
PRC1 0.009 0.1 -10000 0 -0.42 27 27
ECT2 0.004 0.072 0.23 25 -0.23 16 41
C13orf34 0.003 0.028 0.074 13 -0.078 15 28
NUDC 0.004 0.054 -10000 0 -0.25 20 20
regulation of attachment of spindle microtubules to kinetochore -0.018 0.096 0.12 1 -0.3 43 44
spindle assembly 0.01 0.035 0.088 22 -0.082 12 34
spindle stabilization 0.002 0.019 0.054 10 -0.049 17 27
APC/C/HCDH1 0.03 0.023 -10000 0 -0.25 3 3
MKLP2/PLK1 0.006 0.078 -10000 0 -0.25 36 36
CCNB1 0.011 0.1 -10000 0 -0.44 25 25
PPP1CB 0.036 0.005 -10000 0 -10000 0 0
BTRC 0.034 0.022 -10000 0 -0.42 1 1
ROCK2 0.007 0.059 -10000 0 -0.32 9 9
TUBG1 0.009 0.04 -10000 0 -0.18 16 16
G2/M transition of mitotic cell cycle -0.022 0.11 -10000 0 -0.37 40 40
MLF1IP -0.009 0.069 -10000 0 -0.3 27 27
INCENP 0.028 0.051 -10000 0 -0.43 6 6
S1P1 pathway

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.02 0.071 -10000 0 -0.29 24 24
PDGFRB 0.029 0.058 -10000 0 -0.43 8 8
SPHK1 -0.034 0.2 -10000 0 -0.76 35 35
mol:S1P -0.019 0.19 -10000 0 -0.65 35 35
S1P1/S1P/Gi -0.018 0.16 -10000 0 -0.49 34 34
GNAO1 0.031 0.015 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/PLCgamma1 0 0.14 0.33 1 -0.45 27 28
PLCG1 -0.016 0.14 0.3 1 -0.45 31 32
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.029 0.058 -10000 0 -0.43 8 8
GNAI2 0.029 0.055 -10000 0 -0.42 7 7
GNAI3 0.036 0.008 -10000 0 -10000 0 0
GNAI1 0.018 0.088 -10000 0 -0.42 19 19
mol:GDP 0 0 -10000 0 -10000 0 0
EDG1 0.001 0.12 -10000 0 -0.52 23 23
S1P1/S1P -0.01 0.17 0.25 1 -0.47 49 50
negative regulation of cAMP metabolic process -0.017 0.15 -10000 0 -0.47 34 34
MAPK3 -0.011 0.16 0.31 8 -0.54 26 34
calcium-dependent phospholipase C activity 0 0.002 -10000 0 -10000 0 0
Rac1/GDP 0.026 0.004 -10000 0 -10000 0 0
RhoA/GDP 0.02 0.043 -10000 0 -0.3 9 9
KDR 0.029 0.058 -10000 0 -0.22 21 21
PLCB2 -0.009 0.15 0.24 1 -0.42 47 48
RAC1 0.035 0.006 -10000 0 -10000 0 0
RhoA/GTP -0.017 0.14 -10000 0 -0.4 49 49
receptor internalization -0.009 0.16 0.24 1 -0.43 50 51
PTGS2 -0.011 0.16 -10000 0 -0.74 15 15
Rac1/GTP -0.013 0.14 -10000 0 -0.38 52 52
RHOA 0.026 0.061 -10000 0 -0.42 9 9
VEGFA -0.003 0.033 -10000 0 -0.15 24 24
negative regulation of T cell proliferation -0.017 0.15 -10000 0 -0.47 34 34
GO:0007205 0 0 -10000 0 -10000 0 0
GNAZ 0.024 0.07 -10000 0 -0.42 12 12
MAPK1 -0.019 0.15 -10000 0 -0.54 27 27
S1P1/S1P/PDGFB-D/PDGFRB 0.009 0.18 0.3 1 -0.45 48 49
ABCC1 0.03 0.042 -10000 0 -0.42 4 4
Insulin Pathway

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP 0.012 0.11 -10000 0 -0.22 76 76
TC10/GTP 0.029 0.068 -10000 0 -0.21 34 34
Insulin Receptor/Insulin/IRS1/Shp2 0.054 0.11 -10000 0 -0.25 55 55
HRAS 0.032 0.036 -10000 0 -0.42 3 3
APS homodimer 0 0 -10000 0 -10000 0 0
GRB14 -0.063 0.18 -10000 0 -0.42 98 98
FOXO3 -0.014 0.022 -10000 0 -0.096 2 2
AKT1 -0.045 0.13 0.33 6 -0.36 17 23
INSR 0.037 0.031 -10000 0 -0.42 2 2
Insulin Receptor/Insulin 0.081 0.06 -10000 0 -0.3 5 5
mol:GTP 0 0 -10000 0 -10000 0 0
GRB10 0.023 0.075 -10000 0 -0.42 14 14
SORBS1 0.007 0.11 -10000 0 -0.42 29 29
CRK 0.032 0.023 -10000 0 -0.42 1 1
PTPN1 0.005 0.038 -10000 0 -0.3 5 5
CAV1 -0.008 0.083 0.18 4 -0.23 58 62
CBL/APS/CAP/Crk-II/C3G 0.052 0.075 -10000 0 -0.22 30 30
Insulin Receptor/Insulin/IRS1/NCK2 0.054 0.11 -10000 0 -0.25 53 53
mol:GDP 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.028 0.1 -10000 0 -0.22 66 66
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B 0.019 0.08 -10000 0 -0.42 6 6
RPS6KB1 -0.04 0.11 0.32 5 -0.34 16 21
PARD6A 0.021 0.061 -10000 0 -0.42 9 9
CBL 0.032 0.012 -10000 0 -10000 0 0
tumor necrosis factor-mediated signaling pathway 0 0 -10000 0 -10000 0 0
DOK1 0.007 0.11 -10000 0 -0.67 12 12
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
Insulin Receptor/Insuli/IRS1/GRB2/Shc -0.004 0.12 0.28 3 -0.28 31 34
HRAS/GTP -0.001 0.063 -10000 0 -0.2 40 40
Insulin Receptor 0.037 0.031 -10000 0 -0.42 2 2
Insulin Receptor/Insuli/IRS1/GRB2/SHC 0.049 0.1 -10000 0 -0.23 42 42
PRKCI 0.004 0.11 -10000 0 -0.47 23 23
Insulin Receptor/Insulin/GRB14/PDK1 -0.036 0.12 -10000 0 -0.23 135 135
SHC1 0.028 0.025 -10000 0 -0.42 1 1
negative regulation of MAPKKK cascade 0.046 0.11 -10000 0 -0.58 13 13
PI3K 0.04 0.11 -10000 0 -0.23 66 66
NCK2 0.036 0.005 -10000 0 -10000 0 0
RHOQ 0.031 0.045 -10000 0 -0.42 5 5
mol:H2O2 0 0.005 -10000 0 -10000 0 0
HRAS/GDP 0.024 0.025 -10000 0 -0.3 3 3
AKT2 -0.046 0.13 0.33 6 -0.36 17 23
PRKCZ -0.008 0.084 -10000 0 -0.42 17 17
SH2B2 0 0 -10000 0 -10000 0 0
SHC/SHIP -0.001 0.069 0.17 2 -0.21 44 46
F2RL2 -0.02 0.14 -10000 0 -0.42 58 58
TRIP10 0.032 0.041 -10000 0 -0.42 4 4
Insulin Receptor/Insulin/Shc 0.054 0.041 -10000 0 -0.22 3 3
TC10/GTP/CIP4/Exocyst 0.042 0.041 -10000 0 -0.25 9 9
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0.075 0.06 -10000 0 -0.22 4 4
RAPGEF1 0.036 0.004 -10000 0 -10000 0 0
RASA1 0.029 0.05 -10000 0 -0.42 6 6
NCK1 0.034 0.021 -10000 0 -0.42 1 1
CBL/APS/CAP/Crk-II 0.039 0.072 -10000 0 -0.23 30 30
TC10/GDP 0.023 0.032 -10000 0 -0.3 5 5
Insulin Receptor/Insulin/SHC/GRB10 0.063 0.066 -10000 0 -0.23 13 13
INPP5D -0.03 0.07 -10000 0 -0.22 55 55
SOS1 0.035 0.021 -10000 0 -0.42 1 1
SGK1 -0.008 0.01 -10000 0 -10000 0 0
mol:cAMP 0 0 -10000 0 -10000 0 0
PTPN11 0.036 0.004 -10000 0 -10000 0 0
IRS1 -0.014 0.14 -10000 0 -0.42 54 54
p62DOK/RasGAP 0.046 0.11 -10000 0 -0.58 13 13
INS 0.037 0.024 -10000 0 -0.42 1 1
mol:PI-3-4-P2 -0.03 0.069 -10000 0 -0.22 55 55
GRB2 0.033 0.011 -10000 0 -10000 0 0
EIF4EBP1 -0.049 0.1 0.3 2 -0.34 17 19
PTPRA 0.038 0.013 -10000 0 -10000 0 0
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
TC10/GTP/CIP4 0.042 0.041 -10000 0 -0.25 9 9
PDPK1 0.032 0.023 -10000 0 -0.42 1 1
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos 0.006 0.077 -10000 0 -0.22 39 39
Insulin Receptor/Insulin/IRS1 0.035 0.1 -10000 0 -0.24 55 55
Insulin Receptor/Insulin/IRS3 0.054 0.034 -10000 0 -0.3 3 3
Par3/Par6 0.023 0.11 -10000 0 -0.23 69 69
FOXA2 and FOXA3 transcription factor networks

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL -0.031 0.24 -10000 0 -0.76 23 23
PCK1 0.019 0.17 -10000 0 -0.99 5 5
HNF4A -0.01 0.25 0.56 3 -0.78 20 23
KCNJ11 -0.053 0.34 -10000 0 -0.98 44 44
AKT1 -0.001 0.17 -10000 0 -0.41 22 22
response to starvation 0.004 0.002 -10000 0 -10000 0 0
DLK1 -0.023 0.27 0.63 1 -0.81 21 22
NKX2-1 0.038 0.13 0.36 4 -0.36 5 9
ACADM -0.032 0.26 -10000 0 -0.78 27 27
TAT -0.004 0.15 -10000 0 -0.64 2 2
CEBPB 0.031 0.051 -10000 0 -0.42 6 6
CEBPA 0.03 0.07 -10000 0 -0.42 12 12
TTR -0.03 0.28 0.57 1 -0.72 42 43
PKLR 0.013 0.25 -10000 0 -0.72 21 21
APOA1 -0.028 0.28 -10000 0 -0.88 22 22
CPT1C -0.031 0.27 -10000 0 -0.82 29 29
ALAS1 0.011 0.18 -10000 0 -1.1 4 4
TFRC -0.042 0.36 -10000 0 -1.2 37 37
FOXF1 0.027 0.025 -10000 0 -0.42 1 1
NF1 0.037 0.035 -10000 0 -0.37 3 3
HNF1A (dimer) 0.008 0.02 -10000 0 -0.21 4 4
CPT1A -0.023 0.27 0.56 1 -0.86 24 25
HMGCS1 -0.021 0.24 -10000 0 -0.74 23 23
NR3C1 0.034 0.074 -10000 0 -0.4 14 14
CPT1B -0.024 0.24 -10000 0 -0.75 22 22
chromatin remodeling 0 0 -10000 0 -10000 0 0
SP1 0.035 0.021 -10000 0 -0.42 1 1
GCK -0.025 0.25 -10000 0 -0.76 24 24
CREB1 0.042 0.029 -10000 0 -0.24 4 4
IGFBP1 0.01 0.14 -10000 0 -1.3 1 1
PDX1 0.006 0.15 -10000 0 -0.37 23 23
UCP2 -0.052 0.31 -10000 0 -0.86 45 45
ALDOB -0.024 0.26 -10000 0 -0.8 22 22
AFP -0.024 0.12 -10000 0 -0.82 3 3
BDH1 -0.034 0.26 -10000 0 -0.77 31 31
HADH -0.024 0.26 -10000 0 -0.78 24 24
F2 -0.01 0.28 -10000 0 -0.87 20 20
HNF1A 0.008 0.02 -10000 0 -0.21 4 4
G6PC 0.04 0.091 -10000 0 -1.3 1 1
SLC2A2 0.003 0.2 -10000 0 -1.2 4 4
INS 0.024 0.024 0.2 2 -0.43 1 3
FOXA1 -0.037 0.18 -10000 0 -0.4 97 97
FOXA3 0.043 0.077 -10000 0 -0.23 24 24
FOXA2 -0.011 0.32 -10000 0 -0.88 24 24
ABCC8 -0.2 0.48 -10000 0 -0.9 151 151
ALB -0.03 0.15 -10000 0 -0.81 9 9
TRAIL signaling pathway

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TNFSF10 -0.007 0.13 -10000 0 -0.42 45 45
positive regulation of NF-kappaB transcription factor activity 0.01 0.097 -10000 0 -0.29 45 45
MAP2K4 -0.009 0.1 -10000 0 -0.36 25 25
IKBKB 0.03 0.014 -10000 0 -10000 0 0
TNFRSF10B 0.027 0.016 -10000 0 -10000 0 0
TNFRSF10A 0.023 0.047 -10000 0 -0.42 5 5
SMPD1 -0.006 0.071 -10000 0 -0.21 44 44
IKBKG 0.036 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
TNFRSF10D 0.028 0.016 -10000 0 -10000 0 0
TRAIL/TRAILR2 0.009 0.099 -10000 0 -0.3 45 45
TRAIL/TRAILR3 0.008 0.097 -10000 0 -0.29 46 46
TRAIL/TRAILR1 0.007 0.1 -10000 0 -0.31 47 47
TRAIL/TRAILR4 0.01 0.097 -10000 0 -0.29 45 45
TRAIL/TRAILR1/DAP3/GTP 0.02 0.08 -10000 0 -0.24 36 36
IKK complex 0.013 0.092 -10000 0 -0.4 14 14
RIPK1 0.035 0.007 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
DAP3/GTP 0.021 0.018 -10000 0 -0.3 1 1
MAPK3 -0.01 0.085 -10000 0 -0.3 40 40
MAP3K1 -0.006 0.11 -10000 0 -0.39 24 24
TRAILR4 (trimer) 0.027 0.016 -10000 0 -10000 0 0
TRADD 0.03 0.014 -10000 0 -10000 0 0
TRAILR1 (trimer) 0.023 0.047 -10000 0 -0.42 5 5
TRAIL/TRAILR1/FADD/TRADD/RIP/TRAF2 -0.002 0.085 -10000 0 -0.29 34 34
CFLAR 0.031 0.045 -10000 0 -0.42 5 5
MAPK1 -0.009 0.083 -10000 0 -0.3 38 38
TRAIL/TRAILR1/FADD/TRADD/RIP 0.035 0.09 -10000 0 -0.23 33 33
mol:ceramide -0.006 0.071 -10000 0 -0.21 44 44
FADD 0.029 0.014 -10000 0 -10000 0 0
MAPK8 -0.022 0.11 -10000 0 -0.35 30 30
TRAF2 0.034 0.029 -10000 0 -0.42 2 2
TRAILR3 (trimer) 0.024 0.026 -10000 0 -0.42 1 1
CHUK 0.026 0.067 -10000 0 -0.42 11 11
TRAIL/TRAILR1/FADD 0.023 0.087 -10000 0 -0.26 34 34
DAP3 0.028 0.025 -10000 0 -0.42 1 1
CASP10 0.014 0.083 0.33 4 -0.29 18 22
JNK cascade 0.01 0.097 -10000 0 -0.29 45 45
TRAIL (trimer) -0.007 0.13 -10000 0 -0.42 45 45
TNFRSF10C 0.024 0.026 -10000 0 -0.42 1 1
TRAIL/TRAILR1/DAP3/GTP/FADD 0.027 0.075 -10000 0 -0.22 27 27
TRAIL/TRAILR2/FADD 0.025 0.083 -10000 0 -0.26 33 33
cell death -0.006 0.071 -10000 0 -0.21 44 44
TRAIL/TRAILR2/FADD/TRADD/RIP/TRAF2 -0.001 0.083 -10000 0 -0.28 33 33
TRAILR2 (trimer) 0.027 0.016 -10000 0 -10000 0 0
CASP8 0.025 0.043 -10000 0 -0.66 1 1
negative regulation of caspase activity 0 0 -10000 0 -10000 0 0
TRAIL/TRAILR2/FADD/TRADD/RIP 0.037 0.086 -10000 0 -0.22 32 32
ceramide signaling pathway

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K4 -0.035 0.15 0.23 1 -0.41 41 42
BAG4 0.028 0.025 -10000 0 -0.42 1 1
BAD -0.007 0.049 0.19 2 -0.16 16 18
NFKBIA 0.033 0.03 -10000 0 -0.42 2 2
BIRC3 -0.008 0.12 -10000 0 -0.42 40 40
BAX -0.003 0.056 0.2 9 -0.16 15 24
EnzymeConsortium:3.1.4.12 -0.006 0.034 0.075 4 -0.093 34 38
IKBKB -0.016 0.14 0.3 2 -0.41 29 31
MAP2K2 -0.008 0.055 0.19 11 -0.2 8 19
MAP2K1 -0.007 0.051 0.19 11 -0.19 6 17
SMPD1 -0.006 0.041 -10000 0 -0.16 15 15
GO:0005551 0 0 -10000 0 -10000 0 0
FADD/Caspase 8 0.004 0.15 0.3 5 -0.4 30 35
MAP2K4 -0.015 0.057 0.18 1 -0.19 22 23
protein ubiquitination -0.032 0.14 0.25 1 -0.41 34 35
EnzymeConsortium:2.7.1.37 -0.011 0.056 0.19 10 -0.2 8 18
response to UV 0 0.001 0.002 12 -0.002 6 18
RAF1 -0.007 0.052 0.2 8 -0.17 10 18
CRADD 0.03 0.05 -10000 0 -0.42 6 6
mol:ceramide -0.006 0.05 0.11 2 -0.15 27 29
I-kappa-B-alpha/RELA/p50/ubiquitin 0.044 0.023 -10000 0 -0.25 2 2
MADD 0.036 0.005 -10000 0 -10000 0 0
MAP3K1 -0.016 0.06 -10000 0 -0.17 40 40
TRADD 0.03 0.014 -10000 0 -10000 0 0
RELA/p50 0.035 0.006 -10000 0 -10000 0 0
MAPK3 -0.004 0.055 0.19 9 -0.19 5 14
MAPK1 -0.007 0.062 0.19 9 -0.2 13 22
p50/RELA/I-kappa-B-alpha 0.049 0.026 -10000 0 -0.3 2 2
FADD -0.001 0.15 0.24 13 -0.41 30 43
KSR1 -0.007 0.05 0.19 3 -0.17 14 17
MAPK8 -0.019 0.058 0.21 3 -0.21 11 14
TRAF2 0.034 0.029 -10000 0 -0.42 2 2
response to radiation 0 0 0.002 3 -10000 0 3
CHUK -0.042 0.14 -10000 0 -0.4 41 41
TNF R/SODD 0.039 0.028 -10000 0 -0.3 1 1
TNF 0.026 0.061 -10000 0 -0.42 9 9
CYCS 0.015 0.069 0.16 28 -0.16 10 38
IKBKG -0.039 0.14 -10000 0 -0.4 38 38
TNF/TNF R/TRADD/MADD/cIAP/RIP/TRAF2/RAIDD -0.03 0.15 -10000 0 -0.42 39 39
RELA 0.035 0.006 -10000 0 -10000 0 0
RIPK1 0.035 0.008 -10000 0 -10000 0 0
AIFM1 0.012 0.067 0.15 27 -0.16 13 40
TNF/TNF R/SODD 0.048 0.047 -10000 0 -0.25 6 6
TNFRSF1A 0.033 0.022 -10000 0 -0.42 1 1
response to heat 0 0 0.002 3 -10000 0 3
CASP8 0.011 0.12 -10000 0 -0.63 16 16
NSMAF -0.011 0.14 0.22 23 -0.4 31 54
response to hydrogen peroxide 0 0.001 0.002 12 -0.002 6 18
BCL2 -0.057 0.18 -10000 0 -0.42 99 99
Calcium signaling in the CD4+ TCR pathway

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 0.008 0.055 -10000 0 -0.25 16 16
NFATC2 0.014 0.035 -10000 0 -0.27 3 3
NFATC3 0.016 0.026 -10000 0 -10000 0 0
CD40LG -0.019 0.18 0.38 3 -0.44 52 55
PTGS2 -0.022 0.17 0.38 3 -0.45 43 46
JUNB 0.032 0.041 -10000 0 -0.42 4 4
CaM/Ca2+/Calcineurin A alpha-beta B1 0.021 0.025 -10000 0 -0.11 1 1
CaM/Ca2+ 0.021 0.025 -10000 0 -0.11 1 1
CALM1 0.033 0.019 -10000 0 -10000 0 0
JUN -0.002 0.12 -10000 0 -0.42 39 39
mol:Ca2+ -0.001 0.009 -10000 0 -0.082 1 1
Calcineurin A alpha-beta B1/FKBP12/FK506 0.023 0.01 -10000 0 -10000 0 0
FOSL1 0.035 0.007 -10000 0 -10000 0 0
CREM 0.035 0.007 -10000 0 -10000 0 0
Jun/NFAT1-c-4/p21SNFT 0.016 0.12 -10000 0 -0.33 26 26
FOS -0.033 0.15 -10000 0 -0.42 66 66
IFNG -0.035 0.2 0.38 3 -0.51 58 61
AP-1/NFAT1-c-4 0.003 0.22 -10000 0 -0.5 53 53
FASLG -0.031 0.2 0.38 3 -0.52 52 55
NFAT1-c-4/ICER1 0.028 0.08 0.23 2 -0.24 14 16
IL2RA -0.029 0.2 0.38 3 -0.48 58 61
FKBP12/FK506 0.026 0.005 -10000 0 -10000 0 0
CSF2 -0.019 0.18 0.38 3 -0.44 51 54
JunB/Fra1/NFAT1-c-4 0.045 0.092 -10000 0 -0.28 9 9
IL4 -0.019 0.18 0.38 3 -0.44 52 55
IL2 0.009 0.15 -10000 0 -1 10 10
IL3 0.02 0.12 -10000 0 -0.7 12 12
FKBP1A 0.035 0.007 -10000 0 -10000 0 0
BATF3 0 0 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
POU2F1 0.034 0.017 -10000 0 -10000 0 0
Class I PI3K signaling events

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP -0.018 0.059 0.19 12 -0.2 19 31
DAPP1 -0.04 0.16 -10000 0 -0.44 49 49
Src family/SYK family/BLNK-LAT/BTK-ITK -0.061 0.23 -10000 0 -0.59 59 59
mol:DAG -0.017 0.092 0.22 4 -0.23 41 45
HRAS 0.031 0.038 -10000 0 -0.42 3 3
RAP1A 0.03 0.047 -10000 0 -0.42 5 5
ARF5/GDP -0.004 0.11 -10000 0 -0.32 29 29
PLCG2 0.02 0.055 -10000 0 -0.42 7 7
PLCG1 0.034 0.008 -10000 0 -10000 0 0
ARF5 0.034 0.021 -10000 0 -0.42 1 1
mol:GTP -0.018 0.06 0.19 14 -0.21 19 33
ARF1/GTP -0.009 0.052 0.2 10 -0.19 19 29
RHOA 0.026 0.061 -10000 0 -0.42 9 9
YES1 0.029 0.05 -10000 0 -0.42 6 6
RAP1A/GTP -0.017 0.061 0.18 28 -0.21 19 47
ADAP1 -0.018 0.056 0.18 13 -0.2 19 32
ARAP3 -0.018 0.06 0.19 14 -0.21 19 33
INPPL1 0.031 0.036 -10000 0 -0.42 3 3
PREX1 -0.036 0.16 -10000 0 -0.42 75 75
ARHGEF6 0.015 0.093 -10000 0 -0.42 22 22
ARHGEF7 0.032 0.011 -10000 0 -10000 0 0
ARF1 0.027 0.025 -10000 0 -0.42 1 1
NRAS 0.028 0.054 -10000 0 -0.41 7 7
FYN 0.027 0.054 -10000 0 -0.42 7 7
ARF6 0.034 0.029 -10000 0 -0.42 2 2
FGR 0.035 0.008 -10000 0 -10000 0 0
mol:Ca2+ -0.009 0.05 0.15 8 -0.13 20 28
mol:IP4 0 0 -10000 0 -10000 0 0
TIAM1 0.028 0.057 -10000 0 -0.42 8 8
ZAP70 0.033 0.022 -10000 0 -0.42 1 1
mol:IP3 -0.016 0.067 0.18 8 -0.18 32 40
LYN 0.03 0.014 -10000 0 -10000 0 0
ARF1/GDP -0.002 0.1 -10000 0 -0.33 24 24
RhoA/GDP 0.012 0.091 0.23 6 -0.25 25 31
PDK1/Src/Hsp90 0.042 0.025 -10000 0 -0.25 2 2
BLNK 0.013 0.099 -10000 0 -0.42 25 25
actin cytoskeleton reorganization -0.021 0.11 0.23 5 -0.33 27 32
SRC 0.033 0.029 -10000 0 -0.42 2 2
PLEKHA2 -0.009 0.022 -10000 0 -0.25 4 4
RAC1 0.035 0.006 -10000 0 -10000 0 0
PTEN 0.027 0.059 -10000 0 -0.4 9 9
HSP90AA1 0 0 -10000 0 -10000 0 0
ARF6/GTP -0.019 0.059 0.2 13 -0.2 19 32
RhoA/GTP -0.022 0.067 0.17 27 -0.24 23 50
Src family/SYK family/BLNK-LAT -0.027 0.16 -10000 0 -0.49 40 40
BLK 0.022 0.038 -10000 0 -0.42 3 3
PDPK1 0.032 0.023 -10000 0 -0.42 1 1
CYTH1 -0.018 0.056 0.18 13 -0.2 19 32
HCK 0.018 0.087 -10000 0 -0.42 19 19
CYTH3 -0.018 0.056 0.18 13 -0.2 19 32
CYTH2 -0.018 0.056 0.18 13 -0.2 19 32
KRAS 0.027 0.055 -10000 0 -0.42 7 7
GO:0030676 0 0 -10000 0 -10000 0 0
FOXO3 0.006 0.038 0.21 3 -0.2 2 5
SGK1 0.008 0.039 0.24 2 -0.21 2 4
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP -0.02 0.11 -10000 0 -0.34 29 29
SOS1 0.035 0.021 -10000 0 -0.42 1 1
SYK 0.005 0.11 -10000 0 -0.42 34 34
ARF6/GDP -0.003 0.075 0.22 6 -0.23 21 27
mol:PI-3-4-5-P3 -0.018 0.06 0.22 11 -0.21 19 30
ARAP3/RAP1A/GTP -0.017 0.061 0.18 28 -0.21 19 47
VAV1 0.019 0.082 -10000 0 -0.42 17 17
mol:PI-3-4-P2 0.006 0.023 -10000 0 -0.3 3 3
RAS family/GTP/PI3K Class I 0.045 0.064 0.21 20 -0.21 19 39
PLEKHA1 -0.011 0.029 -10000 0 -0.25 7 7
Rac1/GDP -0.003 0.11 -10000 0 -0.33 28 28
LAT 0.03 0.031 -10000 0 -0.42 2 2
Rac1/GTP -0.018 0.12 -10000 0 -0.35 36 36
ITK -0.032 0.073 0.19 10 -0.22 47 57
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma -0.028 0.12 0.25 4 -0.32 47 51
LCK -0.017 0.14 -10000 0 -0.42 54 54
BTK -0.025 0.068 0.2 10 -0.23 29 39
VEGFR1 specific signals

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.003 0.12 -10000 0 -0.32 51 51
VEGFR1 homodimer/NRP1 -0.017 0.11 -10000 0 -0.31 52 52
mol:DAG -0.009 0.11 -10000 0 -0.56 9 9
VEGFR1 homodimer/NRP1/VEGFR 121 -0.015 0.098 -10000 0 -0.28 52 52
CaM/Ca2+ 0.009 0.11 -10000 0 -0.54 9 9
HIF1A -0.006 0.14 -10000 0 -0.41 53 53
GAB1 0.027 0.061 -10000 0 -0.42 9 9
AKT1 -0.016 0.11 0.33 1 -0.43 16 17
PLCG1 -0.009 0.11 -10000 0 -0.57 9 9
NOS3 0 0.11 0.48 1 -0.46 17 18
CBL 0.032 0.012 -10000 0 -10000 0 0
mol:NO 0.002 0.11 0.33 4 -0.46 16 20
FLT1 -0.015 0.12 -10000 0 -0.37 47 47
PGF 0.031 0.041 -10000 0 -0.42 4 4
VEGFR1 homodimer/NRP2/VEGFR121 0.002 0.11 -10000 0 -0.29 52 52
CALM1 0.035 0.007 -10000 0 -10000 0 0
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
eNOS/Hsp90 -0.004 0.11 0.24 1 -0.44 16 17
endothelial cell proliferation -0.002 0.12 0.3 8 -0.49 12 20
mol:Ca2+ -0.009 0.11 -10000 0 -0.56 9 9
MAPK3 -0.024 0.083 0.35 1 -0.48 10 11
MAPK1 -0.028 0.086 0.35 1 -0.49 9 10
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
PLGF homodimer 0.031 0.041 -10000 0 -0.42 4 4
PRKACA 0.036 0.005 -10000 0 -10000 0 0
RP11-342D11.1 0 0 -10000 0 -10000 0 0
CAV1 0.027 0.054 -10000 0 -0.42 7 7
VEGFA homodimer 0 0 -10000 0 -10000 0 0
VEGFR1 homodimer/VEGFA homodimer -0.017 0.11 -10000 0 -0.31 52 52
platelet activating factor biosynthetic process -0.005 0.1 0.33 5 -0.45 10 15
PI3K 0.026 0.13 -10000 0 -0.28 61 61
PRKCA -0.027 0.093 0.21 9 -0.53 9 18
PRKCB -0.028 0.095 0.18 8 -0.53 9 17
VEGFR1 homodimer/PLGF homodimer 0.002 0.12 -10000 0 -0.31 53 53
VEGFA 0 0 -10000 0 -10000 0 0
VEGFB 0.034 0.021 -10000 0 -0.42 1 1
mol:IP3 -0.009 0.11 -10000 0 -0.56 9 9
RASA1 -0.013 0.11 -10000 0 -0.51 13 13
NRP2 0.034 0.021 -10000 0 -0.42 1 1
VEGFR1 homodimer -0.015 0.12 -10000 0 -0.37 47 47
VEGFB homodimer 0.034 0.021 -10000 0 -0.42 1 1
NCK1 0.034 0.021 -10000 0 -0.42 1 1
eNOS/Caveolin-1 0.015 0.12 0.36 3 -0.46 18 21
PTPN11 0.036 0.004 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.024 0.13 -10000 0 -0.28 61 61
mol:L-citrulline 0.002 0.11 0.33 4 -0.46 16 20
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP 0.016 0.11 -10000 0 -0.29 41 41
VEGFR1 homodimer/VEGFA homodimer/NCK1 0.002 0.11 -10000 0 -0.28 53 53
CD2AP 0.035 0.007 -10000 0 -10000 0 0
PI3K/GAB1 0.032 0.14 -10000 0 -0.46 14 14
PDPK1 -0.007 0.11 0.35 2 -0.46 12 14
VEGFR1 homodimer/VEGFA homodimer/SHP2 0.003 0.11 -10000 0 -0.28 52 52
mol:NADP 0.002 0.11 0.33 4 -0.46 16 20
HSP90AA1 0 0 -10000 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.015 0.1 -10000 0 -0.28 41 41
VEGFR1 homodimer/NRP2 0.003 0.12 -10000 0 -0.32 52 52
EPHB forward signaling

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 0.04 0.038 -10000 0 -0.25 7 7
cell-cell adhesion 0.036 0.06 0.21 45 -10000 0 45
Ephrin B/EPHB2/RasGAP 0.069 0.081 -10000 0 -0.24 23 23
ITSN1 0.034 0.029 -10000 0 -0.42 2 2
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
SHC1 0.028 0.025 -10000 0 -0.42 1 1
Ephrin B1/EPHB3 0.035 0.058 -10000 0 -0.25 19 19
Ephrin B1/EPHB1 0.042 0.036 -10000 0 -0.25 7 7
HRAS/GDP -0.001 0.11 -10000 0 -0.28 40 40
Ephrin B/EPHB1/GRB7 0.063 0.084 -10000 0 -0.22 30 30
Endophilin/SYNJ1 -0.012 0.053 0.18 14 -0.21 20 34
KRAS 0.028 0.054 -10000 0 -0.42 7 7
Ephrin B/EPHB1/Src 0.07 0.079 -10000 0 -0.24 22 22
endothelial cell migration 0.032 0.094 -10000 0 -0.24 48 48
GRB2 0.033 0.011 -10000 0 -10000 0 0
GRB7 0.024 0.058 -10000 0 -0.42 8 8
PAK1 -0.02 0.067 0.29 2 -0.22 31 33
HRAS 0.032 0.036 -10000 0 -0.42 3 3
RRAS -0.015 0.057 0.18 13 -0.22 22 35
DNM1 0.033 0.035 -10000 0 -0.42 3 3
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK -0.012 0.058 0.19 8 -0.22 14 22
lamellipodium assembly -0.036 0.06 -10000 0 -0.21 45 45
Ephrin B/EPHB1/Src/p52 SHC/GRB2 0.016 0.069 -10000 0 -0.43 6 6
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
EPHB2 0.032 0.03 -10000 0 -0.42 2 2
EPHB3 0.018 0.085 -10000 0 -0.42 18 18
EPHB1 0.026 0.05 -10000 0 -0.42 6 6
EPHB4 0.016 0.091 -10000 0 -0.42 21 21
mol:GDP -0.018 0.09 -10000 0 -0.33 25 25
Ephrin B/EPHB2 0.058 0.064 -10000 0 -0.22 19 19
Ephrin B/EPHB3 0.048 0.081 -10000 0 -0.23 32 32
JNK cascade -0.014 0.059 0.26 9 -0.23 18 27
Ephrin B/EPHB1 0.056 0.068 -10000 0 -0.22 22 22
RAP1/GDP -0.005 0.11 -10000 0 -0.28 39 39
EFNB2 0.017 0.08 -10000 0 -0.42 16 16
EFNB3 0.032 0.012 -10000 0 -10000 0 0
EFNB1 0.035 0.021 -10000 0 -0.42 1 1
Ephrin B2/EPHB1-2 0.044 0.067 -10000 0 -0.24 23 23
RAP1B 0.033 0.03 -10000 0 -0.42 2 2
RAP1A 0.031 0.045 -10000 0 -0.42 5 5
CDC42/GTP 0.036 0.091 -10000 0 -0.26 23 23
Rap1/GTP 0.015 0.069 -10000 0 -0.25 20 20
axon guidance 0.039 0.038 -10000 0 -0.25 7 7
MAPK3 0.025 0.072 0.2 20 -0.39 6 26
MAPK1 0.016 0.066 0.24 2 -0.39 6 8
Rac1/GDP -0.017 0.1 -10000 0 -0.29 38 38
actin cytoskeleton reorganization -0.023 0.076 -10000 0 -0.24 30 30
CDC42/GDP -0.016 0.1 -10000 0 -0.29 36 36
PI3K 0.038 0.098 -10000 0 -0.24 48 48
EFNA5 0.03 0.046 -10000 0 -0.42 5 5
Ephrin B2/EPHB4 0.02 0.081 -10000 0 -0.26 35 35
Ephrin B/EPHB2/Intersectin/N-WASP 0.011 0.074 -10000 0 -0.24 29 29
CDC42 0.035 0.008 -10000 0 -10000 0 0
RAS family/GTP 0.008 0.067 -10000 0 -0.22 33 33
PTK2 0.11 0.23 0.55 112 -10000 0 112
MAP4K4 -0.015 0.059 0.27 9 -0.23 18 27
SRC 0.033 0.029 -10000 0 -0.42 2 2
KALRN 0.034 0.022 -10000 0 -0.42 1 1
Intersectin/N-WASP 0.045 0.048 -10000 0 -0.3 9 9
neuron projection morphogenesis -0.013 0.084 0.26 2 -0.3 15 17
MAP2K1 0.01 0.063 0.21 1 -0.41 6 7
WASL 0.029 0.054 -10000 0 -0.42 7 7
Ephrin B1/EPHB1-2/NCK1 0.079 0.05 -10000 0 -0.23 10 10
cell migration 0.027 0.093 0.25 4 -0.39 9 13
NRAS 0.029 0.054 -10000 0 -0.42 7 7
SYNJ1 -0.012 0.053 0.18 14 -0.21 20 34
PXN 0.036 0.004 -10000 0 -10000 0 0
TF -0.017 0.05 0.17 14 -0.21 16 30
HRAS/GTP 0.042 0.075 -10000 0 -0.22 30 30
Ephrin B1/EPHB1-2 0.058 0.042 -10000 0 -0.23 9 9
cell adhesion mediated by integrin 0.011 0.059 0.22 16 -0.21 12 28
RAC1 0.035 0.006 -10000 0 -10000 0 0
mol:GTP 0.048 0.075 -10000 0 -0.22 28 28
RAC1-CDC42/GTP -0.033 0.061 -10000 0 -0.23 32 32
RASA1 0.029 0.05 -10000 0 -0.42 6 6
RAC1-CDC42/GDP -0.003 0.11 -10000 0 -0.28 36 36
ruffle organization -0.03 0.076 -10000 0 -0.4 5 5
NCK1 0.034 0.021 -10000 0 -0.42 1 1
receptor internalization -0.019 0.051 0.17 13 -0.2 22 35
Ephrin B/EPHB2/KALRN 0.073 0.074 -10000 0 -0.23 19 19
ROCK1 0.018 0.06 0.19 23 -0.23 19 42
RAS family/GDP -0.047 0.07 -10000 0 -0.25 31 31
Rac1/GTP 0 0.076 -10000 0 -0.22 45 45
Ephrin B/EPHB1/Src/Paxillin 0.014 0.075 -10000 0 -0.27 23 23
PDGFR-beta signaling pathway

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
S1P1/Sphingosine-1-phosphate 0.014 0.15 0.28 2 -0.44 26 28
PDGFB-D/PDGFRB/SLAP 0.031 0.056 -10000 0 -0.3 11 11
PDGFB-D/PDGFRB/APS/CBL 0.037 0.041 -10000 0 -0.25 8 8
AKT1 -0.01 0.14 0.34 21 -0.39 11 32
mol:PI-4-5-P2 0 0.001 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate 0.004 0.14 0.28 1 -0.48 22 23
PIK3CA 0.033 0.022 -10000 0 -0.42 1 1
FGR 0.004 0.11 0.32 3 -0.47 16 19
mol:Ca2+ 0.006 0.13 0.26 2 -0.49 21 23
MYC 0.01 0.24 0.36 9 -0.72 40 49
SHC1 0.028 0.025 -10000 0 -0.42 1 1
HRAS/GDP 0.034 0.064 0.19 1 -0.22 16 17
LRP1/PDGFRB/PDGFB 0.058 0.06 -10000 0 -0.29 12 12
GRB10 0.023 0.075 -10000 0 -0.42 14 14
PTPN11 0.036 0.004 -10000 0 -10000 0 0
GO:0007205 0.005 0.13 0.26 2 -0.5 21 23
PTEN 0.027 0.061 -10000 0 -0.42 9 9
GRB2 0.033 0.011 -10000 0 -10000 0 0
GRB7 0.024 0.058 -10000 0 -0.42 8 8
PDGFB-D/PDGFRB/SHP2 0.047 0.046 -10000 0 -0.3 8 8
PDGFB-D/PDGFRB/GRB10 0.036 0.073 -10000 0 -0.3 22 22
cell cycle arrest 0.031 0.055 -10000 0 -0.3 11 11
HRAS 0.032 0.036 -10000 0 -0.42 3 3
HIF1A -0.025 0.13 0.32 19 -0.35 16 35
GAB1 -0.004 0.14 0.32 1 -0.49 25 26
mol:GTP 0 0 -10000 0 -10000 0 0
DNM2 -0.005 0.14 0.3 4 -0.44 24 28
PDGFB-D/PDGFRB 0.052 0.055 -10000 0 -0.27 9 9
mol:GDP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/LMW-PTP 0.045 0.053 -10000 0 -0.3 11 11
S1P1/Sphingosine-1-phosphate/PDGFB-D/PDGFRB 0.01 0.15 0.3 1 -0.43 27 28
positive regulation of MAPKKK cascade 0.046 0.046 -10000 0 -0.3 8 8
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
mol:IP3 0.005 0.13 0.26 2 -0.5 21 23
E5 -0.001 0.002 -10000 0 -10000 0 0
CSK 0.034 0.022 -10000 0 -0.42 1 1
PDGFB-D/PDGFRB/GRB7 0.036 0.064 -10000 0 -0.3 16 16
SHB 0.031 0.046 -10000 0 -0.42 5 5
BLK -0.065 0.2 0.3 2 -0.43 95 97
PTPN2 0.034 0.01 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SNX15 0.045 0.046 -10000 0 -0.3 8 8
BCAR1 0.03 0.014 -10000 0 -10000 0 0
VAV2 -0.007 0.16 0.29 1 -0.48 30 31
CBL 0.032 0.012 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/DEP1 0.042 0.058 -10000 0 -0.3 13 13
LCK -0.051 0.21 0.3 2 -0.55 67 69
PDGFRB 0.028 0.059 -10000 0 -0.43 8 8
ACP1 0.034 0.035 -10000 0 -0.42 3 3
HCK -0.003 0.14 0.32 4 -0.53 26 30
ABL1 -0.007 0.13 0.26 1 -0.44 26 27
PDGFB-D/PDGFRB/CBL -0.011 0.16 -10000 0 -0.55 28 28
PTPN1 0.03 0.031 -10000 0 -0.42 2 2
SNX15 0.035 0.007 -10000 0 -10000 0 0
STAT3 0.028 0.031 -10000 0 -0.42 2 2
STAT1 0.02 0.075 -10000 0 -0.42 14 14
cell proliferation 0.016 0.22 0.35 10 -0.64 40 50
SLA 0.022 0.047 -10000 0 -0.42 5 5
actin cytoskeleton reorganization 0.039 0.071 0.35 4 -0.22 10 14
SRC 0.013 0.094 0.32 3 -0.63 4 7
PI3K -0.038 0.095 -10000 0 -0.24 82 82
PDGFB-D/PDGFRB/GRB7/SHC 0.042 0.062 -10000 0 -0.26 15 15
SH2B2 0 0 -10000 0 -10000 0 0
PLCgamma1/SPHK1 0.004 0.14 0.28 1 -0.49 22 23
LYN 0.015 0.079 0.3 4 -0.36 9 13
LRP1 0.035 0.021 -10000 0 -0.42 1 1
SOS1 0.035 0.021 -10000 0 -0.42 1 1
STAT5B 0.03 0.024 -10000 0 -0.42 1 1
STAT5A 0.027 0.037 -10000 0 -0.42 3 3
NCK1-2/p130 Cas 0.067 0.068 -10000 0 -0.22 9 9
SPHK1 0.006 0.11 -10000 0 -0.42 30 30
EDG1 0.013 0.096 -10000 0 -0.42 23 23
mol:DAG 0.005 0.13 0.26 2 -0.5 21 23
PLCG1 0.005 0.14 0.26 2 -0.52 21 23
NHERF/PDGFRB 0.002 0.13 -10000 0 -0.28 80 80
YES1 -0.004 0.14 0.31 3 -0.52 23 26
cell migration 0.001 0.13 -10000 0 -0.28 80 80
SHC/Grb2/SOS1 0.06 0.068 -10000 0 -0.23 9 9
SLC9A3R2 -0.004 0.12 -10000 0 -0.42 40 40
SLC9A3R1 -0.009 0.13 -10000 0 -0.42 46 46
NHERF1-2/PDGFRB/PTEN 0.011 0.14 -10000 0 -0.27 86 86
FYN -0.013 0.16 0.31 2 -0.52 33 35
DOK1 0.021 0.071 0.22 16 -0.24 15 31
HRAS/GTP 0.024 0.025 -10000 0 -0.3 3 3
PDGFB 0.029 0.046 -10000 0 -0.42 5 5
RAC1 -0.022 0.2 -10000 0 -0.56 43 43
PRKCD 0.022 0.068 0.2 32 -0.26 10 42
FER 0.024 0.069 0.2 35 -0.24 10 45
MAPKKK cascade 0.043 0.11 0.35 21 -0.22 7 28
RASA1 0.021 0.072 0.21 25 -0.24 14 39
NCK1 0.034 0.021 -10000 0 -0.42 1 1
NCK2 0.036 0.005 -10000 0 -10000 0 0
p62DOK/Csk 0.042 0.065 0.34 2 -0.22 16 18
PDGFB-D/PDGFRB/SHB 0.042 0.058 -10000 0 -0.31 13 13
chemotaxis -0.006 0.13 0.26 1 -0.43 26 27
STAT1-3-5/STAT1-3-5 0.049 0.075 -10000 0 -0.22 24 24
Bovine Papilomavirus E5/PDGFRB 0.019 0.042 -10000 0 -0.3 8 8
PTPRJ 0.031 0.046 -10000 0 -0.42 5 5
ErbB2/ErbB3 signaling events

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 -0.009 0.017 -10000 0 -0.26 2 2
RAS family/GTP 0.03 0.11 0.25 1 -0.3 19 20
NFATC4 -0.03 0.068 0.23 1 -0.32 7 8
ERBB2IP 0.034 0.022 -10000 0 -0.42 1 1
HSP90 (dimer) 0 0 -10000 0 -10000 0 0
mammary gland morphogenesis -0.003 0.087 -10000 0 -0.26 35 35
JUN 0.008 0.074 0.21 1 -10000 0 1
HRAS 0.032 0.036 -10000 0 -0.42 3 3
DOCK7 -0.034 0.077 0.26 1 -0.27 27 28
ErbB2/ErbB3/neuregulin 1 beta/SHC 0.02 0.089 -10000 0 -0.27 34 34
AKT1 0.003 0.021 -10000 0 -0.3 2 2
BAD -0.01 0.019 -10000 0 -0.25 3 3
MAPK10 -0.024 0.061 0.2 7 -0.2 16 23
mol:GTP 0 0.002 -10000 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta -0.002 0.094 -10000 0 -0.28 35 35
RAF1 0.011 0.11 0.28 10 -0.3 21 31
ErbB2/ErbB3/neuregulin 2 0.011 0.093 -10000 0 -0.27 45 45
STAT3 0.005 0.18 -10000 0 -0.89 18 18
cell migration -0.018 0.064 0.23 8 -0.21 10 18
mol:PI-3-4-5-P3 -0.001 0.001 -10000 0 -10000 0 0
cell proliferation -0.043 0.25 -10000 0 -0.62 59 59
FOS -0.045 0.21 0.31 1 -0.44 104 105
NRAS 0.029 0.054 -10000 0 -0.42 7 7
mol:Ca2+ -0.003 0.087 -10000 0 -0.26 35 35
MAPK3 -0.018 0.2 -10000 0 -0.52 47 47
MAPK1 -0.03 0.21 0.35 1 -0.55 49 50
JAK2 -0.032 0.078 0.26 1 -0.26 29 30
NF2 0.01 0.046 -10000 0 -0.68 2 2
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 0.002 0.072 0.18 3 -0.27 26 29
NRG1 0.028 0.015 -10000 0 -10000 0 0
GRB2/SOS1 0.048 0.023 -10000 0 -0.3 1 1
MAPK8 -0.019 0.098 0.21 3 -0.28 30 33
MAPK9 -0.023 0.058 0.2 6 -0.2 10 16
ERBB2 -0.03 0.055 0.6 1 -0.32 13 14
ERBB3 0.006 0.11 -10000 0 -0.42 32 32
SHC1 0.028 0.025 -10000 0 -0.42 1 1
RAC1 0.035 0.006 -10000 0 -10000 0 0
apoptosis 0.005 0.03 0.33 2 -0.21 4 6
STAT3 (dimer) 0.005 0.17 -10000 0 -0.87 18 18
RNF41 -0.013 0.016 -10000 0 -0.24 2 2
FRAP1 -0.009 0.012 -10000 0 -0.26 1 1
RAC1-CDC42/GTP -0.015 0.06 -10000 0 -0.2 28 28
ErbB2/ErbB2/HSP90 (dimer) -0.025 0.04 -10000 0 -0.26 13 13
CHRNA1 -0.004 0.16 0.33 1 -0.41 45 46
myelination -0.023 0.083 0.26 12 -0.32 7 19
PPP3CB -0.034 0.072 0.24 1 -0.25 30 31
KRAS 0.028 0.054 -10000 0 -0.42 7 7
RAC1-CDC42/GDP 0.039 0.096 0.25 1 -0.25 25 26
NRG2 0.025 0.061 -10000 0 -0.42 9 9
mol:GDP 0.002 0.072 0.18 3 -0.26 26 29
SOS1 0.035 0.021 -10000 0 -0.42 1 1
MAP2K2 -0.001 0.11 0.26 10 -0.32 25 35
SRC 0.033 0.029 -10000 0 -0.42 2 2
mol:cAMP -0.001 0.001 -10000 0 -10000 0 0
PTPN11 -0.035 0.076 0.26 1 -0.26 29 30
MAP2K1 -0.029 0.21 -10000 0 -0.6 33 33
heart morphogenesis -0.003 0.087 -10000 0 -0.26 35 35
RAS family/GDP 0.041 0.11 0.26 1 -0.29 18 19
GRB2 0.033 0.011 -10000 0 -10000 0 0
PRKACA 0.014 0.054 -10000 0 -0.67 3 3
CHRNE 0.009 0.018 -10000 0 -10000 0 0
HSP90AA1 0 0 -10000 0 -10000 0 0
activation of caspase activity -0.003 0.021 0.3 2 -10000 0 2
nervous system development -0.003 0.087 -10000 0 -0.26 35 35
CDC42 0.035 0.008 -10000 0 -10000 0 0
RXR and RAR heterodimerization with other nuclear receptor

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.027 0.1 0.9 1 -0.78 1 2
VDR 0.02 0.082 -10000 0 -0.42 17 17
FAM120B 0 0 -10000 0 -10000 0 0
RXRs/LXRs/DNA/9cRA 0.004 0.1 -10000 0 -0.27 49 49
RXRs/LXRs/DNA/Oxysterols 0.013 0.16 -10000 0 -0.42 49 49
MED1 0 0 -10000 0 -10000 0 0
mol:9cRA -0.001 0.019 -10000 0 -10000 0 0
RARs/THRs/DNA/Src-1 0.004 0.092 -10000 0 -0.24 48 48
RXRs/NUR77 0.055 0.08 -10000 0 -0.25 11 11
RXRs/PPAR 0.009 0.076 -10000 0 -0.26 27 27
NCOR2 0.036 0.005 -10000 0 -10000 0 0
VDR/VDR/Vit D3 0.015 0.058 -10000 0 -0.3 17 17
RARs/VDR/DNA/Vit D3 0.053 0.083 -10000 0 -0.23 35 35
RARA 0.03 0.042 -10000 0 -0.42 4 4
NCOA1 0.031 0.045 -10000 0 -0.42 5 5
VDR/VDR/DNA 0.02 0.082 -10000 0 -0.42 17 17
RARs/RARs/DNA/9cRA 0.041 0.063 -10000 0 -0.22 23 23
RARG 0.036 0.005 -10000 0 -10000 0 0
RPS6KB1 0.054 0.15 0.54 42 -10000 0 42
RARs/THRs/DNA/SMRT 0.005 0.09 -10000 0 -0.24 47 47
THRA 0.02 0.075 -10000 0 -0.42 14 14
mol:Bile acids 0 0 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.015 0.058 -10000 0 -0.3 17 17
RXRs/PPAR/9cRA/PGJ2/DNA 0.039 0.083 -10000 0 -0.24 15 15
NR1H4 0.035 0.021 -10000 0 -0.42 1 1
RXRs/LXRs/DNA 0.059 0.11 -10000 0 -0.25 14 14
NR1H2 0.029 0.031 -10000 0 -10000 0 0
NR1H3 0.026 0.052 -10000 0 -0.43 4 4
RXRs/VDR/DNA/Vit D3 0.044 0.084 -10000 0 -0.24 19 19
NR4A1 0.034 0.021 -10000 0 -0.42 1 1
mol:ATRA 0 0 -10000 0 -10000 0 0
RXRs/FXR/9cRA/MED1 0.026 0.063 -10000 0 -0.21 16 16
RXRG 0.017 0.06 -10000 0 -0.43 7 7
RXR alpha/CCPG 0.021 0.029 -10000 0 -0.31 2 2
RXRA 0.028 0.042 -10000 0 -0.44 2 2
RXRB 0.027 0.044 -10000 0 -0.42 2 2
THRB 0.024 0.07 -10000 0 -0.42 12 12
PPARG 0.012 0.093 -10000 0 -0.42 22 22
PPARD 0.036 0.006 -10000 0 -10000 0 0
TNF -0.001 0.19 -10000 0 -0.78 18 18
mol:Oxysterols -0.001 0.017 -10000 0 -10000 0 0
cholesterol transport 0.014 0.16 -10000 0 -0.42 49 49
PPARA 0.032 0.03 -10000 0 -0.42 2 2
mol:Vit D3 0 0 -10000 0 -10000 0 0
RARB 0.015 0.089 -10000 0 -0.42 20 20
RXRs/NUR77/BCL2 -0.02 0.097 -10000 0 -0.22 84 84
SREBF1 -0.045 0.29 -10000 0 -0.92 46 46
RXRs/RXRs/DNA/9cRA 0.04 0.083 -10000 0 -0.24 16 16
ABCA1 -0.007 0.22 -10000 0 -0.95 17 17
RARs/THRs 0.063 0.1 -10000 0 -0.24 45 45
RXRs/FXR 0.056 0.081 -10000 0 -0.25 12 12
BCL2 -0.057 0.18 -10000 0 -0.42 99 99
Ras signaling in the CD4+ TCR pathway

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 0.018 0.14 -9999 0 -0.33 46 46
MAP3K8 0.003 0.11 -9999 0 -0.42 32 32
FOS 0.021 0.097 -9999 0 -0.42 7 7
PRKCA 0.025 0.022 -9999 0 -10000 0 0
PTPN7 0.02 0.032 -9999 0 -0.44 1 1
HRAS 0.032 0.036 -9999 0 -0.42 3 3
PRKCB -0.002 0.006 -9999 0 -0.017 73 73
NRAS 0.029 0.054 -9999 0 -0.42 7 7
RAS family/GTP 0.05 0.055 -9999 0 -0.23 15 15
MAPK3 0.028 0.067 -9999 0 -0.44 6 6
MAP2K1 0.009 0.064 -9999 0 -0.23 8 8
ELK1 0.025 0.038 -9999 0 -0.42 2 2
BRAF 0.006 0.047 -9999 0 -0.35 7 7
mol:GTP -0.001 0.002 -9999 0 -0.005 73 73
MAPK1 0.013 0.099 -9999 0 -0.41 18 18
RAF1 0.01 0.023 -9999 0 -0.24 1 1
KRAS 0.028 0.054 -9999 0 -0.42 7 7
EPO signaling pathway

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.003 0.14 -10000 0 -0.42 2 2
CRKL 0 0.076 0.2 13 -0.23 12 25
mol:DAG 0.019 0.08 0.25 2 -10000 0 2
HRAS 0.023 0.099 0.27 19 -10000 0 19
MAPK8 0.037 0.073 0.2 56 -0.25 2 58
RAP1A 0.001 0.077 0.24 5 -0.23 12 17
GAB1 0 0.076 0.23 4 -0.24 12 16
MAPK14 0.037 0.071 0.2 54 -10000 0 54
EPO 0.023 0.027 -10000 0 -10000 0 0
PLCG1 0.019 0.081 0.25 2 -10000 0 2
EPOR/TRPC2/IP3 Receptors 0.026 0.028 -10000 0 -10000 0 0
RAPGEF1 0.036 0.004 -10000 0 -10000 0 0
EPO/EPOR (dimer)/SOCS3 0.046 0.052 -10000 0 -0.27 4 4
GAB1/SHC/GRB2/SOS1 0.029 0.075 0.29 1 -0.2 8 9
EPO/EPOR (dimer) 0.037 0.039 -10000 0 -10000 0 0
IRS2 -0.009 0.087 0.21 10 -0.25 30 40
STAT1 -0.003 0.13 0.26 2 -0.28 63 65
STAT5B 0.021 0.081 0.26 1 -0.26 2 3
cell proliferation 0.014 0.079 0.19 76 -0.24 2 78
GAB1/SHIP/PIK3R1/SHP2/SHC 0.009 0.074 -10000 0 -0.21 22 22
TEC 0.001 0.076 0.25 4 -0.22 12 16
SOCS3 0.028 0.046 -10000 0 -0.42 5 5
STAT1 (dimer) -0.001 0.13 0.26 2 -0.28 63 65
JAK2 0.028 0.036 -10000 0 -0.44 2 2
PIK3R1 0.019 0.08 -10000 0 -0.42 16 16
EPO/EPOR (dimer)/JAK2 0.036 0.089 0.22 3 -0.17 40 43
EPO/EPOR 0.037 0.039 -10000 0 -10000 0 0
LYN 0.021 0.027 -10000 0 -10000 0 0
TEC/VAV2 0.016 0.081 0.29 2 -0.22 11 13
elevation of cytosolic calcium ion concentration 0.026 0.028 -10000 0 -10000 0 0
SHC1 0.028 0.025 -10000 0 -0.42 1 1
EPO/EPOR (dimer)/LYN 0.044 0.053 -10000 0 -10000 0 0
mol:IP3 0.019 0.08 0.25 2 -10000 0 2
PI3K regualtory subunit polypeptide 1/IRS2/SHIP -0.005 0.095 0.29 1 -0.23 43 44
SH2B3 -0.003 0.009 -10000 0 -10000 0 0
NFKB1 0.038 0.072 0.2 56 -10000 0 56
EPO/EPOR (dimer)/JAK2/SOCS3 0.023 0.035 -10000 0 -0.21 6 6
PTPN6 -0.002 0.068 0.17 9 -0.18 26 35
TEC/VAV2/GRB2 0.028 0.084 0.3 2 -0.21 7 9
EPOR 0.026 0.028 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.028 0.076 0.3 1 -0.2 8 9
SOS1 0.035 0.021 -10000 0 -0.42 1 1
PLCG2 0.02 0.055 -10000 0 -0.42 7 7
CRKL/CBL/C3G 0.021 0.085 0.3 1 -0.23 10 11
VAV2 0.003 0.074 0.24 5 -0.24 7 12
CBL 0 0.071 0.23 4 -0.24 7 11
SHC/Grb2/SOS1 0.015 0.063 -10000 0 -0.2 5 5
STAT5A 0.019 0.082 0.26 1 -0.26 3 4
GRB2 0.033 0.011 -10000 0 -10000 0 0
STAT5 (dimer) 0.018 0.12 0.28 1 -0.31 44 45
LYN/PLCgamma2 0.03 0.043 -10000 0 -0.3 6 6
PTPN11 0.036 0.004 -10000 0 -10000 0 0
BTK -0.003 0.083 0.24 5 -0.24 20 25
BCL2 -0.11 0.33 -10000 0 -0.73 105 105
Syndecan-3-mediated signaling events

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.027 0.032 -9999 0 -0.42 2 2
Syndecan-3/Src/Cortactin 0.007 0.15 -9999 0 -0.48 27 27
Syndecan-3/Neurocan -0.018 0.12 -9999 0 -0.48 30 30
POMC 0.032 0.036 -9999 0 -0.42 3 3
EGFR -0.015 0.13 -9999 0 -0.42 49 49
Syndecan-3/EGFR -0.011 0.15 -9999 0 -0.51 31 31
AGRP 0.029 0.025 -9999 0 -0.42 1 1
NCSTN 0.028 0.025 -9999 0 -0.42 1 1
PSENEN 0.035 0.006 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B 0.025 0.067 -9999 0 -0.42 11 11
APH1A 0.031 0.036 -9999 0 -0.42 3 3
NCAN 0 0 -9999 0 -10000 0 0
long-term memory 0.018 0.12 -9999 0 -0.44 28 28
Syndecan-3/IL8 -0.007 0.14 -9999 0 -0.52 30 30
PSEN1 0.032 0.041 -9999 0 -0.42 4 4
Src/Cortactin 0.039 0.038 -9999 0 -0.3 4 4
FYN 0.027 0.054 -9999 0 -0.42 7 7
limb bud formation -0.015 0.12 -9999 0 -0.53 26 26
MC4R 0.034 0.022 -9999 0 -0.42 1 1
SRC 0.033 0.029 -9999 0 -0.42 2 2
PTN -0.029 0.15 -9999 0 -0.42 65 65
FGFR/FGF/Syndecan-3 -0.015 0.12 -9999 0 -0.53 26 26
neuron projection morphogenesis -0.031 0.12 -9999 0 -0.48 25 25
Syndecan-3/AgRP 0.009 0.13 -9999 0 -0.47 30 30
Syndecan-3/AgRP/MC4R 0.024 0.13 -9999 0 -0.48 27 27
Fyn/Cortactin 0.035 0.044 -9999 0 -0.3 6 6
SDC3 -0.016 0.12 -9999 0 -0.54 26 26
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration -0.006 0.14 -9999 0 -0.51 30 30
IL8 -0.004 0.12 -9999 0 -0.42 37 37
Syndecan-3/Fyn/Cortactin 0.019 0.13 -9999 0 -0.45 28 28
Syndecan-3/CASK -0.018 0.12 -9999 0 -0.48 30 30
alpha-MSH/MC4R 0.047 0.034 -9999 0 -0.3 4 4
Gamma Secretase 0.069 0.069 -9999 0 -0.22 13 13
Regulation of Telomerase

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex -0.072 0.23 -10000 0 -0.78 21 21
RAD9A 0.034 0.01 -10000 0 -10000 0 0
AP1 -0.025 0.15 -10000 0 -0.34 88 88
IFNAR2 0.028 0.03 -10000 0 -0.43 1 1
AKT1 -0.034 0.11 -10000 0 -0.24 60 60
ER alpha/Oestrogen -0.063 0.14 -10000 0 -0.3 132 132
NFX1/SIN3/HDAC complex 0.012 0.072 -10000 0 -0.35 12 12
EGF -0.069 0.19 -10000 0 -0.42 110 110
SMG5 0 0 -10000 0 -10000 0 0
SMG6 0 0 -10000 0 -10000 0 0
SP3/HDAC2 0.039 0.037 -10000 0 -0.3 1 1
TERT/c-Abl -0.061 0.22 -10000 0 -0.72 21 21
SAP18 0.033 0.01 -10000 0 -10000 0 0
MRN complex 0.048 0.044 -10000 0 -0.26 4 4
WT1 -0.025 0.14 -10000 0 -0.42 54 54
WRN 0.027 0.025 -10000 0 -0.42 1 1
SP1 0.026 0.033 -10000 0 -0.43 1 1
SP3 0.035 0.007 -10000 0 -10000 0 0
TERF2IP 0.03 0.014 -10000 0 -10000 0 0
Telomerase/Nucleolin -0.046 0.21 -10000 0 -0.63 24 24
Mad/Max 0.048 0.019 -10000 0 -10000 0 0
TERT -0.075 0.24 -10000 0 -0.82 21 21
CCND1 -0.15 0.44 -10000 0 -1.1 85 85
MAX 0.034 0.009 -10000 0 -10000 0 0
RBBP7 0.034 0.029 -10000 0 -0.42 2 2
RBBP4 0.034 0.021 -10000 0 -0.42 1 1
TERF2 0.027 0.031 -10000 0 -0.36 2 2
PTGES3 0.035 0.021 -10000 0 -0.42 1 1
SIN3A 0.035 0.007 -10000 0 -10000 0 0
Telomerase/911 0.021 0.069 -10000 0 -0.46 5 5
CDKN1B -0.028 0.14 -10000 0 -0.37 66 66
RAD1 0.033 0.029 -10000 0 -0.42 2 2
XRCC5 0.036 0.005 -10000 0 -10000 0 0
XRCC6 0.034 0.009 -10000 0 -10000 0 0
SAP30 0.03 0.046 -10000 0 -0.42 5 5
TRF2/PARP2 0.043 0.032 -10000 0 -0.28 2 2
UBE3A 0.034 0.029 -10000 0 -0.42 2 2
JUN -0.002 0.12 -10000 0 -0.42 39 39
E6 -0.001 0.004 -10000 0 -10000 0 0
HPV-16 E6/E6AP 0.02 0.027 -10000 0 -0.3 2 2
FOS -0.032 0.15 -10000 0 -0.42 66 66
IFN-gamma/IRF1 0.001 0.12 -10000 0 -0.3 70 70
PARP2 0.036 0.002 -10000 0 -10000 0 0
BLM 0.012 0.097 -10000 0 -0.42 24 24
Telomerase 0.012 0.044 0.18 1 -0.15 1 2
IRF1 0.016 0.083 -10000 0 -0.26 34 34
ESR1 -0.089 0.2 -10000 0 -0.42 132 132
KU/TER 0.05 0.015 -10000 0 -10000 0 0
ATM/TRF2 0.036 0.035 -10000 0 -0.18 2 2
ubiquitin-dependent protein catabolic process 0.023 0.06 -10000 0 -0.27 11 11
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.025 0.056 -10000 0 -0.28 7 7
HDAC1 0.034 0.021 -10000 0 -0.42 1 1
HDAC2 0.025 0.032 -10000 0 -0.42 1 1
ATM 0.02 0.025 0.19 2 -10000 0 2
SMAD3 0.011 0.044 -10000 0 -0.3 10 10
ABL1 0.036 0.005 -10000 0 -10000 0 0
MXD1 0.035 0.007 -10000 0 -10000 0 0
MRE11A 0.031 0.013 -10000 0 -10000 0 0
HUS1 0.035 0.006 -10000 0 -10000 0 0
RPS6KB1 0.031 0.013 -10000 0 -10000 0 0
TERT/NF kappa B1/14-3-3 -0.058 0.23 -10000 0 -0.74 22 22
NR2F2 -0.01 0.14 -10000 0 -0.42 49 49
MAPK3 0.008 0.032 -10000 0 -0.3 4 4
MAPK1 0.008 0.032 -10000 0 -0.3 4 4
TGFB1/TGF beta receptor Type II 0.035 0.021 -10000 0 -0.42 1 1
NFKB1 0.036 0.005 -10000 0 -10000 0 0
HNRNPC 0 0 -10000 0 -10000 0 0
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0.02 0.025 0.19 2 -10000 0 2
NBN 0.028 0.025 -10000 0 -0.42 1 1
EGFR -0.015 0.13 -10000 0 -0.42 49 49
mol:Oestrogen 0 0.002 -10000 0 -10000 0 0
EGF/EGFR -0.063 0.16 -10000 0 -0.31 152 152
MYC -0.002 0.1 -10000 0 -0.42 29 29
IL2 0.024 0.043 -10000 0 -0.42 3 3
KU 0.05 0.015 -10000 0 -10000 0 0
RAD50 0.032 0.041 -10000 0 -0.42 4 4
HSP90AA1 0 0 -10000 0 -10000 0 0
TGFB1 0.035 0.021 -10000 0 -0.42 1 1
TRF2/BLM 0.026 0.073 -10000 0 -0.28 25 25
FRAP1 0.035 0.007 -10000 0 -10000 0 0
KU/TERT -0.049 0.23 -10000 0 -0.72 22 22
SP1/HDAC2 0.038 0.043 -10000 0 -0.3 2 2
PINX1 0.028 0.015 -10000 0 -10000 0 0
Telomerase/EST1A -0.059 0.2 -10000 0 -0.62 25 25
Smad3/Myc 0.006 0.074 -10000 0 -0.25 35 35
911 complex 0.063 0.032 -10000 0 -0.26 2 2
IFNG -0.014 0.12 -10000 0 -0.34 56 56
Telomerase/PinX1 -0.057 0.2 -10000 0 -0.63 24 24
Telomerase/AKT1/mTOR/p70S6K -0.006 0.1 -10000 0 -0.43 15 15
SIN3B 0.036 0.005 -10000 0 -10000 0 0
YWHAE 0.032 0.012 -10000 0 -10000 0 0
Telomerase/EST1B -0.059 0.2 -10000 0 -0.62 25 25
response to DNA damage stimulus -0.001 0.033 0.13 1 -0.1 35 36
MRN complex/TRF2/Rap1 0.059 0.061 -10000 0 -0.27 4 4
TRF2/WRN 0.034 0.036 -10000 0 -0.28 3 3
Telomerase/hnRNP C1/C2 -0.059 0.2 -10000 0 -0.62 25 25
E2F1 0.021 0.057 -10000 0 -0.42 7 7
ZNFX1 0 0.001 -10000 0 -10000 0 0
PIF1 0 0 -10000 0 -10000 0 0
NCL 0.036 0.006 -10000 0 -10000 0 0
DKC1 0.036 0.003 -10000 0 -10000 0 0
telomeric DNA binding 0 0 -10000 0 -10000 0 0
Aurora A signaling

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A 0.032 0.055 -10000 0 -0.24 15 15
BIRC5 -0.002 0.12 -10000 0 -0.42 38 38
NFKBIA 0.018 0.051 0.25 15 -0.25 2 17
CPEB1 0.03 0.046 -10000 0 -0.42 5 5
AKT1 0.014 0.041 0.25 7 -0.25 2 9
NDEL1 0.032 0.012 -10000 0 -10000 0 0
Aurora A/BRCA1 0.028 0.047 -10000 0 -0.23 12 12
NDEL1/TACC3 0.042 0.049 -10000 0 -0.16 17 17
GADD45A 0.019 0.08 -10000 0 -0.42 16 16
GSK3B 0.039 0.016 -10000 0 -10000 0 0
PAK1/Aurora A 0.028 0.06 -10000 0 -0.24 18 18
MDM2 0.034 0.009 -10000 0 -10000 0 0
JUB 0.003 0.12 -10000 0 -0.42 35 35
TPX2 -0.007 0.083 -10000 0 -0.3 37 37
TP53 -0.004 0.093 -10000 0 -0.23 67 67
DLG7 -0.006 0.06 0.25 5 -0.18 39 44
AURKAIP1 0 0 -10000 0 -10000 0 0
ARHGEF7 0.032 0.011 -10000 0 -10000 0 0
G2 phase of mitotic cell cycle 0 0 -10000 0 -10000 0 0
Aurora A/NDEL1/TACC3 0.045 0.052 -10000 0 -0.17 17 17
G2/M transition of mitotic cell cycle 0.028 0.047 -10000 0 -0.22 12 12
AURKA 0.024 0.035 0.14 41 -10000 0 41
AURKB 0.001 0.06 -10000 0 -0.18 43 43
CDC25B 0.014 0.048 -10000 0 -0.29 5 5
G2/M transition checkpoint 0.018 0.069 -10000 0 -0.22 35 35
mRNA polyadenylation 0.033 0.035 -10000 0 -0.2 5 5
Aurora A/CPEB 0.033 0.035 -10000 0 -0.2 5 5
Aurora A/TACC1/TRAP/chTOG 0.05 0.078 -10000 0 -0.23 23 23
BRCA1 0.022 0.07 -10000 0 -0.42 12 12
centrosome duplication 0.028 0.06 -10000 0 -0.24 18 18
regulation of centrosome cycle 0.041 0.048 -10000 0 -0.16 17 17
spindle assembly 0.048 0.076 -10000 0 -0.23 23 23
TDRD7 0.027 0.064 -10000 0 -0.42 10 10
Aurora A/RasGAP/Survivin 0.034 0.08 -10000 0 -0.21 27 27
CENPA -0.005 0.084 -10000 0 -0.27 43 43
Aurora A/PP2A 0.042 0.029 -10000 0 -10000 0 0
meiosis 0 0 -10000 0 -10000 0 0
protein catabolic process 0.001 0.044 0.17 5 -0.24 1 6
negative regulation of DNA binding -0.006 0.097 -10000 0 -0.24 68 68
prophase 0 0 -10000 0 -10000 0 0
GIT1/beta-PIX 0.046 0.024 -10000 0 -0.3 1 1
RASA1 0.029 0.05 -10000 0 -0.42 6 6
Ajuba/Aurora A 0.019 0.069 -10000 0 -0.22 35 35
mitotic prometaphase 0.004 0.024 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.024 0.035 0.14 41 -10000 0 41
TACC1 0.011 0.089 -10000 0 -0.42 20 20
TACC3 0.017 0.087 -10000 0 -0.42 19 19
Aurora A/Antizyme1 0.037 0.025 -10000 0 -10000 0 0
Aurora A/RasGAP 0.038 0.042 -10000 0 -0.25 6 6
OAZ1 0.035 0.006 -10000 0 -10000 0 0
RAN 0.036 0.005 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
PRKACA 0.039 0.016 -10000 0 -10000 0 0
GIT1 0.034 0.022 -10000 0 -0.42 1 1
GIT1/beta-PIX/PAK1 0.044 0.068 -10000 0 -0.27 18 18
Importin alpha/Importin beta/TPX2 -0.007 0.082 -10000 0 -0.3 37 37
PPP2R5D 0.035 0.006 -10000 0 -10000 0 0
Aurora A/TPX2 0.008 0.052 -10000 0 -0.16 37 37
PAK1 0.015 0.085 -10000 0 -0.42 18 18
CKAP5 0.036 0.006 -10000 0 -10000 0 0
p75(NTR)-mediated signaling

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

<
Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.047 0.04 -10000 0 -0.3 6 6
Necdin/E2F1 0.013 0.11 -10000 0 -0.31 54 54
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E 0.031 0.11 -10000 0 -0.23 70 70
NGF (dimer)/p75(NTR)/BEX1 0.038